BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7-33. [PMID: 33433946 DOI: 10.3322/caac.21654] [Cited by in Crossref: 809] [Cited by in F6Publishing: 980] [Article Influence: 809.0] [Reference Citation Analysis]
Number Citing Articles
1 Caulfield JI, Kluger HM. Emerging Studies of Melanoma Brain Metastasis. Curr Oncol Rep 2022. [PMID: 35212922 DOI: 10.1007/s11912-022-01237-9] [Reference Citation Analysis]
2 El Masri J, Phadke S. Breast Cancer Epidemiology and Contemporary Breast Cancer Care: A Review of the Literature and Clinical Applications. Clin Obstet Gynecol 2022. [PMID: 35703213 DOI: 10.1097/GRF.0000000000000721] [Reference Citation Analysis]
3 Banerjee DK, Seijo Lebrón A, Baksi K. Glycotherapy: A New Paradigm in Breast Cancer Research. Biomolecules 2022;12:487. [DOI: 10.3390/biom12040487] [Reference Citation Analysis]
4 Yousefi B, Akbari H, Hershman M, Kawakita S, Fernandes HC, Ibarra-castanedo C, Ahadian S, Maldague XPV. SPAER: Sparse Deep Convolutional Autoencoder Model to Extract Low Dimensional Imaging Biomarkers for Early Detection of Breast Cancer Using Dynamic Thermography. Applied Sciences 2021;11:3248. [DOI: 10.3390/app11073248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Xu M, Fang L, Guo X, Qin H, Sun R, Ning Z, Wang A. RIOK3 promotes pancreatic ductal adenocarcinoma cell invasion and metastasis by stabilizing FAK. Heliyon 2022;8:e10116. [DOI: 10.1016/j.heliyon.2022.e10116] [Reference Citation Analysis]
6 Nathwani N, Bell J, Cherepanov D, Sowell FG, Shah R, McCarrier K, Hari P. Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myeloma. Support Care Cancer 2022. [PMID: 35364733 DOI: 10.1007/s00520-022-06979-7] [Reference Citation Analysis]
7 Gu P, Yang D, Zhu J, Zhang M, He X. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis. Math Biosci Eng 2021;18:3180-96. [PMID: 34198380 DOI: 10.3934/mbe.2021158] [Reference Citation Analysis]
8 Sun Y, Fang K, Hu X, Yang J, Jiang Z, Feng L, Li R, Rao Y, Shi S, Dong C. NIR-light-controlled G-quadruplex hydrogel for synergistically enhancing photodynamic therapy via sustained delivery of metformin and catalase-like activity in breast cancer. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100375] [Reference Citation Analysis]
9 Nehlsen AD, Sindhu KK, Jones BM, Lehrer EJ, Rowley JP, Bakst RL. Moving beyond Definitive Therapy: Increasing Physical Activity in Survivors of Cancers of the Head and Neck. Current Oncology 2022;29:1213-22. [DOI: 10.3390/curroncol29020103] [Reference Citation Analysis]
10 Zhao B, Tang M, Lv Y. Shear stress regulates the migration of suspended breast cancer cells by nuclear lamina protein A/C and large tumor suppressor through yes-associated protein. Hum Cell 2022. [PMID: 34984662 DOI: 10.1007/s13577-021-00666-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Katsaros D, Hawthorne J, Patel J, Pothier K, Aungst T, Franzese C. Optimizing Social Support in Oncology with Digital Platforms (Preprint). JMIR Cancer. [DOI: 10.2196/36258] [Reference Citation Analysis]
12 Song X, Zhang S, Li S, Wang Y, Zhang X, Xue F. Expression of the CLCA4 Gene in Esophageal Carcinoma and Its Impact on the Biologic Function of Esophageal Carcinoma Cells. J Oncol 2021;2021:1649344. [PMID: 34194494 DOI: 10.1155/2021/1649344] [Reference Citation Analysis]
13 Cozzi S, Augugliaro M, Ciammella P, Botti A, Trojani V, Najafi M, Blandino G, Ruggieri MP, Giaccherini L, Alì E, Iori F, Sardaro A, Finocchi Ghersi S, Deantonio L, Gutierrez Miguelez C, Iotti C, Bardoscia L. The Role of Interstitial Brachytherapy for Breast Cancer Treatment: An Overview of Indications, Applications, and Technical Notes. Cancers (Basel) 2022;14:2564. [PMID: 35626168 DOI: 10.3390/cancers14102564] [Reference Citation Analysis]
14 Morshed N, Zhan FB. Racial/ethnic, social characteristics and geographic disparities of childhood cancer late-stage diagnosis in Texas, 2005 to 2014. Annals of GIS 2021;27:329-40. [DOI: 10.1080/19475683.2021.1981999] [Reference Citation Analysis]
15 Maran M, Gangadharan S, Emerson IA. Molecular dynamics study of quercetin families and its derivative compounds from Carica papaya leaf as breast cancer inhibitors. Chemical Physics Letters 2022;793:139470. [DOI: 10.1016/j.cplett.2022.139470] [Reference Citation Analysis]
16 Coulson-Gilmer C, Morgan RD, Nelson L, Barnes BM, Tighe A, Wardenaar R, Spierings DCJ, Schlecht H, Burghel GJ, Foijer F, Desai S, McGrail JC, Taylor SS. Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models. J Exp Clin Cancer Res 2021;40:323. [PMID: 34656146 DOI: 10.1186/s13046-021-02124-0] [Reference Citation Analysis]
17 Zhang Y, Guo S, Wang C, Liu X, Liu Y, Shang H, Yang P, Wang L, Zhai J, Li X, Jia Y. Acupuncture for prostatectomy incontinence: study protocol for a multicenter single-blind randomized parallel controlled trial. Trials 2022;23:9. [PMID: 34983588 DOI: 10.1186/s13063-021-05805-5] [Reference Citation Analysis]
18 Jenkins FJ, Minas TZ, Tang W, Dorsey TH, Ambs S. Human herpesvirus 8 infection is associated with prostate cancer among IFNL4-ΔG carriers. Prostate Cancer Prostatic Dis. [DOI: 10.1038/s41391-022-00546-1] [Reference Citation Analysis]
19 Zhao Y, Roy S, Wang C, Goel A. A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer. Pharmaceuticals 2022;15:262. [DOI: 10.3390/ph15030262] [Reference Citation Analysis]
20 Ma H, Yao D, Cheng J, Wang W, Liu B, Yu Y, Xing W, Qin J. Older patients more likely to die from cancer-related diseases than younger with stage IA non-small cell lung cancer: a SEER database analysis. J Thorac Dis 2022;14:2178-86. [PMID: 35813764 DOI: 10.21037/jtd-22-505] [Reference Citation Analysis]
21 Jiang J, Lu Y, Zhang F, Pan T, Zhang Z, Wan Y, Ren X, Zhang R. Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma. BMC Cancer 2022;22:632. [PMID: 35676688 DOI: 10.1186/s12885-022-09696-w] [Reference Citation Analysis]
22 Vaughn JL, Soroka O, Epperla N, Safford M, Pinheiro LC. Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States. Cancer Med 2021;10:7330-8. [PMID: 34469069 DOI: 10.1002/cam4.4249] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Wang D, Wan Z, Yang Q, Chen J, Liu Y, Lu F, Tang J. Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes. Drug Deliv 2022;29:702-13. [PMID: 35236203 DOI: 10.1080/10717544.2022.2044937] [Reference Citation Analysis]
24 Chen X, Ma H, Mo S, Zhang Y, Lu Z, Yu S, Chen J. Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma. Front Immunol 2022;13:942154. [DOI: 10.3389/fimmu.2022.942154] [Reference Citation Analysis]
25 Zhang L, Yi H, Chen J, Li H, Luo Y, Cheng T, Yang H, Jiang Z, Pan C, Nair RS. Neutrophil Extracellular Traps Facilitate A549 Cell Invasion and Migration in a Macrophage-Maintained Inflammatory Microenvironment. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/8316525] [Reference Citation Analysis]
26 Wang J, Xing W, Lin Y, Uskenbayeva N, Yan H, Xu Y, Fang L. Blocking PARP activity with the inhibitor veliparib enhances radiotherapy sensitivity in endometrial carcinoma. J Clin Lab Anal 2022;:e24435. [PMID: 35421273 DOI: 10.1002/jcla.24435] [Reference Citation Analysis]
27 Qu H, Wang Z, Zhang Y, Zhao B, Jing S, Zhang J, Ye C, Xue Y, Yang L, Xu Z. Long-Read Nanopore Sequencing Identifies Mismatch Repair-Deficient Related Genes with Alternative Splicing in Colorectal Cancer. Disease Markers 2022;2022:1-16. [DOI: 10.1155/2022/4433270] [Reference Citation Analysis]
28 Yang GJ, Wu J, Miao L, Zhu MH, Zhou QJ, Lu XJ, Lu JF, Leung CH, Ma DL, Chen J. Pharmacological inhibition of KDM5A for cancer treatment. Eur J Med Chem 2021;226:113855. [PMID: 34555614 DOI: 10.1016/j.ejmech.2021.113855] [Reference Citation Analysis]
29 Chang L, Li J, Zhang R. Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022. [DOI: 10.1016/j.bbcan.2022.188729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zheng D, Fu W, Jin L, Jiang X, Jiang W, Guan Y, Hao R. The Overexpression and Clinical Significance of AP1S1 in Breast Cancer. CMAR 2022;Volume 14:1475-92. [DOI: 10.2147/cmar.s346519] [Reference Citation Analysis]
31 Ma Y, Sender S, Sekora A, Kong W, Bauer P, Ameziane N, Al-Ali R, Krake S, Radefeldt M, Weiss FU, Lerch MM, Parveen A, Zechner D, Junghanss C, Murua Escobar H. The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines. Int J Mol Sci 2022;23:4295. [PMID: 35457111 DOI: 10.3390/ijms23084295] [Reference Citation Analysis]
32 Lim YJ, Kong M. Population-based comparative survival analysis of surgery with or without adjuvant radiotherapy and non-operative primary radiotherapy in patients with early-stage oral tongue squamous cell carcinoma. PLoS One 2021;16:e0259384. [PMID: 34762670 DOI: 10.1371/journal.pone.0259384] [Reference Citation Analysis]
33 Liao G, Fu Y, Arooj S, Khan M, Li X, Yan M, Li Z, Yang H, Zheng T, Xu R. Impact of Previous Local Treatment for Brain Metastases on Response to Molecular Targeted Therapy in BRAF-Mutant Melanoma Brain Metastasis: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:704890. [DOI: 10.3389/fonc.2022.704890] [Reference Citation Analysis]
34 [DOI: 10.1109/icoei53556.2022.9777165] [Reference Citation Analysis]
35 Abu-Khalaf M, Wang C, Zhang Z, Luo R, Chong W, Silver DP, Fellin F, Jaslow R, Lopez A, Cescon T, Jiang W, Myers R, Wei Q, Li B, Cristofanilli M, Yang H. Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism. Cancers (Basel) 2022;14:2872. [PMID: 35740538 DOI: 10.3390/cancers14122872] [Reference Citation Analysis]
36 Nozawa H, Kawai K, Sasaki K, Murono K, Emoto S, Yokoyama Y, Abe S, Kishikawa J, Nagai Y, Sonoda H, Anzai H, Ozawa T, Ishihara S. Women are predisposed to early dose-limiting toxicities during adjuvant CAPOX for colorectal cancer. Int J Clin Pract 2021;75:e14863. [PMID: 34516723 DOI: 10.1111/ijcp.14863] [Reference Citation Analysis]
37 Cardin DB, Gilbert J, Whisenant JG, Ayers GD, Jalikis F, Dahlman KB, O'neal JF, Revetta F, Shi C, Berlin J. Safety and Efficacy of Avelumab in Small Bowel Adenocarcinoma. Clinical Colorectal Cancer 2022. [DOI: 10.1016/j.clcc.2022.03.003] [Reference Citation Analysis]
38 Giannini V, Pusceddu L, Defeudis A, Nicoletti G, Cappello G, Mazzetti S, Sartore-Bianchi A, Siena S, Vanzulli A, Rizzetto F, Fenocchio E, Lazzari L, Bardelli A, Marsoni S, Regge D. Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases. Cancers (Basel) 2022;14:241. [PMID: 35008405 DOI: 10.3390/cancers14010241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Hsu FC, Roberts NJ, Childs E, Porter N, Rabe KG, Borgida A, Ukaegbu C, Goggins MG, Hruban RH, Zogopoulos G, Syngal S, Gallinger S, Petersen GM, Klein AP. Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene. JAMA Oncol 2021. [PMID: 34529012 DOI: 10.1001/jamaoncol.2021.3701] [Reference Citation Analysis]
40 Birge Ö, Bakır MS, Sağnıç S, Dinc C, Tuncer HA, Simsek T. A case of cranial bone metastasis after fertility-sparing approach in endometrial cancer. J Obstet Gynaecol 2022;:1-3. [PMID: 34996332 DOI: 10.1080/01443615.2021.2012440] [Reference Citation Analysis]
41 Liang ZQ, Zhong LY, Li J, Shen JH, Tu XY, Zhong ZH, Zeng JJ, Chen JH, Wei ZX, Dang YW, Huang SN, Chen G. Clinicopathological significance and underlying molecular mechanism of downregulation of basonuclin 1 expression in ovarian carcinoma. Exp Biol Med (Maywood) 2021;:15353702211052036. [PMID: 34644201 DOI: 10.1177/15353702211052036] [Reference Citation Analysis]
42 Xu S, Liu Y, Zhang T, Zheng J, Lin W, Cai J, Zou J, Chen Y, Xie Y, Chen Y, Li Z. The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019. Front Oncol 2021;11:689562. [PMID: 34094989 DOI: 10.3389/fonc.2021.689562] [Reference Citation Analysis]
43 Szabo Z, Juhasz E, Schally AV, Dezso B, Huga S, Hernadi Z, Halmos G, Kiss C. Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Primary Human Endometrial Carcinomas: Novel Therapeutic Approaches. Molecules 2022;27:2671. [PMID: 35566020 DOI: 10.3390/molecules27092671] [Reference Citation Analysis]
44 Wang D, Zhang P, Liu Z, Xing' Y, Xiao Y. NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2. Cancers 2022;14:3782. [DOI: 10.3390/cancers14153782] [Reference Citation Analysis]
45 Zhang K, Xu PL, Li YJ, Dong S, Gao HF, Chen LY, Chen H, Chen Z. Comprehensive analysis of expression profile and prognostic significance of interferon regulatory factors in pancreatic cancer. BMC Genom Data 2022;23:5. [PMID: 35012444 DOI: 10.1186/s12863-021-01019-5] [Reference Citation Analysis]
46 Goldstein MR, Mascitelli L. Can Bacillus Calmette-Guérin (BCG) treat localized prostate cancer? Medical Hypotheses 2022. [DOI: 10.1016/j.mehy.2022.110840] [Reference Citation Analysis]
47 Su Z, Dong S, Zhao SC, Liu K, Tan Y, Jiang X, Assaraf YG, Qin B, Chen ZS, Zou C. Novel nanomedicines to overcome cancer multidrug resistance. Drug Resist Updat 2021;58:100777. [PMID: 34481195 DOI: 10.1016/j.drup.2021.100777] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Alrawashdh N, Sweasy J, Erstad B, McBride A, Persky DO, Abraham I. Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985-2017). Ann Hematol 2021. [PMID: 34279676 DOI: 10.1007/s00277-021-04600-1] [Reference Citation Analysis]
49 Abdel-Razeq H, Tamimi F, Abujamous L, Edaily S, Abunasser M, Bater R, Salama O. Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives. Cancer Manag Res 2021;13:4597-604. [PMID: 34135636 DOI: 10.2147/CMAR.S316470] [Reference Citation Analysis]
50 Duréndez-sáez E, Calabuig-fariñas S, Torres-martínez S, Moreno-manuel A, Herreros-pomares A, Escorihuela E, Mosqueda M, Gallach S, Guijarro R, Serna E, Suárez-cabrera C, Paramio JM, Blasco A, Camps C, Jantus-lewintre E. Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer. Cancers 2022;14:3216. [DOI: 10.3390/cancers14133216] [Reference Citation Analysis]
51 de Vries M, Klaassen NJM, Morsink NC, van Nimwegen SA, Nijsen JFW, van den Dobbelsteen JJ. Dedicated holmium microsphere administration device for MRI-guided interstitial brain microbrachytherapy. Med Eng Phys 2021;96:13-21. [PMID: 34565548 DOI: 10.1016/j.medengphy.2021.07.009] [Reference Citation Analysis]
52 Williams V, Brown N, Moore JX, Farrell D, Perumean-Chaney S, Schleicher E, Fontaine K, Demark-Wahnefried W, Pekmezi D. Web-Based Lifestyle Interventions for Survivors of Cancer: Usability Study. JMIR Form Res 2022;6:e30974. [PMID: 35188468 DOI: 10.2196/30974] [Reference Citation Analysis]
53 Hu J, Brendle SA, Li JJ, Walter V, Cladel NM, Cooper T, Shearer DA, Balogh KK, Christensen ND. Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model. Viruses 2022;14:980. [DOI: 10.3390/v14050980] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Liu J, Zou T, Yin J, Wang Z, Liu C, Huang H, Ding F, Lei M, Wang Y, Liu M, Liu Z, Tan L, Chen J. Genetic Variants in Double-Strand Break Repair Pathway Genes to Predict Platinum-Based Chemotherapy Prognosis in Patients With Lung Cancer. Front Pharmacol 2022;13:915822. [DOI: 10.3389/fphar.2022.915822] [Reference Citation Analysis]
55 Liu J, Qian B, Zhou L, Shen G, Tan Y, Liu S, Zhao Z, Shi J, Qi W, Zhou T, Yang X, Gao G, Yang Z. IL25 Enhanced Colitis-Associated Tumorigenesis in Mice by Upregulating Transcription Factor GLI1. Front Immunol 2022;13:837262. [PMID: 35359953 DOI: 10.3389/fimmu.2022.837262] [Reference Citation Analysis]
56 Lee S, Mendoza TR, Burner DN, Muldong MT, Wu CCN, Arreola-Villanueva C, Zuniga A, Greenburg O, Zhu WY, Murtadha J, Koutouan E, Pineda N, Pham H, Kang SG, Kim HT, Pineda G, Lennon KM, Cacalano NA, Jamieson CHM, Kane CJ, Kulidjian AA, Gaasterland T, Jamieson CAM. Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids. Int J Mol Sci 2022;23:3203. [PMID: 35328625 DOI: 10.3390/ijms23063203] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Sarazin BA, Ihle CL, Owens P, Lynch ME. Mechanobiology of Bone Metastatic Cancer. Curr Osteoporos Rep 2021. [PMID: 34729693 DOI: 10.1007/s11914-021-00704-9] [Reference Citation Analysis]
58 Gallion LA, Wang Y, Massaro A, Yao M, Petersen BV, Zhang Q, Huang W, Carr AJ, Zhang Q, Allbritton NL. "Fix and Click" for Assay of Sphingolipid Signaling in Single Primary Human Intestinal Epithelial Cells. Anal Chem 2022. [PMID: 35020354 DOI: 10.1021/acs.analchem.1c03503] [Reference Citation Analysis]
59 Liu JA, Yang IY, Tsai EB. Artificial Intelligence (AI) for Lung Nodules: From the AJR Special Series on AI Applications. AJR Am J Roentgenol 2022. [PMID: 35544377 DOI: 10.2214/AJR.22.27487] [Reference Citation Analysis]
60 Zhang Y, Hua X, Shi H, Zhang L, Xiao H, Liang C. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma. Cancer Cell Int 2021;21:680. [PMID: 34923969 DOI: 10.1186/s12935-021-02364-2] [Reference Citation Analysis]
61 Zhan M, Xu T, Zheng H, He Z. Cost-Effectiveness Analysis of Pembrolizumab in Patients With Advanced Esophageal Cancer Based on the KEYNOTE-181 Study. Front Public Health 2022;10:790225. [PMID: 35309225 DOI: 10.3389/fpubh.2022.790225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Qian B, Huang S, Liao X, Wu J, Lin Q, Lin Y. Serratus anterior plane block reduces the prevalence of chronic postsurgical pain after modified radical mastectomy: A randomized controlled trial. J Clin Anesth 2021;74:110410. [PMID: 34175638 DOI: 10.1016/j.jclinane.2021.110410] [Reference Citation Analysis]
63 Nasser NJ, Klein J, Fenig E, Agbarya A. Automatic localization of the prostatic urethra for image guided radiation therapy. Tech Innov Patient Support Radiat Oncol 2021;19:1-6. [PMID: 34189284 DOI: 10.1016/j.tipsro.2021.05.002] [Reference Citation Analysis]
64 Ding C, Yu Z, Zhu J, Li X, Dai M, QiangHe. Construction and Validation of a Necroptosis-Related Gene Signature for Predicting Prognosis and Tumor Microenvironment of Pancreatic Cancer. Dis Markers 2022;2022:9737587. [PMID: 35756487 DOI: 10.1155/2022/9737587] [Reference Citation Analysis]
65 De Nunzio C, Franco A, Simone G, Tuderti G, Anceschi U, Brassetti A, Daneshmand S, Miranda G, Desai MM, Gill I, Abol-Enein H, Molinaro E, Nacchia A, Lombardo R, Leonardo C, Tubaro A. Validation of the COBRA nomogram for the prediction of cancer specific survival in patients treated with radical cystectomy for bladder cancer: An international wide cohort study. Eur J Surg Oncol 2021:S0748-7983(21)00466-2. [PMID: 33966945 DOI: 10.1016/j.ejso.2021.04.035] [Reference Citation Analysis]
66 Thompson R, Haws J, Rhodus NL, Ondrey FG. Patients with oral preneoplastic lesions and integration of dental pathology referrals. Am J Otolaryngol 2022;43:103270. [PMID: 34757252 DOI: 10.1016/j.amjoto.2021.103270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Wang G, Qu F, Liu S, Zhou J, Wang Y. Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma. Bioengineered 2021;12:4841-55. [PMID: 34334108 DOI: 10.1080/21655979.2021.1960130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Wang J, Hao S, Gu J, Rudd SG, Wang Y. The prognostic and clinicopathological significance of desmoglein 2 in human cancers: a systematic review and meta-analysis. PeerJ 2022;10:e13141. [PMID: 35345582 DOI: 10.7717/peerj.13141] [Reference Citation Analysis]
69 Lu F, Gao J, Hou Y, Cao K, Xia Y, Chen Z, Yu H, Chang L, Li W. Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures. Front Oncol 2022;12:876360. [DOI: 10.3389/fonc.2022.876360] [Reference Citation Analysis]
70 Xiong K, Wang G, Peng T, Zhou F, Chen S, Liu W, Ju L, Xiao Y, Qian K, Wang X. The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer. Cancer Cell Int 2021;21:461. [PMID: 34461908 DOI: 10.1186/s12935-021-02175-5] [Reference Citation Analysis]
71 Tu J, Yao Z, Wu W, Ju J, Xu Y, Liu Y. Perineural Invasion Is a Strong Prognostic Factor but Not a Predictive Factor of Response to Adjuvant Chemotherapy in Node-Negative Colon Cancer. Front Oncol 2021;11:663154. [PMID: 33859950 DOI: 10.3389/fonc.2021.663154] [Reference Citation Analysis]
72 Qiao X, Ma J, Knight T, Su Y, Edwards H, Polin L, Li J, Kushner J, Dzinic SH, White K, Wang J, Lin H, Wang Y, Wang L, Wang G, Taub JW, Ge Y. The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML. Blood Cancer J 2021;11:111. [PMID: 34099621 DOI: 10.1038/s41408-021-00502-7] [Reference Citation Analysis]
73 Raigon Ponferrada A, Guerrero Orriach JL, Molina Ruiz JC, Romero Molina S, Gómez Luque A, Cruz Mañas J. Breast Cancer and Anaesthesia: Genetic Influence. Int J Mol Sci 2021;22:7653. [PMID: 34299272 DOI: 10.3390/ijms22147653] [Reference Citation Analysis]
74 Mallya K, Gautam SK, Aithal A, Batra SK, Jain M. Modeling pancreatic cancer in mice for experimental therapeutics. Biochim Biophys Acta Rev Cancer 2021;1876:188554. [PMID: 33945847 DOI: 10.1016/j.bbcan.2021.188554] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Hou M, Chen J, Jiang W, Zeng G, Zhan J, Mao G, Li C. ATP fluorescent nanoprobe based on ZIF-90 and near-infrared dyes for imaging in tumor mice. Sensors and Actuators B: Chemical 2022;369:132286. [DOI: 10.1016/j.snb.2022.132286] [Reference Citation Analysis]
76 Yu H, Gao HY, Guo H, Wang GZ, Yang YQ, Hu Q, Liang LJ, Zhao Q, Xie DW, Rao Y, Zhou GB. Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells. Acta Pharmacol Sin 2022;43:692-702. [PMID: 34035487 DOI: 10.1038/s41401-021-00691-8] [Reference Citation Analysis]
77 Huang B, Chen Q, Allison D, El Khouli R, Peh KH, Mobley J, Anderson A, Durbin EB, Goodin D, Villano JL, Miller RW, Arnold SM, Kolesar JM. Molecular Tumor Board Review and Improved Overall Survival in Non-Small-Cell Lung Cancer. JCO Precis Oncol 2021;5:PO. [PMID: 34622117 DOI: 10.1200/PO.21.00210] [Reference Citation Analysis]
78 Zhai L, Zhang X, Cui M, Wang J. Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review. Front Oncol 2021;11:701758. [PMID: 34268126 DOI: 10.3389/fonc.2021.701758] [Reference Citation Analysis]
79 Geng Y, Su S, Cao L, Yang T, Ouyang W, Liu L, Wu B, Zhang Q, Lu B, Wang X. Effect of PD-1 Inhibitor Combined with X-Ray Irradiation on the Inflammatory Microenvironment and Lung Tissue Injury in Mice. JIR 2022;Volume 15:545-56. [DOI: 10.2147/jir.s350112] [Reference Citation Analysis]
80 He W, Liu Z, Tian Y, Li Y, Xu C, Xiao R, Hong P, Tang S, Ge L, Zhao X, Zhu G, Zhang H, Liu C, Ma L. Predictive Factors Affecting Metastasis of Small Renal Mass and Its Prognostic Analysis. Clin Med Insights Oncol 2022;16:11795549221075325. [PMID: 35197717 DOI: 10.1177/11795549221075325] [Reference Citation Analysis]
81 Fanale D, Corsini LR, Scalia R, Brando C, Cucinella A, Madonia G, Dimino A, Filorizzo C, Barraco N, Bono M, Fiorino A, Magrin L, Sciacchitano R, Perez A, Russo TDB, Pantuso G, Russo A, Bazan V. Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? Crit Rev Oncol Hematol 2022;:103597. [PMID: 35033663 DOI: 10.1016/j.critrevonc.2022.103597] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
82 Tanutit P, Pakdee W, Laohawiriyakamol T, Iamthanaporn K. Magnetic resonance imaging in differentiating between aggressive and non-aggressive bone tumors. Acta Radiol 2022;:2841851221082098. [PMID: 35306878 DOI: 10.1177/02841851221082098] [Reference Citation Analysis]
83 Burnett WJ, Burnett DM, Parkman G, Ramstead A, Contreras N, Gravley W, Holmen SL, Williams MA, VanBrocklin MW. Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy. Cancers (Basel) 2021;13:4462. [PMID: 34503272 DOI: 10.3390/cancers13174462] [Reference Citation Analysis]
84 Lin Z, Feng F, Liang J, Zeng H, Li J. lncRNA RP11-10A14.5: a potential prognosis biomarker for LUAD through regulation on proliferation and metastasis. Discov Oncol 2022;13:32. [PMID: 35575835 DOI: 10.1007/s12672-022-00493-2] [Reference Citation Analysis]
85 Xu M, Chang J, Wang W, Wang X, Wang X, Weng W, Tan C, Zhang M, Ni S, Wang L, Huang Z, Deng Z, Li W, Huang D, Sheng W. Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy. Front Immunol 2022;13:934083. [DOI: 10.3389/fimmu.2022.934083] [Reference Citation Analysis]
86 Macke AJ, Petrosyan A. Alcohol and Prostate Cancer: Time to Draw Conclusions. Biomolecules 2022;12:375. [DOI: 10.3390/biom12030375] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Wang Z, Li P, Pegram MD, Chen X. Editorial: Metabolic Abnormalities and Breast Cancer: Challenges From Bench to Bedside. Front Oncol 2022;12:890810. [PMID: 35574318 DOI: 10.3389/fonc.2022.890810] [Reference Citation Analysis]
88 Friedberg JW. An Oncology Renaissance. J Clin Oncol 2021;39:2737-8. [PMID: 34270346 DOI: 10.1200/JCO.21.01649] [Reference Citation Analysis]
89 Huang DW, Chou YY, Liu HH, Dai NT, Tzeng YS, Chen SG. Is 3-Dimensional Scanning Really Helpful in Implant-Based Breast Reconstruction?: A Prospective Study. Ann Plast Surg 2022;88:S85-91. [PMID: 35225853 DOI: 10.1097/SAP.0000000000003088] [Reference Citation Analysis]
90 Yan J, Liu M, Ma Y, Le K, Dong B, Li G. Inferences of carboplatin response-related signature by integrating multiomics data in ovarian serous cystadenocarcinoma. Exp Biol Med (Maywood). [DOI: 10.1177/15353702221083254] [Reference Citation Analysis]
91 Lan B, Zeng S, Zhang S, Ren X, Xing Y, Kutschick I, Pfeffer S, Frey B, Britzen-Laurent N, Grützmann R, Cordes N, Pilarsky C. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer. Cancers (Basel) 2022;14:326. [PMID: 35053488 DOI: 10.3390/cancers14020326] [Reference Citation Analysis]
92 Mohsenzadegan M, Razmi M, Vafaei S, Abolhasani M, Madjd Z, Saeednejad Zanjani L, Sharifi L. Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer. Sci Rep 2022;12:599. [PMID: 35022469 DOI: 10.1038/s41598-021-04510-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Williams RM, Kareff SA, Sackstein P, Roy T, Luta G, Kim C, Taylor KL, Tammemägi MC. Race & Sex Disparities Related to Low-Dose Computed Tomography Lung Cancer Screening Eligibility Criteria: A Lung Cancer Cases Review. Lung Cancer 2022. [DOI: 10.1016/j.lungcan.2022.05.008] [Reference Citation Analysis]
94 Zhang J, Xiao H, Song K, Li K, Yuan H, Yuan R, Yang J, Zhao Y, Chang Z, Zhao W. IndGOterm: a qualitative method for the identification of individually dysregulated GO terms in cancer. Briefings in Bioinformatics. [DOI: 10.1093/bib/bbac012] [Reference Citation Analysis]
95 Ren Z, Xu Y, Wang X, Ren M. KCNQ1OT1 affects cell proliferation, invasion, and migration through a miR-34a / Notch3 axis in breast cancer. Environ Sci Pollut Res Int 2022;29:28480-94. [PMID: 34993814 DOI: 10.1007/s11356-021-18434-x] [Reference Citation Analysis]
96 Zhang Q, Meng Y, Du M, Li S, Xin J, Ben S, Zhang Z, Gu D, Wang M. Evaluation of common genetic variants in vitamin E-related pathway genes and colorectal cancer susceptibility. Arch Toxicol 2021;95:2523-32. [PMID: 34009442 DOI: 10.1007/s00204-021-03078-0] [Reference Citation Analysis]
97 Wang C, Xu K, Wang R, Han X, Tang J, Guan X. Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer. J Exp Clin Cancer Res 2021;40:370. [PMID: 34801088 DOI: 10.1186/s13046-021-02164-6] [Reference Citation Analysis]
98 Patil P, Killedar S. Improving Gallic Acid and Quercetin Bioavailability by Polymeric Nanoparticle Formulation. Drug Dev Ind Pharm 2022;:1-22. [PMID: 35179095 DOI: 10.1080/03639045.2022.2043353] [Reference Citation Analysis]
99 Yan Q, Yi Y, Shen J, Shan F, Zhang Z, Yang G, Shi Y. Preliminary study of 3 T-MRI native T1-mapping radiomics in differential diagnosis of non-calcified solid pulmonary nodules/masses. Cancer Cell Int 2021;21:539. [PMID: 34663307 DOI: 10.1186/s12935-021-02195-1] [Reference Citation Analysis]
100 Haque MR, Wessel CR, Leary DD, Wang C, Bhushan A, Bishehsari F. Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment. Microsyst Nanoeng 2022;8:36. [PMID: 35450328 DOI: 10.1038/s41378-022-00370-6] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
101 Wang L, Zhang Z, Zhou X, Wu J, Hong Z. Comprehensive analysis of the expression and prognosis of YPEL family members in clear cell renal cell cancer. Oncol Rep 2022;48:134. [PMID: 35674183 DOI: 10.3892/or.2022.8345] [Reference Citation Analysis]
102 Wenhui Y, Zhongyu X, Kai C, Zhaopeng C, Jinteng L, Mengjun M, Zepeng S, Yunshu C, Peng W, Yanfeng W, Huiyong S. Variations in the Gut Microbiota in Breast Cancer Occurrence and Bone Metastasis. Front Microbiol 2022;13:894283. [DOI: 10.3389/fmicb.2022.894283] [Reference Citation Analysis]
103 Lan T, Luo M, Wei X. Mesenchymal stem/stromal cells in cancer therapy. J Hematol Oncol 2021;14:195. [PMID: 34789315 DOI: 10.1186/s13045-021-01208-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
104 Zhang Z, Xu Y, Zhang Y, Ma B, Ma Z, Han H. Antifouling and sensitive biosensor based on multifunctional peptide and urease@ZIFs for metal matrix protease-7. Sensors and Actuators B: Chemical 2022;364:131844. [DOI: 10.1016/j.snb.2022.131844] [Reference Citation Analysis]
105 Pungsrinont T, Kallenbach J, Baniahmad A. Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer. Int J Mol Sci 2021;22:11088. [PMID: 34681745 DOI: 10.3390/ijms222011088] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Wang J, Yang W, He X, Zhang Z, Zheng X. Assembling p53 Activating Peptide With CeO2 Nanoparticle to Construct a Metallo-Organic Supermolecule Toward the Synergistic Ferroptosis of Tumor. Front Bioeng Biotechnol 2022;10:929536. [DOI: 10.3389/fbioe.2022.929536] [Reference Citation Analysis]
107 Baquero J, Tang XH, Scognamiglio T, Gudas LJ. EZH2 Knockout in Oral Cavity Basal Epithelia Causes More Invasive Squamous Cell Carcinomas. Carcinogenesis 2021:bgab091. [PMID: 34614148 DOI: 10.1093/carcin/bgab091] [Reference Citation Analysis]
108 Dos Santos SP, Morissugui SS, Gimenez Martins APD, Fernandes GMM, Russo A, Galbiatti-Dias ALS, Castanhole-Nunes MMU, Francisco JLE, Pavarino ÉC, Goloni-Bertollo EM. Evaluation of molecular markers GSTM1 and GSTT1 and clinical factors in breast cancer: case-control study and literature review. Xenobiotica 2021;:1-27. [PMID: 34096444 DOI: 10.1080/00498254.2021.1938291] [Reference Citation Analysis]
109 Peng H, Wu X, Wen Y, Ao Y, Li Y, Guan W, Lin J, Li C, Liang H, He J, Liang W. Univariable and Multivariable Two-Sample Mendelian Randomization Investigating the Effects of Leisure Sedentary Behaviors on the Risk of Lung Cancer. Front Genet 2021;12:742718. [PMID: 34899835 DOI: 10.3389/fgene.2021.742718] [Reference Citation Analysis]
110 Cordeiro de Lima VC, Corassa M, Saldanha E, Freitas H, Arrieta O, Raez L, Samtani S, Ramos M, Rojas C, Burotto M, Chamorro DF, Recondo G, Ruiz-Patiño A, Más L, Zatarain-Barrón L, Mejía S, Nicolas Minata J, Martín C, Bautista Blaquier J, Motta Guerrero R, Aliaga-Macha C, Carracedo C, Ordóñez-Reyes C, Garcia-Robledo JE, Corrales L, Sotelo C, Ricaurte L, Santoyo N, Cuello M, Jaller E, Rodríguez J, Archila P, Bermudez M, Gamez T, Russo A, Viola L, Malapelle U, de Miguel Perez D, Rolfo C, Rosell R, Cardona AF. STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP). Lung Cancer 2022;170:114-21. [PMID: 35753125 DOI: 10.1016/j.lungcan.2022.06.010] [Reference Citation Analysis]
111 Pavić K, Beus M, Poje G, Uzelac L, Kralj M, Rajić Z. Synthesis and Biological Evaluation of Harmirins, Novel Harmine-Coumarin Hybrids as Potential Anticancer Agents. Molecules 2021;26:6490. [PMID: 34770906 DOI: 10.3390/molecules26216490] [Reference Citation Analysis]
112 Chen F, Zhao H, Li C, Li P, Zhang Q. An mTOR and DNA-PK dual inhibitor CC-115 hinders non-small cell lung cancer cell growth. Cell Death Discov 2022;8:293. [PMID: 35717530 DOI: 10.1038/s41420-022-01082-6] [Reference Citation Analysis]
113 Iwamoto H, Izumi K, Makino T, Mizokami A. Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer. Cancers 2022;14:1803. [DOI: 10.3390/cancers14071803] [Reference Citation Analysis]
114 Wang Q, Zhou Y, Huang J, Liu Z, Zhang W, Liu Q, Cheng JZ. Cascaded-Recalibrated Multiple Instance Deep Model for Pathologic-Level Lung Cancer Prediction in CT Images. Comput Intell Neurosci 2022;2022:9469234. [PMID: 35733559 DOI: 10.1155/2022/9469234] [Reference Citation Analysis]
115 Anghel SA, Ioniță-Mîndrican CB, Luca I, Pop AL. Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A Systematic Review. Cancers (Basel) 2021;13:4965. [PMID: 34638449 DOI: 10.3390/cancers13194965] [Reference Citation Analysis]
116 Chen X, Sheng L, Ma J, Qi D, Li X, Wang Z, Wu Z, Wong L, Huang JH, Wu E, Ma Q, Zhang D. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone provokes progression from chronic pancreatitis to pancreatic intraepithelial neoplasia. iScience 2022;25:103647. [PMID: 35028532 DOI: 10.1016/j.isci.2021.103647] [Reference Citation Analysis]
117 Sah S, Yun SR, Gaul DA, Botros A, Park EY, Kim O, Kim J, Fernández FM. Targeted Microchip Capillary Electrophoresis-Orbitrap Mass Spectrometry Metabolomics to Monitor Ovarian Cancer Progression. Metabolites 2022;12:532. [PMID: 35736465 DOI: 10.3390/metabo12060532] [Reference Citation Analysis]
118 Franceschini D, Fogliata A, Spoto R, Dominici L, Lo Faro L, Franzese C, Comito T, Lobefalo F, Reggiori G, Cozzi L, Sagona A, Gentile D, Scorsetti M. Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost. Radiother Oncol 2021;164:50-6. [PMID: 34537289 DOI: 10.1016/j.radonc.2021.09.006] [Reference Citation Analysis]
119 Yoon H, Shu X, Shidal C, Wu J, Blot WJ, Zheng W, Cai Q. Associations of Pre-Diagnostic Serum Levels of Total Bilirubin and Albumin With Lung Cancer Risk: Results From the Southern Community Cohort Study. Front Oncol 2022;12:895479. [DOI: 10.3389/fonc.2022.895479] [Reference Citation Analysis]
120 Wang M, Wang J, Tsui AYP, Li Z, Zhang Y, Zhao Q, Xing H, Wang X. Mechanisms of peripheral neurotoxicity associated with four chemotherapy drugs using human induced pluripotent stem cell-derived peripheral neurons. Toxicol In Vitro 2021;77:105233. [PMID: 34390763 DOI: 10.1016/j.tiv.2021.105233] [Reference Citation Analysis]
121 Ren W, Ren J, Zhang N, Liu X, Deng Y, Jiang Y, Yan B, Xiao X, Yu H. CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer. Biochemical and Biophysical Research Communications 2022;613:12-8. [DOI: 10.1016/j.bbrc.2022.04.114] [Reference Citation Analysis]
122 Wu SY, Chang CL, Chen CI, Huang CC. Comparison of Acute and Chronic Surgical Complications Following Robot-Assisted, Laparoscopic, and Traditional Open Radical Prostatectomy Among Men in Taiwan. JAMA Netw Open 2021;4:e2120156. [PMID: 34432012 DOI: 10.1001/jamanetworkopen.2021.20156] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Kreinbrink PJ, Lewis LM, Redmond KP, Takiar V. Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence. Curr Treat Options Oncol 2022;23:295-310. [PMID: 35226310 DOI: 10.1007/s11864-021-00936-y] [Reference Citation Analysis]
124 Tian Z, Hong B, Chen J, Tang Z. Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis. Front Oncol 2022;12:891724. [PMID: 35719978 DOI: 10.3389/fonc.2022.891724] [Reference Citation Analysis]
125 Wang Z, Xie F, Wu Y, Wang L, Bai Y, Long J, Wang X. Differential genes and scoring criteria among immunogenomic clusters of lower-grade gliomas. Int Immunopharmacol 2021;101:108376. [PMID: 34815191 DOI: 10.1016/j.intimp.2021.108376] [Reference Citation Analysis]
126 Fan B, Zhang Q, Wang N, Wang G. LncRNAs, the Molecules Involved in Communications With Colorectal Cancer Stem Cells. Front Oncol 2022;12:811374. [PMID: 35155247 DOI: 10.3389/fonc.2022.811374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Shi Z, Lu L, Resurreccion WK, Yang W, Wei J, Wang Q, Engelmann V, Zheng SL, Cooney KA, Isaacs WB, Helfand BT, Lu J, Xu J. Association of germline rare pathogenic mutations in guideline-recommended genes with prostate cancer progression: A meta-analysis. Prostate 2021. [PMID: 34674288 DOI: 10.1002/pros.24252] [Reference Citation Analysis]
128 Gähler A, Trufa DI, Chiriac MT, Tausche P, Hohenberger K, Brunst A, Rauh M, Geppert CI, Rieker RJ, Krammer S, Leberle A, Neurath MF, Sirbu H, Hartmann A, Finotto S. Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma. Front Oncol 2022;12:873293. [DOI: 10.3389/fonc.2022.873293] [Reference Citation Analysis]
129 Arend RC, Goel N, Roane BM, Foxall ME, Dholakia J, Londoño AI, Wall JA, Leath CA 3rd, Huh WK. Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort study. Gynecol Oncol 2021:S0090-8258(21)00579-5. [PMID: 34372972 DOI: 10.1016/j.ygyno.2021.07.017] [Reference Citation Analysis]
130 Neill T, Iozzo RV. The Role of Decorin Proteoglycan in Mitophagy. Cancers (Basel) 2022;14:804. [PMID: 35159071 DOI: 10.3390/cancers14030804] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Wang Z, He D, Chen C, Liu X, Ke N. Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report. Front Oncol 2021;11:801320. [PMID: 35145907 DOI: 10.3389/fonc.2021.801320] [Reference Citation Analysis]
132 Jacob C, Menon GC. Pathological categorization of lung carcinoma from multimodality images using convolutional neural networks. Int J Imaging Syst Technol. [DOI: 10.1002/ima.22684] [Reference Citation Analysis]
133 Lokeshwar SD, Lopez M, Sarcan S, Aguilar K, Morera DS, Shaheen DM, Lokeshwar BL, Lokeshwar VB. Molecular Oncology of Bladder Cancer from Inception to Modern Perspective. Cancers (Basel) 2022;14:2578. [PMID: 35681556 DOI: 10.3390/cancers14112578] [Reference Citation Analysis]
134 Zakaria A, Al-Share B, Klapman JB, Dam A. The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Cancer. Cancers (Basel) 2022;14:1373. [PMID: 35326524 DOI: 10.3390/cancers14061373] [Reference Citation Analysis]
135 Tang CH, Qin L, Gao YC, Chen TY, Xu K, Liu T, Ren T. APE1 shRNA-loaded cancer stem cell-derived extracellular vesicles reverse Erlotinib resistance in non-small cell lung cancer via the IL-6/STAT3 signalling. Clin Transl Med 2022;12:e876. [PMID: 35605028 DOI: 10.1002/ctm2.876] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Lodestijn SC, van Neerven SM, Vermeulen L, Bijlsma MF. Stem Cells in the Exocrine Pancreas during Homeostasis, Injury, and Cancer. Cancers (Basel) 2021;13:3295. [PMID: 34209288 DOI: 10.3390/cancers13133295] [Reference Citation Analysis]
137 Gudagunti FD, Gundlakunta SG, Lima IT. Dielectrophoresis-Based Biosensor for Detection of the Cancer Biomarkers CEA and CA 242 in Serum. Chemosensors 2022;10:104. [DOI: 10.3390/chemosensors10030104] [Reference Citation Analysis]
138 Joshi S, Raj KA, Rao MR, Ghosh R. An electronic biosensor based on semiconducting tetrazine polymer immobilizing matrix coated on rGO for carcinoembryonic antigen. Sci Rep 2022;12:3006. [PMID: 35194116 DOI: 10.1038/s41598-022-06976-0] [Reference Citation Analysis]
139 Kim DH, Kim NI, Jung EK, Lee JK. Lung Adenocarcinoma Metastasis to the Vocal Cord. Ear Nose Throat J 2022;:1455613221107689. [PMID: 35722943 DOI: 10.1177/01455613221107689] [Reference Citation Analysis]
140 Yang H, Jiang Q. A multi-omics-based investigation of the immunological and prognostic impact of necroptosis-related genes in patients with hepatocellular carcinoma. J Clin Lab Anal 2022;:e24346. [PMID: 35293027 DOI: 10.1002/jcla.24346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Markt SC, Booker BD, Bensken W, Schiltz NK, Schumacher FR, Rose J, Cooper G, Selfridge JE, Koroukian SM. Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer. Cancer Med 2022. [PMID: 35837788 DOI: 10.1002/cam4.4995] [Reference Citation Analysis]
142 Yang S, Yu L, Zhang C, Xu M, Tian Q, Cui X, Liu Y, Yu S, Cao M, Zhang W. Effects of decision aids on breast reconstruction: A systematic review and meta-analysis of randomised controlled trials. J Clin Nurs 2022. [PMID: 35460127 DOI: 10.1111/jocn.16328] [Reference Citation Analysis]
143 Xu W, Huang L, Xie B, Yang B. Serum microRNA-4297 is a sex-specific predictive biomarker of glioma grade and prognosis. Front Neurol 2022;13:888221. [DOI: 10.3389/fneur.2022.888221] [Reference Citation Analysis]
144 Lin W, Sun J, Sadahira T, Xu N, Wada K, Liu C, Araki M, Xu A, Watanabe M, Nasu Y, Huang P. Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer. Int J Biol Sci 2021;17:3255-67. [PMID: 34421363 DOI: 10.7150/ijbs.63125] [Reference Citation Analysis]
145 Chen B, Xie X, Lan F, Liu W. Identification of prognostic markers by weighted gene co-expression network analysis in non-small cell lung cancer. Bioengineered 2021;12:4924-35. [PMID: 34369264 DOI: 10.1080/21655979.2021.1960764] [Reference Citation Analysis]
146 Chen LM, Chai JC, Liu B, Strutt TM, McKinstry KK, Chai KX. Prostasin regulates PD-L1 expression in human lung cancer cells. Biosci Rep 2021;41:BSR20211370. [PMID: 34240739 DOI: 10.1042/BSR20211370] [Reference Citation Analysis]
147 Kang S, Wang X, Zhang Y, Zhang B, Shang F, Guo W. First-Line Treatments for Extensive-Stage Small-Cell Lung Cancer With Immune Checkpoint Inhibitors Plus Chemotherapy: A Network Meta-Analysis and Cost-Effectiveness Analysis. Front Oncol 2022;11:740091. [DOI: 10.3389/fonc.2021.740091] [Reference Citation Analysis]
148 Hughes TM, Ellsworth B, Berlin NL, Sinco B, Bredbeck B, Baskin A, Wang T, Nathan H, Dossett LA. Statewide Episode Spending Variation of Mastectomy for Breast Cancer. J Am Coll Surg 2022;234:14-23. [PMID: 35213456 DOI: 10.1097/XCS.0000000000000005] [Reference Citation Analysis]
149 Wang X, Chen D, Wen J, Mao Y, Zhu X, Fan M, Chen Y. Benefit of adjuvant chemotherapy for patients with stage IB non-small cell lung cancer: a systematic review and meta-analysis. Ann Transl Med 2021;9:1430. [PMID: 34733982 DOI: 10.21037/atm-21-4001] [Reference Citation Analysis]
150 Rizzo R, Onesto V, Forciniti S, Chandra A, Prasad S, Iuele H, Colella F, Gigli G, Del Mercato LL. A pH-sensor scaffold for mapping spatiotemporal gradients in three-dimensional in vitro tumour models. Biosens Bioelectron 2022;212:114401. [PMID: 35617754 DOI: 10.1016/j.bios.2022.114401] [Reference Citation Analysis]
151 Wu HT, Li CL, Fang ZX, Chen WJ, Lin WT, Liu J. Induced Cell Cycle Arrest in Triple-Negative Breast Cancer by Combined Treatment of Itraconazole and Rapamycin. Front Pharmacol 2022;13:873131. [PMID: 35517785 DOI: 10.3389/fphar.2022.873131] [Reference Citation Analysis]
152 Chang P, Chen S, Chang X, Zhu J, Tang Q, Ma L. EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanisms. Eur J Med Res 2022;27:115. [PMID: 35818069 DOI: 10.1186/s40001-022-00740-w] [Reference Citation Analysis]
153 Dorman K, Gerckens M, Kruger S, Krueger K, Mayer Z, Rupp A, Zhang D, Weiss L, Westphalen CB, Haas M, Guenther M, Ormanns S, Klawonn F, Werner J, von Bergwelt-Baildon M, Heinemann V, Boeck S, Holdenrieder S. Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-γ, TNF-α and PD-1/PD-L1 in comparison to established serum tumor markers. J Cancer Res Clin Oncol 2022. [PMID: 35737090 DOI: 10.1007/s00432-022-04112-z] [Reference Citation Analysis]
154 Clarke R, Jones BC, Sevigny CM, Hilakivi-Clarke LA, Sengupta S. Experimental models of endocrine responsive breast cancer: strengths, limitations, and use. Cancer Drug Resist 2021;4:762-83. [PMID: 34532657 DOI: 10.20517/cdr.2021.33] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Wang Q, Liu Z, Zhai G, Yu X, Ke S, Shao H, Guo J. Overexpression of GATA5 Inhibits Prostate Cancer Progression by Regulating PLAGL2 via the FAK/PI3K/AKT Pathway. Cancers 2022;14:2074. [DOI: 10.3390/cancers14092074] [Reference Citation Analysis]
156 Carneiro MM. Reflections on Pink October. Women Health 2021;61:915-6. [PMID: 34895090 DOI: 10.1080/03630242.2021.2010307] [Reference Citation Analysis]
157 Zuo Z, He L, Duan X, Peng Z, Han J. Glycyrrhizic acid exhibits strong anticancer activity in colorectal cancer cells via SIRT3 inhibition. Bioengineered 2021. [PMID: 34747319 DOI: 10.1080/21655979.2021.2001925] [Reference Citation Analysis]
158 Jan YH, Tan KT, Chen SJ, Yip TTC, Lu CT, Lam AK. Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing. Br J Cancer 2022. [PMID: 35842545 DOI: 10.1038/s41416-022-01913-4] [Reference Citation Analysis]
159 Rice MA, Kumar V, Tailor D, Garcia-Marques FJ, Hsu EC, Liu S, Bermudez A, Kanchustambham V, Shankar V, Inde Z, Alabi BR, Muruganantham A, Shen M, Pandrala M, Nolley R, Aslan M, Ghoochani A, Agarwal A, Buckup M, Kumar M, Going CC, Peehl DM, Dixon SJ, Zare RN, Brooks JD, Pitteri SJ, Malhotra SV, Stoyanova T. SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer. Cell Rep Med 2022;3:100502. [PMID: 35243415 DOI: 10.1016/j.xcrm.2021.100502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
160 Aguilera KY, Dawson DW. WNT Ligand Dependencies in Pancreatic Cancer. Front Cell Dev Biol 2021;9:671022. [PMID: 33996827 DOI: 10.3389/fcell.2021.671022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
161 Wang L, Qiao Y, Zong H, Han L, Ke Y, Pan Z, Chen J, Lu J, Li J, Ying T, Zhang B, Zhu J. IgG-like Bispecific Antibody CD3×EpCAM Generated by Split Intein Against Colorectal Cancer. Front Pharmacol 2022;13:803059. [PMID: 35281893 DOI: 10.3389/fphar.2022.803059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Hanuma Kumar Ghali EN, Dhevan V, K narmala S, Jaggi M, C chauhan S, M yallapu M. Breakthrough medicines during the COVID-19 pandemic era. Future Drug Discovery. [DOI: 10.4155/fdd-2022-0002] [Reference Citation Analysis]
163 Shi S, Du Y, Huang L, Cui J, Niu J, Xu Y, Zhu Q. Discovery of novel potent covalent inhibitor-based EGFR degrader with excellent in vivo efficacy. Bioorganic Chemistry 2022;120:105605. [DOI: 10.1016/j.bioorg.2022.105605] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
164 Advani S, Zhang D, Tammemagi M, Akinyemiju T, Gould MK, Silvestri GA, Braithwaite D. Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017 to 2019. Ann Am Thorac Soc 2021. [PMID: 33939595 DOI: 10.1513/AnnalsATS.202010-1276OC] [Reference Citation Analysis]
165 Dunn M, Milius L, Ivarra A, Cooper M, Bhakta N. Motivations and Experiences in a Physical Activity Program for Cancer Survivors: Findings from Key Informant Interviews. Am J Health Promot 2021;:8901171211061939. [PMID: 34969306 DOI: 10.1177/08901171211061939] [Reference Citation Analysis]
166 Jakobsson AW, Kundu S, Guo J, Chowdhury A, Zhao M, Lindell E, Bergsten P, Swartling FJ, Sjöblom T, Zhang X. Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions. Cancers 2022;14:3225. [DOI: 10.3390/cancers14133225] [Reference Citation Analysis]
167 Curvello R, Kast V, Abuwarwar MH, Fletcher AL, Garnier G, Loessner D. 3D Collagen-Nanocellulose Matrices Model the Tumour Microenvironment of Pancreatic Cancer. Front Digit Health 2021;3:704584. [PMID: 34713176 DOI: 10.3389/fdgth.2021.704584] [Reference Citation Analysis]
168 Nishino H, Hirata Y, Nagaoka Y, Uesato S. Isoform Selectivity of HDAC Inhibitors Has a Significant Effect on PD-L1 Expression in the Triple-negative Cancer Cell Line MDA-MB-231. YAKUGAKU ZASSHI 2022;142:431-7. [DOI: 10.1248/yakushi.21-00213] [Reference Citation Analysis]
169 Radziszewski P, Szabłoński W. Re: Bladder Cancer in Patients Younger than 40 Years: Outcomes from the National Cancer Database de la Calle CM, Washington SL 3rd, Lonergan PE, et al World J Urol 2021;39:1911–6. European Urology 2022. [DOI: 10.1016/j.eururo.2022.04.008] [Reference Citation Analysis]
170 Ren H, Li W, Liu X, Li S, Guo H, Wang W, Zhao N. Identification and Validation of an 6-Metabolism-Related Gene Signature and Its Correlation With Immune Checkpoint in Hepatocellular Carcinoma. Front Oncol 2021;11:783934. [PMID: 34869039 DOI: 10.3389/fonc.2021.783934] [Reference Citation Analysis]
171 Zahid MU, Mohamed ASR, Caudell JJ, Harrison LB, Fuller CD, Moros EG, Enderling H. Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck Cancer Radiotherapy Dose Personalization. J Pers Med 2021;11:1124. [PMID: 34834476 DOI: 10.3390/jpm11111124] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Amadeo T, Van Lewen D, Janke T, Ranzani T, Devaiah A, Upadhyay U, Russo S. Soft Robotic Deployable Origami Actuators for Neurosurgical Brain Retraction. Front Robot AI 2022;8:731010. [DOI: 10.3389/frobt.2021.731010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Yu T, Lin N, Zhong X, Zhang X, Zhang X, Chen Y, Liu J, Hu W, Duan H, Si J. Multi-label recognition of cancer-related lesions with clinical priors on white-light endoscopy. Comput Biol Med 2022;143:105255. [PMID: 35151153 DOI: 10.1016/j.compbiomed.2022.105255] [Reference Citation Analysis]
174 Zhou K, Ning F, Wang X, Wang W, Han D, Li X. Perceived social support and coping style as mediators between resilience and health-related quality of life in women newly diagnosed with breast cancer: a cross-sectional study. BMC Womens Health 2022;22:198. [PMID: 35643446 DOI: 10.1186/s12905-022-01783-1] [Reference Citation Analysis]
175 Jin Y, He C, Di X, Fu L, Qi X, Liu R, Zheng L, Wang Y, Wang Z, Tu F. Simultaneous determination of lidocaine and its active metabolites in plasma by UPLC-MS/MS and application to a clinical pharmacokinetic study in liver cancer patients with laparoscopic hepatectomy. J Chromatogr B Analyt Technol Biomed Life Sci 2022;1207:123362. [PMID: 35839626 DOI: 10.1016/j.jchromb.2022.123362] [Reference Citation Analysis]
176 Moser B, Edtmayer S, Witalisz-Siepracka A, Stoiber D. The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia. Biomedicines 2021;9:1051. [PMID: 34440253 DOI: 10.3390/biomedicines9081051] [Reference Citation Analysis]
177 Rice O, Surian A, Chen Y. Modeling the blood-brain barrier for treatment of central nervous system (CNS) diseases. J Tissue Eng 2022;13:20417314221095997. [PMID: 35586265 DOI: 10.1177/20417314221095997] [Reference Citation Analysis]
178 Du X, Bai H, Wang Z, Daun J, Liu Z, Xu J, Chang G, Zhu Y, Wang J. Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIs. Thorac Cancer 2022. [PMID: 35347870 DOI: 10.1111/1759-7714.14380] [Reference Citation Analysis]
179 Kharenko OA, Patel RG, Calosing C, van der Horst EH. Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer. Cancer Gene Ther 2021. [PMID: 34385584 DOI: 10.1038/s41417-021-00375-9] [Reference Citation Analysis]
180 Coletta S, Lonardi S, Sensi F, D'Angelo E, Fassan M, Pucciarelli S, Valzelli A, Biccari A, Vermi W, Della Bella C, Barizza A, D'Elios MM, de Bernard M, Agostini M, Codolo G. Tumor Cells and the Extracellular Matrix Dictate the Pro-Tumoral Profile of Macrophages in CRC. Cancers (Basel) 2021;13:5199. [PMID: 34680345 DOI: 10.3390/cancers13205199] [Reference Citation Analysis]
181 Ding J, Li H, Liu Y, Xie Y, Yu J, Sun H, Xiao D, Zhou Y, Bao L, Wang H, Gao C. OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma. Front Oncol 2021;11:698302. [PMID: 34804914 DOI: 10.3389/fonc.2021.698302] [Reference Citation Analysis]
182 Crombie JL, Brown JR. The future of antibody therapy in chronic lymphocytic leukemia. Expert Opin Emerg Drugs 2021;26:323-36. [PMID: 34375544 DOI: 10.1080/14728214.2021.1966414] [Reference Citation Analysis]
183 Kim D, Park H, Jang M, Lee K. Mask Branch Network: Weakly Supervised Branch Network with a Template Mask for Classifying Masses in 3D Automated Breast Ultrasound. Applied Sciences 2022;12:6332. [DOI: 10.3390/app12136332] [Reference Citation Analysis]
184 Begum H, Chirra N, Kumar D, Murugesan P, Kantevari S, Tangutur AD. Autophagic and apoptotic cell death induced by the quinoline derivative 2‐(6‐methoxynaphthalen‐2‐yl)quinolin‐4‐amine in pancreatic cancer cells is via ER stress and inhibition of Akt/ mTOR signaling pathway. Drug Development Research. [DOI: 10.1002/ddr.21916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Li JX, Li XL, Yu SY, Xu HX. Repeated ultrasound-guided percutaneous thermal ablation combined with systemic therapy achieves a stable condition in an end-stage patient with more than 10 liver metastases from breast cancer: The importance of sonazoid assisted contrast-enhanced ultrasound and fusion imaging. Clin Hemorheol Microcirc 2022. [PMID: 35662111 DOI: 10.3233/CH-221413] [Reference Citation Analysis]
186 Corsini RR, Costa A, Fichera S, Pluchino A. A configurable computer simulation model for reducing patient waiting time in oncology departments. Health Systems. [DOI: 10.1080/20476965.2022.2030655] [Reference Citation Analysis]
187 Tian Y, Ran L, Liu Y, Xu Y, Shen J, Mi G, Ke F. Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study. Front Oncol 2022;12:800957. [DOI: 10.3389/fonc.2022.800957] [Reference Citation Analysis]
188 Chen S, Jiang L, Zhang E, Hu S, Wang T, Gao F, Zhang N, Wang X, Zheng J. A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer Patients. Front Oncol 2021;11:703033. [PMID: 34222026 DOI: 10.3389/fonc.2021.703033] [Reference Citation Analysis]
189 Ren LX, Zeng BW, Zhu M, Zhao AN, Shi B, Zhang H, Wang DD, Gu JF, Yang Z. A Novel ZNF304/miR-183-5p/FOXO4 Pathway Regulates Cell Proliferation in Clear Cell Renal Carcinoma. Front Oncol 2021;11:710525. [PMID: 34692488 DOI: 10.3389/fonc.2021.710525] [Reference Citation Analysis]
190 Shaffie A, Soliman A, Eledkawy A, van Berkel V, El-baz A. Computer-Assisted Image Processing System for Early Assessment of Lung Nodule Malignancy. Cancers 2022;14:1117. [DOI: 10.3390/cancers14051117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
191 Zhong Z, Liu C, Xu Y, Si W, Wang W, Zhong L, Zhao Y, Dong X. γ-Fe2 O3 Loading Mitoxantrone and Glucose Oxidase for pH-Responsive Chemo/Chemodynamic/Photothermal Synergistic Cancer Therapy. Adv Healthc Mater 2022;11:e2102632. [PMID: 35107866 DOI: 10.1002/adhm.202102632] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Ge P, Luo Y, Chen H, Liu J, Guo H, Xu C, Qu J, Zhang G, Chen H. Application of Mass Spectrometry in Pancreatic Cancer Translational Research. Front Oncol 2021;11:667427. [PMID: 34707986 DOI: 10.3389/fonc.2021.667427] [Reference Citation Analysis]
193 Chen X, Jia M, Ji J, Zhao Z, Zhao Y. Exosome-Derived Non-Coding RNAs in the Tumor Microenvironment of Colorectal Cancer: Possible Functions, Mechanisms and Clinical Applications. Front Oncol 2022;12:887532. [PMID: 35646623 DOI: 10.3389/fonc.2022.887532] [Reference Citation Analysis]
194 González-Borja I, Alors-Pérez E, Amat I, Alonso L, Viyuela-García C, Goñi S, Reyes JC, Ceballos-Chávez M, Hernández-García I, Sánchez-Frías ME, Santamaría E, Razquin S, Arjona-Sánchez Á, Arrazubi V, Pérez-Sanz J, Vera R, Fernández-Irigoyen J, Castaño JP, Viúdez A. Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. Front Med (Lausanne) 2021;8:720128. [PMID: 34869418 DOI: 10.3389/fmed.2021.720128] [Reference Citation Analysis]
195 Wang Q, Liu J, Zeng J, Yang Z, Ran F, Wu L, Yang G, Mei Q, Wang X, Chen Q. Determination of miRNA derived from exosomes of prostate cancer via toehold-aided cyclic amplification combined with HRP enzyme catalysis and magnetic nanoparticles. Anal Biochem 2021;630:114336. [PMID: 34400146 DOI: 10.1016/j.ab.2021.114336] [Reference Citation Analysis]
196 Wang F, Chen C, Chen WP, Li ZL, Cheng H. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer. Biomed Res Int 2021;2021:6014202. [PMID: 34708125 DOI: 10.1155/2021/6014202] [Reference Citation Analysis]
197 Chen H, Wang W, Yu S, Wang H, Tian Z, Zhu S. Procyanidins and Their Therapeutic Potential against Oral Diseases. Molecules 2022;27:2932. [PMID: 35566283 DOI: 10.3390/molecules27092932] [Reference Citation Analysis]
198 Nguyen LD, Fischer TT, Ehrlich BE. Pharmacological rescue of cognitive function in a mouse model of chemobrain. Mol Neurodegener 2021;16:41. [PMID: 34174909 DOI: 10.1186/s13024-021-00463-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Qu Z, Lu YJ, Feng JW, Chen YX, Shi LQ, Chen J, Rambaran N, Duan YF, He XZ. Preoperative Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Predict Survival Outcomes of Patients With Hepatocellular Carcinoma After Curative Resection. Front Oncol 2021;11:823054. [PMID: 35155212 DOI: 10.3389/fonc.2021.823054] [Reference Citation Analysis]
200 Qi Y, Zhao T, Li R, Han M, Guo X. Macrophage-Secreted S100A4 Supports Breast Cancer Metastasis by Remodeling the Extracellular Matrix in the Premetastatic Niche. BioMed Research International 2022;2022:1-14. [DOI: 10.1155/2022/9895504] [Reference Citation Analysis]
201 Wróbel TM, Rogova O, Sharma K, Rojas Velazquez MN, Pandey AV, Jørgensen FS, Arendrup FS, Andersen KL, Björkling F. Synthesis and Structure–Activity Relationships of Novel Non-Steroidal CYP17A1 Inhibitors as Potential Prostate Cancer Agents. Biomolecules 2022;12:165. [DOI: 10.3390/biom12020165] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Seyedabadi N, Shoushtari SY, Soofi A, Arabpour J, Shams Z, Akhavan H, Hosseini-asl S. Molecular profiles of predictive biomarkers for platinum-based chemotherapy in Non-Small Cell Lung Cancer (NSCLC). Meta Gene 2022;31:100993. [DOI: 10.1016/j.mgene.2021.100993] [Reference Citation Analysis]
203 Yu P, Xu R, Li S, Coelho MSZS, Saldiva PHN, Sim MR, Abramson MJ, Guo Y. Associations between long-term exposure to PM2.5 and site-specific cancer mortality: A nationwide study in Brazil between 2010 and 2018. Environ Pollut 2022;:119070. [PMID: 35231538 DOI: 10.1016/j.envpol.2022.119070] [Reference Citation Analysis]
204 Pawar SD, Sharma KK, Sapate SG, Yadav GY. Segmentation of pectoral muscle from digital mammograms with depth-first search algorithm towards breast density classification. Biocybernetics and Biomedical Engineering 2021;41:1224-41. [DOI: 10.1016/j.bbe.2021.08.005] [Reference Citation Analysis]
205 Yao X, Li W, Li L, Li M, Zhao Y, Fang, Zeng X, Luo Z. YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis. Cell Death Dis 2022;13:258. [PMID: 35319018 DOI: 10.1038/s41419-022-04711-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
206 Zhang Y, Yang J, Bronze MS, Houchen CW, Li M. Interplay of Tumor Microenvironment Factors and Cancer Stem Cell Enrichment in Pancreatic Ductal Adenocarcinoma. Gastroenterology 2021;161:1800-2. [PMID: 34536452 DOI: 10.1053/j.gastro.2021.09.024] [Reference Citation Analysis]
207 Pepe F, Pisapia P, Russo G, Nacchio M, Pallante P, Vigliar E, De Angelis C, Insabato L, Bellevicine C, De Placido S, Troncone G, Malapelle U. BRCA1/2 NGS Somatic Testing in Clinical Practice: A Short Report. Genes 2021;12:1917. [DOI: 10.3390/genes12121917] [Reference Citation Analysis]
208 Luo C, Wang P, He S, Zhu J, Shi Y, Wang J. Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer. Front Oncol 2022;12:919072. [DOI: 10.3389/fonc.2022.919072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
209 Xu Y, Shu D, Shen M, Wu Q, Peng Y, Liu L, Tang Z, Gao S, Wang Y, Liu S, Cui D. Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer. Journal of Immunology Research 2022;2022:1-22. [DOI: 10.1155/2022/9412119] [Reference Citation Analysis]
210 Kashyap VK, Peasah-darkwah G, Dhasmana A, Jaggi M, Yallapu MM, Chauhan SC. Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics. Pharmaceutics 2022;14:611. [DOI: 10.3390/pharmaceutics14030611] [Reference Citation Analysis]
211 Tappeiner E, Welk M, Schubert R. Tackling the class imbalance problem of deep learning-based head and neck organ segmentation. Int J Comput Assist Radiol Surg 2022. [PMID: 35578086 DOI: 10.1007/s11548-022-02649-5] [Reference Citation Analysis]
212 Hsu BW, Tseng VS. Hierarchy-aware contrastive learning with late fusion for skin lesion classification. Computer Methods and Programs in Biomedicine 2022;216:106666. [DOI: 10.1016/j.cmpb.2022.106666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Benot-Dominguez R, Cimini A, Barone D, Giordano A, Pentimalli F. The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers? Cancers (Basel) 2022;14:2709. [PMID: 35681689 DOI: 10.3390/cancers14112709] [Reference Citation Analysis]
214 Liu W, Miao C, Zhang S, Liu Y, Niu X, Xi Y, Guo W, Chu J, Lin A, Liu H, Yang X, Chen X, Zhong C, Ma Y, Wang Y, Zhu S, Liu S, Tan W, Lin D, Wu C. VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance. Signal Transduct Target Ther 2021;6:322. [PMID: 34462423 DOI: 10.1038/s41392-021-00735-9] [Reference Citation Analysis]
215 Li Y, Du Q, Wei X, Guo Z, Lei T, Li Y, Han D, Wu X, Zhang K, Zhang T, Chen X, Dong J, Zhang B, Wei H, Zhang W, Pang Q, Wang P. A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis. Front Oncol 2021;11:703074. [PMID: 34912702 DOI: 10.3389/fonc.2021.703074] [Reference Citation Analysis]
216 Barbolina MV. Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin. Pharmacol Res 2021;168:105585. [PMID: 33798735 DOI: 10.1016/j.phrs.2021.105585] [Reference Citation Analysis]
217 Hong J, Tang Y, Zhou M, Deng J, Hu H, Xu D. Polyethylene glycol-modified mesoporous polydopamine nanoparticles co-loaded with dimethylcurcumin and indocyanine green for combination therapy of castration-resistant prostate cancer. Journal of Drug Delivery Science and Technology 2022;69:103158. [DOI: 10.1016/j.jddst.2022.103158] [Reference Citation Analysis]
218 Li L, Song Q, Cao D, Jiao Y, Yuan G, Song Y. Whole-Exome Sequencing Could Distinguish Primary Pulmonary Squamous Cell Carcinoma From Lung Metastases in Individuals With Cervical Squamous Cell Carcinoma. Pathol Oncol Res 2022;28:1610325. [PMID: 35645619 DOI: 10.3389/pore.2022.1610325] [Reference Citation Analysis]
219 Tian Y, Wei Y, Liu H, Shang H, Xu Y, Wu T, Liu W, Huang A, Dang Q, Sun Y. Significance of CD8+ T cell infiltration-related biomarkers and the corresponding prediction model for the prognosis of kidney renal clear cell carcinoma. Aging (Albany NY) 2021;13:22912-33. [PMID: 34606472 DOI: 10.18632/aging.203584] [Reference Citation Analysis]
220 Wang N, Huo X, Zhang B, Chen X, Zhao S, Shi X, Xu H, Wei X. METTL3-Mediated ADAMTS9 Suppression Facilitates Angiogenesis and Carcinogenesis in Gastric Cancer. Front Oncol 2022;12:861807. [PMID: 35574388 DOI: 10.3389/fonc.2022.861807] [Reference Citation Analysis]
221 Presley CJ, Mohamed MR, Culakova E, Flannery M, Vibhakar PH, Hoyd R, Amini A, Vanderwalde N, Wong ML, Tsubata Y, Spakowicz DJ, Mohile SG. A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled Trial. Front Oncol 2022;12:835582. [DOI: 10.3389/fonc.2022.835582] [Reference Citation Analysis]
222 Ota S, Miyashita M, Yamagishi Y, Ogasawara M. Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy. Hum Vaccin Immunother 2021;:1-10. [PMID: 34919493 DOI: 10.1080/21645515.2021.2003645] [Reference Citation Analysis]
223 Ding Y, Li Y, Duan Y, Wang W, Zheng W, Cheng W, Qi Y, Feng J, Chen Z, Yu T, Hu A, Wang T, Li M, Zhang H, Li Y, Ma F, Guo B, Sagar V. LncRNA MBNL1-AS1 Represses Proliferation and Cancer Stem-Like Properties of Breast Cancer through MBNL1-AS1/ZFP36/CENPA Axis. Journal of Oncology 2022;2022:1-22. [DOI: 10.1155/2022/9999343] [Reference Citation Analysis]
224 Elzamzamy OM, Johnson BE, Chen WC, Hu G, Penner R, Hazlehurst LA. Transient Receptor Potential C 1/4/5 Is a Determinant of MTI-101 Induced Calcium Influx and Cell Death in Multiple Myeloma. Cells 2021;10:1490. [PMID: 34199280 DOI: 10.3390/cells10061490] [Reference Citation Analysis]
225 Provencio M, Serna-Blasco R, Nadal E, Insa A, García-Campelo MR, Casal Rubio J, Dómine M, Majem M, Rodríguez-Abreu D, Martínez-Martí A, De Castro Carpeño J, Cobo M, López Vivanco G, Del Barco E, Bernabé Caro R, Viñolas N, Barneto Aranda I, Viteri S, Pereira E, Royuela A, Calvo V, Martín-López J, García-García F, Casarrubios M, Franco F, Sánchez-Herrero E, Massuti B, Cruz-Bermúdez A, Romero A. Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial). J Clin Oncol 2022;:JCO2102660. [PMID: 35576508 DOI: 10.1200/JCO.21.02660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
226 Wang JF, Zhao LB, Bin YD, Zhang KL, Sun C, Wang YR, Feng X, Ji J, He LS, Chen FY, Li QL. Efficacy and Safety of Placebo During the Maintenance Therapy of Ovarian Cancer in Randomized Controlled Trials: A Systematic Review and Meta-analysis. Front Oncol 2022;12:796983. [PMID: 35692766 DOI: 10.3389/fonc.2022.796983] [Reference Citation Analysis]
227 Chiang YC, Lin PH, Lu TP, Kuo KT, Tai YJ, Hsu HC, Wu CY, Lee CY, Shen H, Chen CA, Cheng WF. A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes. Biomedicines 2021;9:1384. [PMID: 34680501 DOI: 10.3390/biomedicines9101384] [Reference Citation Analysis]
228 Zhou C, Wang J, Wang B, Cheng Y, Wang Z, Han B, Lu Y, Wu G, Zhang L, Song Y, Zhu B, Hu Y, Wang Z, Song Q, Ren S, He Y, Hu X, Zhang J, Yao Y, Zhao H, Wang Z, Chu Q, Duan J, Liu J, Qin S. [Chinese Experts Consensus on Immune Checkpoint Inhibitors 
for Non-small Cell Lung Cancer (2020 Version)]. Zhongguo Fei Ai Za Zhi 2021;24:217-35. [PMID: 33896153 DOI: 10.3779/j.issn.1009-3419.2021.101.13] [Reference Citation Analysis]
229 Fang Y, Liu Z, Wang H, Luo X, Xu Y, Chan HF, Lv S, Tao Y, Li M. Implantable Sandwich-like Scaffold/Fiber Composite Spatiotemporally Releasing Combretastatin A4 and Doxorubicin for Efficient Inhibition of Postoperative Tumor Recurrence. ACS Appl Mater Interfaces 2022;14:27525-37. [PMID: 35687834 DOI: 10.1021/acsami.2c02103] [Reference Citation Analysis]
230 LeBlanc MR, Bryant AL, LeBlanc TW, Yang Q, Sellars E, Chase CC, Smith SK. A cross-sectional observational study of health-related quality of life in adults with multiple myeloma. Support Care Cancer 2022. [PMID: 35262791 DOI: 10.1007/s00520-022-06943-5] [Reference Citation Analysis]
231 Qin S, Li B, Ming H, Nice EC, Zou B, Huang C. Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy. Biochim Biophys Acta Rev Cancer 2022;1877:188749. [PMID: 35716972 DOI: 10.1016/j.bbcan.2022.188749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Samy ALPA, Shah D, Shahagadkar P, Shah H, Munirathinam G. Can diallyl trisulfide, a dietary garlic-derived compound, activate ferroptosis to overcome therapy resistance in prostate cancer? Nutr Health 2021;:2601060211018360. [PMID: 34044656 DOI: 10.1177/02601060211018360] [Reference Citation Analysis]
233 Zhang S, Wang Z, Kong Z, Wang Y, Zhang X, Sun B, Zhang H, Kan Q, He Z, Luo C, Sun J. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy. Theranostics 2021;11:6019-32. [PMID: 33897896 DOI: 10.7150/thno.59065] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
234 Zhao P, Zhen H, Zhao H, Zhao L, Cao B. Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09444-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Domen A, Quatannens D, Zanivan S, Deben C, Van Audenaerde J, Smits E, Wouters A, Lardon F, Roeyen G, Verhoeven Y, Janssens A, Vandamme T, van Dam P, Peeters M, Prenen H. Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. Cancers (Basel) 2021;13:987. [PMID: 33673405 DOI: 10.3390/cancers13050987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
236 Deval JC, Benito MB, Cuesta JCP, Pérez EM, Contreras SS, Mojarrieta JC, Quevedo KA, Martínez MA, Arana E. [Translated article] Lung Cancer Screening: Survival in an Extensive Early Detection Program in Spain (I-ELCAP). Arch Bronconeumol 2022:S0300-2896(22)00297-6. [PMID: 35525715 DOI: 10.1016/j.arbres.2021.10.012] [Reference Citation Analysis]
237 Francis GL. The Future of Molecular Profiling for the Treatment of Pediatric Thyroid Cancer. Clinical Thyroidology 2022;34:157-60. [DOI: 10.1089/ct.2022;34.157-160] [Reference Citation Analysis]
238 Ko YH, Kim BH. Should Contemporary Western Guidelines Based on Studies Conducted in the 2000s Be Adopted for the Prostate-Specific Antigen Screening Policy for Asian Men in the 2020s? World J Mens Health 2022;40:e52. [DOI: 10.5534/wjmh.220002] [Reference Citation Analysis]
239 Wu Z, Tan F, Yang Z, Wang F, Cao W, Qin C, Dong X, Zheng Y, Luo Z, Zhao L, Yu Y, Xu Y, Ren J, Shi J, Chen H, Li J, Tang W, Shen S, Wu N, Chen W, Li N, He J. Sex disparity of lung cancer risk in non-smokers: a multicenter population-based prospective study based on China National Lung Cancer Screening Program. Chin Med J (Engl) 2022. [PMID: 35830209 DOI: 10.1097/CM9.0000000000002161] [Reference Citation Analysis]
240 Alhaj-suliman SO, Wafa EI, Salem AK. Engineering nanosystems to overcome barriers to cancer diagnosis and treatment. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114482] [Reference Citation Analysis]
241 Al Hadidi S, Schinke C, Thanendrarajan S, Zangari M, van Rhee F. Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant Neoplasms. JAMA Netw Open 2022;5:e228161. [PMID: 35442451 DOI: 10.1001/jamanetworkopen.2022.8161] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
242 Alaimo A, De Felice D, Genovesi S, Lorenzoni M, Lunardi A. Tune the channel: TRPM8 targeting in prostate cancer. Oncoscience 2021;8:97-100. [PMID: 34514058 DOI: 10.18632/oncoscience.543] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
243 Malinova A, Veghini L, Real FX, Corbo V. Cell Lineage Infidelity in PDAC Progression and Therapy Resistance. Front Cell Dev Biol 2021;9:795251. [PMID: 34926472 DOI: 10.3389/fcell.2021.795251] [Reference Citation Analysis]
244 Cooke M. Novel insights into the RTK-dependent metastatic phenotype of KRAS-mutant lung adenocarcinoma. Molecular & Cellular Oncology 2021;8:2013723. [DOI: 10.1080/23723556.2021.2013723] [Reference Citation Analysis]
245 Zou T, Lan M, Liu F, Li L, Cai T, Tian H, Cai Y. Emodin-loaded polymer-lipid hybrid nanoparticles enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transition. Cancer Nano 2021;12. [DOI: 10.1186/s12645-021-00093-9] [Reference Citation Analysis]
246 Tang H, Wang J, Luo X, Wang Q, Chen J, Zhang X, Li Q, Gao C, Li Y, Han S. An Apoptosis-Related Gene Prognostic Index for Colon Cancer. Front Cell Dev Biol 2021;9:790878. [PMID: 34957118 DOI: 10.3389/fcell.2021.790878] [Reference Citation Analysis]
247 Du C, Liu X, Li M, Zhao Y, Li J, Wen Z, Liu M, Yang M, Fu B, Wei M. Analysis of 5-Methylcytosine Regulators and DNA Methylation-Driven Genes in Colon Cancer. Front Cell Dev Biol 2021;9:657092. [PMID: 35174154 DOI: 10.3389/fcell.2021.657092] [Reference Citation Analysis]
248 Barot S, Stephenson O, Priya Vemana H, Yadav A, Bhutkar S, Trombetta L, Dukhande VV. Metabolic Alterations and Mitochondrial Dysfunction Underlie Hepatocellular Carcinoma Cell Death Induced by a Glycogen Metabolic Inhibitor. Biochem Pharmacol 2022;:115201. [PMID: 35926650 DOI: 10.1016/j.bcp.2022.115201] [Reference Citation Analysis]
249 Duan Y, Du Y, Gu Z, Zheng X, Wang C. Expression, Prognostic Value, and Functional Mechanism of the KDM5 Family in Pancreatic Cancer. Front Cell Dev Biol 2022;10:887385. [DOI: 10.3389/fcell.2022.887385] [Reference Citation Analysis]
250 Ahmed N, Hamadani M. Evaluating efficacy and safety of loncastuximab tesirine injection for the treatment of adult patients with relapsed or refractory large B-cell lymphoma. Expert Rev Anticancer Ther 2021;21:1313-20. [PMID: 34597242 DOI: 10.1080/14737140.2021.1988853] [Reference Citation Analysis]
251 Lee JY, Yang H, Kim D, Kyaw KZ, Hu R, Fan Y, Lee SK. Antiproliferative Activity of a New Quinazolin-4(3H)-One Derivative via Targeting Aurora Kinase A in Non-Small Cell Lung Cancer. Pharmaceuticals 2022;15:698. [DOI: 10.3390/ph15060698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
252 Zhong Y, Huang S, Zheng C, Huang J, Li B, Han S, Xiao H, Wang Y, Shuai X. A light and hypoxia-activated nanodrug for cascade photodynamic-chemo cancer therapy. Biomater Sci 2021;9:5218-26. [PMID: 34169939 DOI: 10.1039/d1bm00660f] [Reference Citation Analysis]
253 White T, Szelinger S, LoBello J, King A, Aldrich J, Garinger N, Halbert M, Richholt RF, Mastrian SD, Babb C, Ozols AA, Goodman LJ, Basu GD, Royce T. Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra®. Oncotarget 2021;12:726-39. [PMID: 33889297 DOI: 10.18632/oncotarget.27945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
254 Jha P, Pōder L, Glanc P, Patel-Lippmann K, McGettigan M, Moshiri M, Nougaret S, Revzin MV, Javitt MC. Imaging Cancer in Pregnancy. Radiographics 2022;:220005. [PMID: 35839139 DOI: 10.1148/rg.220005] [Reference Citation Analysis]
255 Wang L, Margolis DJ, Chen M, Zhao X, Li Q, Yang Z, Tian J, Wang Z. Quality in MR reporting (include improvements in acquisition using AI). Br J Radiol 2022;95:20210816. [PMID: 35119914 DOI: 10.1259/bjr.20210816] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
256 Lazo M, Martinez-Folgar K, Bilal U. Racial/Ethnic Disparities in Hepatocellular Carcinoma: The Role of Neighborhood Socioeconomic Deprivation. Cancer Epidemiol Biomarkers Prev 2022;31:1254-6. [PMID: 35775232 DOI: 10.1158/1055-9965.EPI-22-0378] [Reference Citation Analysis]
257 Couture F, Wang L, Dufour F, Chabot-maheux K, Ekindi Ndongo N, Sabbagh R, Day R. PACE4-altCT isoform of proprotein convertase PACE4 as tissue and plasmatic biomarker for prostate cancer. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-09778-6] [Reference Citation Analysis]
258 Wang X, Xu W, Hu X, Yang X, Zhang M. The Prognostic Role of Glycemia in Patients With Pancreatic Carcinoma: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:780909. [PMID: 35223469 DOI: 10.3389/fonc.2022.780909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Hafiz SS, Xavierselvan M, Gokalp S, Labadini D, Barros S, Duong J, Foster M, Mallidi S. Eutectic Gallium-Indium Nanoparticles for Photodynamic Therapy of Pancreatic Cancer. ACS Appl Nano Mater 2022;5:6125-39. [PMID: 35655927 DOI: 10.1021/acsanm.1c04353] [Reference Citation Analysis]
260 Dalmartello M, La Vecchia C, Bertuccio P, Boffetta P, Levi F, Negri E, Malvezzi M. European cancer mortality predictions for the year 2022 with focus on ovarian cancer. Annals of Oncology 2022. [DOI: 10.1016/j.annonc.2021.12.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
261 Tu Z, Zhu Y, Xiao Y, Chen J, Shannon S, Zhang F, Li Z, Zhou J, Hu H, Ho T, Gao W, Shao D, Leong KW. Scavenging Tumor‐Derived Small Extracellular Vesicles by Functionalized 2D Materials to Inhibit Tumor Regrowth and Metastasis Following Radiotherapy. Adv Funct Materials. [DOI: 10.1002/adfm.202205663] [Reference Citation Analysis]
262 Loomans-Kropp HA, Umar A, Minasian LM, Pinsky PF. Multi-Cancer Early Detection Tests: Current Progress and Future Perspectives. Cancer Epidemiol Biomarkers Prev 2022;31:512-4. [PMID: 35253043 DOI: 10.1158/1055-9965.EPI-21-1387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Brunette LL, Khetan VU, Deshpande RR, Nusbaum DJ, Klar M, Roman LD, Wright JD, Matsuo K. Population-level trends and outcomes of sentinel lymph node biopsy in vulvar cancer surgery in the United States. Gynecol Oncol 2022:S0090-8258(22)00002-6. [PMID: 35031190 DOI: 10.1016/j.ygyno.2022.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
264 Hsueh CY, Huang Q, Gong H, Shen Y, Sun J, Lau HC, Zhang D, Tang D, Wu C, Guo Y, Huang H, Cao P, Tao L, Zhang M, Zhou L. A positive feed-forward loop between Fusobacterium nucleatum and ethanol metabolism reprogramming drives laryngeal cancer progression and metastasis. iScience 2022;25:103829. [PMID: 35198889 DOI: 10.1016/j.isci.2022.103829] [Reference Citation Analysis]
265 Ding J, Guo Y. Recent Advances in Chitosan and its Derivatives in Cancer Treatment. Front Pharmacol 2022;13:888740. [DOI: 10.3389/fphar.2022.888740] [Reference Citation Analysis]
266 Aregui A, Pluvy J, Sanchez M, Israel T, Esnault H, Guyard A, Meyer M, Khalil A, Zalcman G, Raynaud Simon A, Gounant V. Measuring Walking Speed Failed to Predict Early Death and Toxicity in Elderly Patients with Metastatic Non-Small-Cell Lung Cancer (NSCLC) Selected for Undergoing First-Line Systemic Treatment: An Observational Exploratory Study. Cancers 2022;14:1344. [DOI: 10.3390/cancers14051344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Khodabandeh Z, Valilo M, Velaei K, Pirpour Tazehkand A. The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy. Breast Cancer 2022. [PMID: 35583594 DOI: 10.1007/s12282-022-01369-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
268 Whiteside SA, McGinniss JE, Collman RG. The lung microbiome: progress and promise. J Clin Invest 2021;131:150473. [PMID: 34338230 DOI: 10.1172/JCI150473] [Reference Citation Analysis]
269 Hanson ED, Alzer M, Carver J, Stopforth CK, Lucas AR, Whang YE, Milowsky MI, Bartlett DB, Harrison MR, Bitting RL, Deal AM, Stoner L, Hackney AC, Battaglini CL. Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. [DOI: 10.1038/s41391-022-00523-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
270 Edinoff AN, Derise OC, Sheppard AJ, Miriyala S, Virgen CG, Kaye AJ, Niakan M, Cornett EM, Kaye AD. The Influence of Analgesic Modalities on Postoperative Cancer Recurrence. Anesth Pain Med 2022;12. [DOI: 10.5812/aapm.123463] [Reference Citation Analysis]
271 Zhu Y, Hu H, Ding D, Li S, Liao M, Shi Y, Huang J. First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis. Cost Eff Resour Alloc 2021;19:77. [PMID: 34863203 DOI: 10.1186/s12962-021-00329-w] [Reference Citation Analysis]
272 Khushman M, Prodduturvar P, Mneimneh W, Zotto VD, Akbar S, Grimm L, Rider P, Hunter J, Alkharabsheh O, Patel GK, Fabregas JC, Singh AP. The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma. Oncotarget 2021;12:1490-8. [PMID: 34316329 DOI: 10.18632/oncotarget.28025] [Reference Citation Analysis]
273 Gong S, Li X, Tian H, Song S, Lu T, Jing W, Huang X, Xu Y, Wang X, Zhao K, Yang K, Guo T. Clinical efficacy and safety of robotic distal gastrectomy for gastric cancer: a systematic review and meta-analysis. Surg Endosc 2022;36:2734-48. [PMID: 35020057 DOI: 10.1007/s00464-021-08994-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
274 Fradley MG, Lefebvre B, Carver J, Cheung JW, Feigenberg SJ, Lampert R, Liu J, Rajagopalan B, Lenihan DJ. How to Manage Patients With Cardiac Implantable Electronic Devices Undergoing Radiation Therapy. JACC CardioOncol 2021;3:447-51. [PMID: 34604807 DOI: 10.1016/j.jaccao.2021.08.005] [Reference Citation Analysis]
275 Yuan C, Zhang J, Lou J, Wang S, Jiang Y, Wu F, Wang S. Comprehensive Analysis of Monocarboxylate Transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis. Bioengineered 2021;12:3850-63. [PMID: 34269158 DOI: 10.1080/21655979.2021.1951928] [Reference Citation Analysis]
276 Okwuosa TM, Zaha VG. Sex Differences in Cardio-Oncology: Considerations for the Practicing Clinician and Researcher. Circulation 2022;145:510-2. [PMID: 35157522 DOI: 10.1161/CIRCULATIONAHA.122.058906] [Reference Citation Analysis]
277 Visan KS, Lobb RJ, Wen SW, Bedo J, Lima LG, Krumeich S, Palma C, Ferguson K, Green B, Niland C, Cloonan N, Simpson PT, McCart Reed AE, Everitt SJ, MacManus MP, Hartel G, Salomon C, Lakhani SR, Fielding D, Möller A. Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients. Cancers (Basel) 2022;14:257. [PMID: 35008424 DOI: 10.3390/cancers14010257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
278 Chen MY, Gillanders WE. Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound. Breast Cancer (Dove Med Press) 2021;13:311-23. [PMID: 34040436 DOI: 10.2147/BCTT.S273039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
279 Liu L, Shi L, Wang Z, Zeng J, Wang Y, Xiao H, Zhu Y. Targeting Oncoproteins for Degradation by Small Molecule-Based Proteolysis-Targeting Chimeras (PROTACs) in Sex Hormone-Dependent Cancers. Front Endocrinol 2022;13:839857. [DOI: 10.3389/fendo.2022.839857] [Reference Citation Analysis]
280 Young SAE, Muthami J, Pitcher M, Antovski P, Wamea P, Murphy RD, Haghniaz R, Schmidt A, Clark S, Khademhosseini A, Sheikhi A. Engineering hairy cellulose nanocrystals for chemotherapy drug capture. Mater Today Chem 2022;23:100711. [PMID: 35224320 DOI: 10.1016/j.mtchem.2021.100711] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
281 Chen Q, Yin H, Pu N, Zhang J, Zhao G, Wenhui L, Wu W. Chemokine C-C motif ligand 21 synergized with programmed death-ligand 1 blockade restrains tumor growth. Cancer Sci 2021. [PMID: 34402138 DOI: 10.1111/cas.15110] [Reference Citation Analysis]
282 Wang S, Hu W, Xie Y, Wu H, Jia Z, Zhang Z, Zhang X. Functional genetic variants in complement component 7 confer susceptibility to gastric cancer. PeerJ 2022;10:e12816. [DOI: 10.7717/peerj.12816] [Reference Citation Analysis]
283 Gao W, Li M, Zhang Y. Fibrinogen/Albumin Ratio (FAR) in Patients with Triple Negative Breast Cancer and Its Relationship with Epidermal Growth Factor Receptor Expression. Onco Targets Ther 2021;14:5403-15. [PMID: 34908845 DOI: 10.2147/OTT.S339973] [Reference Citation Analysis]
284 Xu Z, Peng B, Kang F, Zhang W, Xiao M, Li J, Hong Q, Cai Y, Liu W, Yan Y, Peng J. The Roles of Drug Metabolism-Related ADH1B in Immune Regulation and Therapeutic Response of Ovarian Cancer. Front Cell Dev Biol 2022;10:877254. [PMID: 35756990 DOI: 10.3389/fcell.2022.877254] [Reference Citation Analysis]
285 Kalemci S, Kizilay F, Ergun KE, Aliyev B, Simsir A. Postchemotherapy retroperitoneal residual mass resection for germ cell testicular tumors: a single-center experience. Rev Assoc Med Bras 2022;68:524-9. [DOI: 10.1590/1806-9282.20211247] [Reference Citation Analysis]
286 Zhang L, Zhe X, Tang M, Zhang J, Ren J, Zhang X, Li L. Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature. Contrast Media Mol Imaging 2021;2021:7830909. [PMID: 35024015 DOI: 10.1155/2021/7830909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
287 Johnson BD, Zhu Z, Lequio M, Powers CGD, Bai Q, Xiao H, Fajardo E, Wakefield MR, Fang Y. SARS-CoV-2 spike protein inhibits growth of prostate cancer: a potential role of the COVID-19 vaccine killing two birds with one stone. Med Oncol 2022;39. [DOI: 10.1007/s12032-021-01628-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
288 Fantozzi PJ, Bavarian R, Tamayo I, Bind MA, Woo SB, Villa A. The role of family history of Cancer in Oral Cavity Cancer. Head Face Med 2021;17:48. [PMID: 34809651 DOI: 10.1186/s13005-021-00298-8] [Reference Citation Analysis]
289 Luo F, Huang Y, Li Y, Zhao X, Xie Y, Zhang Q, Mei J, Liu X. A narrative review of the relationship between TGF-β signaling and gynecological malignant tumor. Ann Transl Med 2021;9:1601. [PMID: 34790807 DOI: 10.21037/atm-21-4879] [Reference Citation Analysis]
290 Wang L, Weng W, Yang S, Yang S, Du R. Circle RNA circ_0007331 promotes colorectal carcinoma by targeting miR-205-5p/high-mobility group A2 axis. Bioengineered 2022;13:9312-21. [DOI: 10.1080/21655979.2022.2051857] [Reference Citation Analysis]
291 Niture S, Tricoli L, Qi Q, Gadi S, Hayes K, Kumar D. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation. TUB 2022;44:107-26. [DOI: 10.3233/tub-211568] [Reference Citation Analysis]
292 Chen N, Zhou YS, Wang LC, Huang JB. Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review). Oncol Rep 2022;47:55. [PMID: 35039878 DOI: 10.3892/or.2022.8266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
293 Zhang X, Li L, Liu P, Tian Y, Gong P, Wang F. Development of a Transcription Factor-Based Prognostic Model for Predicting the Immune Status and Outcome in Pancreatic Adenocarcinoma. Journal of Immunology Research 2022;2022:1-16. [DOI: 10.1155/2022/4946020] [Reference Citation Analysis]
294 Paro A, Dalmacy D, Tslimigras DI, Cloyd J, Ejaz A, Pawlik TM. Association of County-Level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment among Patients with Hepatocellular Carcinoma. Ann Surg Oncol 2022. [PMID: 35441305 DOI: 10.1245/s10434-022-11726-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
295 Oganesyan A, Ghahramanyan N, Mekinian A, Bejanyan N, Kazandjian D, Hakobyan Y. Managing multiple myeloma in a resource-limited region: Diagnosis and treatment in Armenia. Semin Oncol 2021;48:269-78. [PMID: 34895914 DOI: 10.1053/j.seminoncol.2021.11.003] [Reference Citation Analysis]
296 Opitz FV, Haeberle L, Daum A, Esposito I. Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia. Cancers 2021;13:6188. [DOI: 10.3390/cancers13246188] [Reference Citation Analysis]
297 Kraus S, Khandadash R, Hof R, Nyska A, Sigalov E, Eltanani M, Rukenstein P, Rabinovitz R, Kassem R, Antebi A, Shalev O, Cohen-Erner M, Goss G, Cyjon A. Novel Nanoparticle-Based Cancer Treatment, Effectively Inhibits Lung Metastases and Improves Survival in a Murine Breast Cancer Model. Front Oncol 2021;11:761045. [PMID: 34804962 DOI: 10.3389/fonc.2021.761045] [Reference Citation Analysis]
298 Li P, Rozich N, Wang J, Wang J, Xu Y, Herbst B, Yu R, Muth S, Niu N, Li K, Funes V, Gai J, Osipov A, Edil BH, Wolfgang CL, Lei M, Liang T, Zheng L. Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215722] [Reference Citation Analysis]
299 Shao R, Wang Y, Li L, Dong Y, Zhao J, Liang W. Bone tumors effective therapy through functionalized hydrogels: current developments and future expectations. Drug Deliv 2022;29:1631-47. [PMID: 35612368 DOI: 10.1080/10717544.2022.2075983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 Kurniawan YS, Priyangga KTA, Jumina, Pranowo HD, Sholikhah EN, Zulkarnain AK, Fatimi HA, Julianus J. An Update on the Anticancer Activity of Xanthone Derivatives: A Review. Pharmaceuticals (Basel) 2021;14:1144. [PMID: 34832926 DOI: 10.3390/ph14111144] [Reference Citation Analysis]
301 Kirk JA, Cheung JY, Feldman AM. Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease. J Clin Invest 2021;131:149415. [PMID: 34396980 DOI: 10.1172/JCI149415] [Reference Citation Analysis]
302 Perez Holguin RA, Stahl KA, Hendriksen BS, Wong WG, Olecki EJ, Vining CC, Dixon ME, Peng JS, Shen C. Predictors of Conversion During Minimally Invasive Gastrectomy for Malignancy. J Surg Res 2022;279:275-84. [PMID: 35802942 DOI: 10.1016/j.jss.2022.05.017] [Reference Citation Analysis]
303 Shoucair S, Habib JR, Pu N, Kinny-Köster B, van Ooston AF, Javed AA, Lafaro KJ, He J, Wolfgang CL, Yu J. Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Reveals KRAS G12D and Mutant TP53 Combination as an Independent Predictor of Clinical Outcome. Ann Surg Oncol 2021. [PMID: 34792696 DOI: 10.1245/s10434-021-11081-z] [Reference Citation Analysis]
304 Wang H, Yu D, Zhang H, Ma R, Wu H, Zhai H, Wang H, Li J, Li L, Wang Y, Cheng T, Shi J. Quercetin inhibits the proliferation of multiple myeloma cells by upregulating PTPRR expression. Acta Biochim Biophys Sin (Shanghai) 2021;53:1505-15. [PMID: 34558606 DOI: 10.1093/abbs/gmab128] [Reference Citation Analysis]
305 De Carlo C, Valeri M, Corbitt DN, Cieri M, Colombo P. Non-muscle invasive bladder cancer biomarkers beyond morphology. Front Oncol 2022;12:947446. [DOI: 10.3389/fonc.2022.947446] [Reference Citation Analysis]
306 Bassanelli M, Borro M, Roberto M, Giannarelli D, Giacinti S, Di Martino S, Ceribelli A, Russo A, Aschelter A, Scarpino S, Montori A, Pescarmona E, Tomao S, Simmaco M, Cognetti F, Milella M, Marchetti P. A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma. Cancers (Basel) 2021;14:178. [PMID: 35008342 DOI: 10.3390/cancers14010178] [Reference Citation Analysis]
307 Khan H, Alam W, Alsharif KF, Aschner M, Pervez S, Saso L. Alkaloids and Colon Cancer: Molecular Mechanisms and Therapeutic Implications for Cell Cycle Arrest. Molecules 2022;27:920. [DOI: 10.3390/molecules27030920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Ma H, Li M, Jia Z, Chen X, Bu N. miR-876-3p suppresses the progression of colon cancer and correlates the prognosis of patients. Exp Mol Pathol 2021;122:104682. [PMID: 34509500 DOI: 10.1016/j.yexmp.2021.104682] [Reference Citation Analysis]
309 Ali H. Future incidence and mortality of colorectal carcinoma in the United States: an updated overview of risk factors and preventative measures. Exploration of Medicine. [DOI: 10.37349/emed.2021.00063] [Reference Citation Analysis]
310 Li M, Zhu Y, Yang C, Yang M, Ran H, Zhu Y, Zhang W. Acoustic triggered nanobomb for US imaging guided sonodynamic therapy and activating antitumor immunity. Drug Deliv 2022;29:2177-89. [PMID: 35815688 DOI: 10.1080/10717544.2022.2095058] [Reference Citation Analysis]
311 Pang SS, Murphy M, Markham MJ. Current Management of Locally Advanced and Metastatic Cervical Cancer in the United States. JCO Oncol Pract 2022;:OP2100795. [PMID: 35286157 DOI: 10.1200/OP.21.00795] [Reference Citation Analysis]
312 Jacobsen A, Hobbs M, Merkel S, Mittelstädt A, Czubayko F, Krautz C, Weber GF, Grützmann R, Brunner M. Time to Surgery Does Not Affect Overall or Disease-Free Survival of Patients with Primary Resectable PDAC. JCM 2022;11:4433. [DOI: 10.3390/jcm11154433] [Reference Citation Analysis]
313 Khaddour K, Jonna S, Deneka A, Patel JD, Abazeed ME, Golemis E, Borghaei H, Boumber Y. Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies. Cancers (Basel) 2021;13:3164. [PMID: 34202748 DOI: 10.3390/cancers13133164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
314 Ouyang W, Jiang Y, Bu S, Tang T, Huang L, Chen M, Tan Y, Ou Q, Mao L, Mai Y, Yao H, Yu Y, Lin X. A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma. Front Cell Dev Biol 2022;9:758777. [DOI: 10.3389/fcell.2021.758777] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
315 Carmona CA, Yee S, Seminsky M, Glass K, Foong S, Lipson E, Baxter NN, Friedenreich CM, Metcalfe K, Isherwood S, Akbari MR, Narod S, Quan ML, Warner E. Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective, Pan-Canadian Study of Young Women with Breast Cancer. Ann Surg Oncol. [DOI: 10.1245/s10434-021-11254-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Kim SI, Chung JY, Paik H, Seol A, Yoon SH, Kim TM, Kim HS, Chung HH, Cho JY, Kim JW, Lee M. Prognostic role of computed tomography-based, artificial intelligence-driven waist skeletal muscle volume in uterine endometrial carcinoma. Insights Imaging 2021;12:192. [PMID: 34928453 DOI: 10.1186/s13244-021-01134-y] [Reference Citation Analysis]
317 Rickard BP, Conrad C, Sorrin AJ, Ruhi MK, Reader JC, Huang SA, Franco W, Scarcelli G, Polacheck WJ, Roque DM, Del Carmen MG, Huang HC, Demirci U, Rizvi I. Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response. Cancers (Basel) 2021;13:4318. [PMID: 34503128 DOI: 10.3390/cancers13174318] [Reference Citation Analysis]
318 Wang Z, Sun A, Yan A, Yao J, Huang H, Gao Z, Han T, Gu J, Li N, Wu H, Li K. Circular RNA MTCL1 promotes advanced laryngeal squamous cell carcinoma progression by inhibiting C1QBP ubiquitin degradation and mediating beta-catenin activation. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01570-4] [Reference Citation Analysis]
319 Zhang Q, Rui W, Jiang Y, Yuan F, Chen Y, Guo X, Zhou Y, Wu Z, Wang C, Ding X. Tumor-infiltrating OX40+ lymphocytes is an independent positive prognostic factor for patients with pancreatic ductal adenocarcinoma. Clin Transl Oncol 2022. [PMID: 35731350 DOI: 10.1007/s12094-022-02864-1] [Reference Citation Analysis]
320 Walker BS, Sutton TL, Zarour L, Hunter JG, Wood SG, Tsikitis VL, Herzig DO, Lopez CD, Chen EY, Mayo SC, Wong MH. Circulating Hybrid Cells: A Novel Liquid Biomarker of Treatment Response in Gastrointestinal Cancers. Ann Surg Oncol 2021. [PMID: 34365557 DOI: 10.1245/s10434-021-10379-2] [Reference Citation Analysis]
321 Van der Groen T, Shupak RP, Kim RY. Synchronous oral squamous cell carcinoma and a lymphoproliferative disorder in an adult: a challenge in diagnosis and management. BMJ Case Rep 2022;15:e246641. [PMID: 35135796 DOI: 10.1136/bcr-2021-246641] [Reference Citation Analysis]
322 Yoon HS, Shu XO, Cai H, Zheng W, Wu J, Wen W, Courtney R, Shidal C, Waterboer T, Blot WJ, Cai Q. Associations of lung cancer risk with biomarkers of Helicobacter pylori infection. Carcinogenesis 2022;43:538-46. [PMID: 35605986 DOI: 10.1093/carcin/bgac047] [Reference Citation Analysis]
323 Yoshikawa T, Takenaka D, Ohno Y. Editorial for “ MRI Radiomics‐Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study”. Magnetic Resonance Imaging. [DOI: 10.1002/jmri.28090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
324 Zhou Y, Zou Y, Yang M, Mei S, Liu X, Han H, Zhang CD, Niu MM. Highly Potent, Selective, Biostable, and Cell-Permeable Cyclic d-Peptide for Dual-Targeting Therapy of Lung Cancer. J Am Chem Soc 2022. [PMID: 35417174 DOI: 10.1021/jacs.1c12075] [Reference Citation Analysis]
325 Pallauf M, König F, D’andrea D, Laukhtina E, Mostafaei H, Motlagh RS, Quhal F, Aydh A, Yanagisawa T, Kawada T, Rajwa P, Lusuardi L, Soria F, Karakiewicz PI, Rouprêt M, Rink M, Lotan Y, Margulis V, Singla N, Xylinas E, Shariat SF, Pradere B. A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery. Front Oncol 2022;12:907975. [DOI: 10.3389/fonc.2022.907975] [Reference Citation Analysis]
326 Ruo SW, Alkayyali T, Win M, Tara A, Joseph C, Kannan A, Srivastava K, Ochuba O, Sandhu JK, Went TR, Sultan W, Kantamaneni K, Poudel S. Role of Gut Microbiota Dysbiosis in Breast Cancer and Novel Approaches in Prevention, Diagnosis, and Treatment. Cureus 2021;13:e17472. [PMID: 34513524 DOI: 10.7759/cureus.17472] [Reference Citation Analysis]
327 Henry EC, Strugari M, Mawko G, Brewer K, Liu D, Gordon AC, Bryan JN, Maitz C, Abraham R, Kappadath SC, Syme A. Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model. EJNMMI Phys 2022;9:21. [PMID: 35312882 DOI: 10.1186/s40658-022-00447-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
328 Li X, Sun H, Liu Q, Liu Y, Hou Y, Jin W. Conjoint analysis of circulating tumor cells and solid tumors for exploring potential prognostic markers and constructing a robust novel predictive signature for breast cancer. Cancer Cell Int 2021;21:708. [PMID: 34953500 DOI: 10.1186/s12935-021-02415-8] [Reference Citation Analysis]
329 Sun CY. Current status of immunotherapy for pancreatic cancer. Shijie Huaren Xiaohua Zazhi 2021; 29(20): 1151-1157 [DOI: 10.11569/wcjd.v29.i20.1151] [Reference Citation Analysis]
330 Zheng P, Zhang H, Jiang W, Wang L, Liu L, Zhou Y, Zhou L, Liu H. Establishment of a Prognostic Model of Lung Adenocarcinoma Based on Tumor Heterogeneity. Front Mol Biosci 2022;9:807497. [DOI: 10.3389/fmolb.2022.807497] [Reference Citation Analysis]
331 Jiang T, Wang H, Liu L, Song H, Zhang Y, Wang J, Liu L, Xu T, Fan R, Xu Y, Wang S, Shi L, Zheng L, Wang R, Song J. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer. Mol Cancer 2021;20:167. [PMID: 34922544 DOI: 10.1186/s12943-021-01474-9] [Reference Citation Analysis]
332 Villano AM, O'Halloran E, Goel N, Ruth K, Barrak D, Lefton M, Reddy SS. Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma. J Surg Oncol 2022. [PMID: 35476892 DOI: 10.1002/jso.26906] [Reference Citation Analysis]
333 Zhang F, Ferrero M, Dong N, D'Auria G, Reyes-Prieto M, Herreros-Pomares A, Calabuig-Fariñas S, Duréndez E, Aparisi F, Blasco A, García C, Camps C, Jantus-Lewintre E, Sirera R. Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:2514. [PMID: 34063829 DOI: 10.3390/cancers13112514] [Reference Citation Analysis]
334 Kumari K, Groza P, Aguilo F. Regulatory roles of RNA modifications in breast cancer. NAR Cancer 2021;3:zcab036. [PMID: 34541538 DOI: 10.1093/narcan/zcab036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
335 Zhao Y, Liu L, Zhao J, Du X, Yu Q, Wu J, Wang B, Ou R. Construction and Verification of a Hypoxia-Related 4-lncRNA Model for Prediction of Breast Cancer. Int J Gen Med 2021;14:4605-17. [PMID: 34429643 DOI: 10.2147/IJGM.S322007] [Reference Citation Analysis]
336 Cheung K, Bossler AD, Mott SL, Zeisler M, McKillip J, Zakharia Y, Swick BL, Powers JG. The Genetics of Early-Stage Melanoma in a Veteran Population. Front Oncol 2022;12:887768. [PMID: 35712493 DOI: 10.3389/fonc.2022.887768] [Reference Citation Analysis]
337 Lin C, Yang H, Zhao W, Wang W. CTSB+ macrophage repress memory immune hub in the liver metastasis site of colorectal cancer patient revealed by multi-omics analysis. Biochemical and Biophysical Research Communications 2022. [DOI: 10.1016/j.bbrc.2022.06.037] [Reference Citation Analysis]
338 Li X, Wang X, Zhao J, Wang J, Wu J. PRMT5 promotes colorectal cancer growth by interaction with MCM7. J Cell Mol Med 2021;25:3537-47. [PMID: 33675123 DOI: 10.1111/jcmm.16436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
339 Zhang Y, Xing Z, Liu T, Tang M, Mi L, Zhu J, Wu W, Wei T. Targeted therapy and drug resistance in thyroid cancer. European Journal of Medicinal Chemistry 2022;238:114500. [DOI: 10.1016/j.ejmech.2022.114500] [Reference Citation Analysis]
340 Shu Y, Zhang Q, He X, Chen L. Cost-Effectiveness Analysis of Gefitinib Plus Chemotherapy versus Gefitinib Alone for Advanced Non-Small-Cell Lung Cancer with EGFR Mutations in China. Cancer Manag Res 2021;13:8297-306. [PMID: 34764692 DOI: 10.2147/CMAR.S334643] [Reference Citation Analysis]
341 Sair AT, Liu RH. Molecular regulation of phenolic compounds on IGF-1 signaling cascade in breast cancer. Food Funct 2022;13:3170-84. [PMID: 35253808 DOI: 10.1039/d1fo03283f] [Reference Citation Analysis]
342 Liu Q, Luo X, Yi L, Zeng X, Tan C. First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis. Front Oncol 2021;11:699781. [PMID: 34268124 DOI: 10.3389/fonc.2021.699781] [Reference Citation Analysis]
343 Pincus J, Greenberg JW, Natale C, Koller CR, Miller S, Silberstein JL, Krane LS. Five-Year Prospective Observational Study of African-American Men on Active Surveillance for Prostate Cancer Demonstrates Race Is Not Predictive of Oncologic Outcomes. Oncologist 2022:oyac154. [PMID: 35920550 DOI: 10.1093/oncolo/oyac154] [Reference Citation Analysis]
344 Qian H, Shao X, Zhang H, Wang Y, Liu S, Pan J, Xue W. Diagnosis of urogenital cancer combining deep learning algorithms and surface-enhanced Raman spectroscopy based on small extracellular vesicles. Spectrochim Acta A Mol Biomol Spectrosc 2022;281:121603. [PMID: 35868057 DOI: 10.1016/j.saa.2022.121603] [Reference Citation Analysis]
345 Chen X, Yang D, Carey JPW, Karakas C, Albarracin C, Sahin AA, Arun BK, Guray Durak M, Li M, Kohansal M, Bui TN, Ha MJ, Hunt KK, Keyomarsi K. Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration. Cancers (Basel) 2021;13:1656. [PMID: 33916118 DOI: 10.3390/cancers13071656] [Reference Citation Analysis]
346 Hao S, Mitsakos A, Popowicz P, Irish W, Snyder RA, Parikh AA. Differential effects of the Affordable Care Act on the stage at presentation and receipt of treatment for pancreatic adenocarcinoma. J Surg Oncol 2022. [PMID: 35699593 DOI: 10.1002/jso.26984] [Reference Citation Analysis]
347 Pastorino U, Boeri M, Sestini S, Sabia F, Milanese G, Silva M, Suatoni P, Verri C, Cantarutti A, Sverzellati N, Corrao G, Marchianò A, Sozzi G. Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial. Annals of Oncology 2022. [DOI: 10.1016/j.annonc.2022.01.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
348 Xie Q, Li S, Feng X, Shi J, Li Y, Yuan G, Yang C, Shen Y, Kong L, Zhang Z. All-in-one approaches for triple-negative breast cancer therapy: metal-phenolic nanoplatform for MR imaging-guided combinational therapy. J Nanobiotechnology 2022;20:226. [PMID: 35549947 DOI: 10.1186/s12951-022-01416-7] [Reference Citation Analysis]
349 Ma P, Zou C, Xia S. Oncogenic signaling pathway mediated by Notch pathway-related genes induces immunosuppression and immunotherapy resistance in hepatocellular carcinoma. Immunogenetics 2022. [PMID: 35895154 DOI: 10.1007/s00251-022-01273-6] [Reference Citation Analysis]
350 Yang R, Xiong X, Wang H, Li W. Explainable Machine Learning Model to Prediction EGFR Mutation in Lung Cancer. Front Oncol 2022;12:924144. [DOI: 10.3389/fonc.2022.924144] [Reference Citation Analysis]
351 Wang X, Lu X, Wang P, Chen Q, Xiong L, Tang M, Hong C, Lin X, Shi K, Liang L, Lin J. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner. J Transl Med 2022;20:198. [PMID: 35509101 DOI: 10.1186/s12967-022-03399-3] [Reference Citation Analysis]
352 Harvey M, Ong WL, Chao M, Udovicich C, McBride S, Bolton D, Eastham J, Perera M. Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer. BJU Int 2022. [PMID: 35689413 DOI: 10.1111/bju.15821] [Reference Citation Analysis]
353 Heard JR, Naser-Tavakolian A, Nazmifar M, Ahdoot M. Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes. Prostate Cancer Prostatic Dis 2022. [PMID: 35246609 DOI: 10.1038/s41391-022-00501-0] [Reference Citation Analysis]
354 Goyal S, Sharma M, Sharma R. Bioactive compound from Lagerstroemia speciosa: activating apoptotic machinery in pancreatic cancer cells. 3 Biotech 2022;12:96. [PMID: 35371901 DOI: 10.1007/s13205-022-03155-w] [Reference Citation Analysis]
355 Omofuma OO, Steck SE, Olshan AF, Troester MA. The association between meat and fish intake by preparation methods and breast cancer in the Carolina Breast Cancer Study (CBCS). Breast Cancer Res Treat 2022. [PMID: 35275284 DOI: 10.1007/s10549-022-06555-x] [Reference Citation Analysis]
356 Du YB, Wang XF, Liu XJ, Li Y, Miao QF, Jiang M, Sheng WJ, Zhen YS. The recombinant defensin/HSA fusion protein that inhibits NF-κb associated with intensive macropinocytosis shows potent efficacy against pancreatic cancer. Biochem Pharmacol 2022;:115057. [PMID: 35489393 DOI: 10.1016/j.bcp.2022.115057] [Reference Citation Analysis]
357 Rhea LP, Aragon-Ching JB. Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer. Clin Med Insights Oncol 2021;15:11795549211044963. [PMID: 34602833 DOI: 10.1177/11795549211044963] [Reference Citation Analysis]
358 Wang L, Peng Y, Zeng X, Peng L, Li S, Qin S, Wan X, Tan C. Cost-Effectiveness Analysis of Cemiplimab Versus Chemotherapy as First-Line Treatment in Advanced NSCLC with PD-L1 Expression Levels of at Least 50. Adv Ther 2021;38:4354-65. [PMID: 34241780 DOI: 10.1007/s12325-021-01828-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
359 Lee MS, Pant S. Personalizing Medicine With Germline and Somatic Sequencing in Advanced Pancreatic Cancer: Current Treatments and Novel Opportunities. Am Soc Clin Oncol Educ Book 2021;41:1-13. [PMID: 33929876 DOI: 10.1200/EDBK_321255] [Reference Citation Analysis]
360 Guo Y, Zheng Z, Zhang W, Mao S, Yang F, Li W, Yan Y, Yao X. Gender dimorphism in survival of patients with lymph node metastasis of bladder cancer. Ther Adv Med Oncol 2022;14:17588359221108690. [PMID: 35782750 DOI: 10.1177/17588359221108690] [Reference Citation Analysis]
361 Zhang X, Tao X, Feng F. Downregulation of C12orf75 gene inhibits migration and invasion of liver cancer cell via suppressing the Wnt/β-catenin signaling pathway in vitro. Biochemical and Biophysical Research Communications 2022;614:92-9. [DOI: 10.1016/j.bbrc.2022.05.018] [Reference Citation Analysis]
362 Qu M, Li J, Yuan L. Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation. Bioengineered 2021;12:12940-53. [PMID: 34847838 DOI: 10.1080/21655979.2021.2012626] [Reference Citation Analysis]
363 Folch EE, Bowling MR, Pritchett MA, Murgu SD, Nead MA, Flandes J, Krimsky WS, Mahajan AK, LeMense GP, Murillo BA, Bansal S, Lau K, Gildea TR, Christensen M, Arenberg DA, Singh J, Bhadra K, Hogarth DK, Towe CW, Lamprecht B, Bezzi M, Mattingley JS, Hood KL, Lin H, Wolvers JJ, Khandhar SJ; NAVIGATE Study Investigators. NAVIGATE 24-Month Results: Electromagnetic navigation bronchoscopy for pulmonary lesions at 37 centers in Europe and the United States. J Thorac Oncol 2021:S1556-0864(21)03414-6. [PMID: 34973418 DOI: 10.1016/j.jtho.2021.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
364 Liu Z, Qin T, Yuan X, Yang J, Shi W, Zhang X, Jia Y, Liu S, Wang J, Li K. Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab. Front Oncol 2022;12:875888. [PMID: 35664796 DOI: 10.3389/fonc.2022.875888] [Reference Citation Analysis]
365 Alghanim F, Li KZ, An M, Verceles AC, Grier WR, Abbas H, Deepak J. Exploring the effects of racial and socioeconomic factors on timeliness of lung cancer diagnosis and treatment in Baltimore Veterans. Seminars in Oncology 2022. [DOI: 10.1053/j.seminoncol.2022.07.001] [Reference Citation Analysis]
366 Kumar R, Maurya AK, Parker KD, Kant R, Ibrahim H, Kabir MI, Kumar D, Weber AM, Agarwal R, Kuhn KA, Ryan EP, Raina K. Gender-based effect of absence of gut microbiota on the protective efficacy of Bifidobacterium longum-fermented rice bran diet against inflammation-associated colon tumorigenesis. Mol Carcinog 2022. [PMID: 35856887 DOI: 10.1002/mc.23452] [Reference Citation Analysis]
367 Xiong X, Xu H, Wang S, Liao X, Yi X, Jin K, Lei H, Bai S, Qiu S, Yang L. Association of Novel Androgen Receptor Axis-Targeted Therapies With Diarrhea in Patients With Prostate Cancer: A Bayesian Network Analysis. Front Med 2022;8:800823. [DOI: 10.3389/fmed.2021.800823] [Reference Citation Analysis]
368 Attili I, Del Re M, Guerini-Rocco E, Crucitta S, Pisapia P, Pepe F, Barberis M, Troncone G, Danesi R, de Marinis F, Malapelle U, Passaro A. The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies. Expert Rev Mol Diagn 2021;21:757-66. [PMID: 34278933 DOI: 10.1080/14737159.2021.1943365] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
369 Xiao R, Liu C, He W, Ma L. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma. Biomed Res Int 2021;2021:6736008. [PMID: 34805402 DOI: 10.1155/2021/6736008] [Reference Citation Analysis]
370 Kim MC, Jin Z, Kolb R, Borcherding N, Chatzkel JA, Falzarano SM, Zhang W. Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma. Cancers (Basel) 2021;13:5856. [PMID: 34831009 DOI: 10.3390/cancers13225856] [Reference Citation Analysis]
371 Tsai CW, Chang WS, Xu Y, Huang M, Bau DT, Gu J. Associations of genetically predicted circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with bladder cancer risk. Mol Carcinog 2021. [PMID: 34293213 DOI: 10.1002/mc.23334] [Reference Citation Analysis]
372 Meng W, Li Y, Chai B, Liu X, Ma Z. miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer. IJMS 2022;23:8518. [DOI: 10.3390/ijms23158518] [Reference Citation Analysis]
373 Boettcher M, Joechner A, Li Z, Yang SF, Schlegel P. Development of CAR T Cell Therapy in Children-A Comprehensive Overview. J Clin Med 2022;11:2158. [PMID: 35456250 DOI: 10.3390/jcm11082158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
374 Sugumar K, Hue JJ, Hardacre JM, Ammori JB, Rothermel LD, Dorth J, Saltzman J, Mohamed A, Selfridge JE, Bajor D, Winter JM, Ocuin LM. Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-operatively managed stage II-III pancreatic adenocarcinoma. HPB (Oxford) 2021:S1365-182X(21)01582-3. [PMID: 34465529 DOI: 10.1016/j.hpb.2021.08.938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
375 Liu J, Kang R, Tang D. The Art of War: Ferroptosis and Pancreatic Cancer. Front Pharmacol 2021;12:773909. [PMID: 34955844 DOI: 10.3389/fphar.2021.773909] [Reference Citation Analysis]
376 Song Q, Zheng Y, Wu J, Wang S, Meng L, Yao Q, Li Z, Lian S. PTP4A3 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Papillary Renal Cell Carcinoma. Front Immunol 2021;12:717688. [PMID: 34630392 DOI: 10.3389/fimmu.2021.717688] [Reference Citation Analysis]
377 Becker L, Janssen N, Layland SL, Mürdter TE, Nies AT, Schenke-Layland K, Marzi J. Raman Imaging and Fluorescence Lifetime Imaging Microscopy for Diagnosis of Cancer State and Metabolic Monitoring. Cancers (Basel) 2021;13:5682. [PMID: 34830837 DOI: 10.3390/cancers13225682] [Reference Citation Analysis]
378 Pan C, Luo N, Guo K, Wang W, Li L, Fan N, Tian Y. Members of the Chromobox Family Have Prognostic Value in Hepatocellular Carcinoma. Front Genet 2022;13:887925. [DOI: 10.3389/fgene.2022.887925] [Reference Citation Analysis]
379 Lin X, Guo L, Lin X, Wang Y, Zhang G. Expression and prognosis analysis of mitochondrial ribosomal protein family in breast cancer. Sci Rep 2022;12:10658. [PMID: 35739158 DOI: 10.1038/s41598-022-14724-7] [Reference Citation Analysis]
380 Shao Y, Xu K, Zheng X, Zhou B, Zhang X, Wang L, Sun Y, Li D, Chen T, Wang J, Yu S, Sun L, Xu X, Dai S, Gao H, Ruan G, Liu W, Cai X, Zhu T, Qi L, Chen J, Hu W, Weng X, Zhu Y, Xiang X, Hu Z, Li J, Chen L, Shao J, Zheng S, Guo T. Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target. Cancer Commun (Lond) 2021. [PMID: 34862750 DOI: 10.1002/cac2.12240] [Reference Citation Analysis]
381 Isaac EI, Hall J, Dault JB, Elbich J, Mcghee A, Fields EC. Transarterial Chemoembolization with LC Bead LUMI followed by Stereotactic Body Radiation Therapy in Treatment of Hepatocellular Carcinoma. Advances in Radiation Oncology 2022;7:100830. [DOI: 10.1016/j.adro.2021.100830] [Reference Citation Analysis]
382 Li Q, Deng Y, Wei W, Yang F, Lin A, Yao D, Zhu X, Li J. Development and External Validation of a Novel Model for Predicting Postsurgical Recurrence and Overall Survival After Cytoreductive R0 Resection of Epithelial Ovarian Cancer. Front Oncol 2022;12:859409. [DOI: 10.3389/fonc.2022.859409] [Reference Citation Analysis]
383 Kang HS, Kim JY, Kim JJ, Kim S, Lee NK, Lee JW, Suh HB, Hwangbo L, Son Y, Grimm R. Diffusion Kurtosis MR Imaging of Invasive Breast Cancer: Correlations With Prognostic Factors and Molecular Subtypes. J Magn Reson Imaging 2021. [PMID: 34792837 DOI: 10.1002/jmri.27999] [Reference Citation Analysis]
384 Hu S, Gu S, Wang S, Qi C, Shi C, Qian F, Fan G. Robust Prediction of Prognosis and Immunotherapy Response for Bladder Cancer through Machine Learning Algorithm. Genes (Basel) 2022;13:1073. [PMID: 35741835 DOI: 10.3390/genes13061073] [Reference Citation Analysis]
385 Hu D, Pan M, Yang Y, Sun A, Chen Y, Yuan L, Huang K, Qu Y, He C, Wei Q, Qian Z. Trimodal Sono/Photoinduced Focal Therapy for Localized Prostate Cancer: Single‐Drug‐Based Nanosensitizer under Dual‐Activation. Adv Funct Mater 2021;31:2104473. [DOI: 10.1002/adfm.202104473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
386 Len JM, Hussein N, Malla S, Mcintosh K, Patidar R, Elangovan M, Chandrabose K, Moorthy NSHN, Pandey M, Raman D, Trivedi P, Tiwari AK. A Novel Dialkylamino-Functionalized Chalcone, DML6, Inhibits Cervical Cancer Cell Proliferation, In Vitro, via Induction of Oxidative Stress, Intrinsic Apoptosis and Mitotic Catastrophe. Molecules 2021;26:4214. [PMID: 34299490 DOI: 10.3390/molecules26144214] [Reference Citation Analysis]
387 Yu M, Tan J, Wang J. [Research Progress of Single Cell Sequencing in Lung Cancer]. Zhongguo Fei Ai Za Zhi 2021;24:279-83. [PMID: 33910276 DOI: 10.3779/j.issn.1009-3419.2021.102.04] [Reference Citation Analysis]
388 Yang J, Li X, Yang X, Wei H, Deng L, Fu N. Aberrant blood cell division cycle 42 expression and its correlation with disease severity, inflammation and mortality risk in patients with acute pancreatitis. Exp Ther Med 2022;24:458. [PMID: 35747149 DOI: 10.3892/etm.2022.11385] [Reference Citation Analysis]
389 Islami F, Fedewa SA, Thomson B, Nogueira L, Yabroff KR, Jemal A. Association between disparities in intergenerational economic mobility and cause-specific mortality among Black and White persons in the United States. Cancer Epidemiol 2021;:101998. [PMID: 34364819 DOI: 10.1016/j.canep.2021.101998] [Reference Citation Analysis]
390 Wang X, Yin G, Zhang W, Song K, Zhang L, Guo Z. Prostaglandin Reductase 1 as a Potential Therapeutic Target for Cancer Therapy. Front Pharmacol 2021;12:717730. [PMID: 34421612 DOI: 10.3389/fphar.2021.717730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Yin X, Chen H, Chen S, Zhang S, Korivi M. Screening and Validation of a Carvacrol-Targeting Viability-Regulating Protein, SLC6A3, in Liver Hepatocellular Carcinoma. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/3736104] [Reference Citation Analysis]
392 Sassine D, Liu C, Sonoda Y, Chi DS. Safety and Efficacy of Supradiaphragmatic Lymph Node Dissection in Advanced Ovarian Cancer. Journal of Gynecologic Surgery. [DOI: 10.1089/gyn.2022.0030] [Reference Citation Analysis]
393 Habib JR, He J. Time for a More Holistic Approach to Peri-Pancreatoduodenectomy Care. Ann Surg Oncol 2021;28:4084-5. [PMID: 33811305 DOI: 10.1245/s10434-021-09876-1] [Reference Citation Analysis]
394 Gan J, Zeng X, Wang X, Wu Y, Lei P, Wang Z, Yang C, Hu Z. Effective Diagnosis of Prostate Cancer Based on mRNAs From Urinary Exosomes. Front Med (Lausanne) 2022;9:736110. [PMID: 35402423 DOI: 10.3389/fmed.2022.736110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Luo D, Liu Y, Yuan S, Bi X, Yang Y, Zhu H, Li Z, Ji L, Yu X. The emerging role of NR2F1-AS1 in the tumorigenesis and progression of human cancer. Pathology - Research and Practice 2022;235:153938. [DOI: 10.1016/j.prp.2022.153938] [Reference Citation Analysis]
396 Hu Q, Hong X, Xu L, Jia R. A nomogram for accurately predicting the pathological upgrading of prostate cancer, based on 68 Ga-PSMA PET/CT. Prostate 2022. [PMID: 35468221 DOI: 10.1002/pros.24358] [Reference Citation Analysis]
397 Yin Z, Zhou M, Liao T, Xu J, Fan J, Deng J, Jin Y. Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma. Front Oncol 2021;11:673567. [PMID: 35083132 DOI: 10.3389/fonc.2021.673567] [Reference Citation Analysis]
398 Li YZ, Zhu HC, Du Y, Zhao HC, Wang L. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling. Technol Cancer Res Treat 2022;21:15330338221077803. [PMID: 35167383 DOI: 10.1177/15330338221077803] [Reference Citation Analysis]
399 Lee EJ, Suh JD, Cho JH. The incidence of prostate cancer is increased in patients with obstructive sleep apnea: Results from the national insurance claim data 2007-2014. Medicine (Baltimore) 2021;100:e24659. [PMID: 33578596 DOI: 10.1097/MD.0000000000024659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
400 Sun L, Xu M, Zhang G, Dong L, Wu J, Wei C, Xu K, Zhang L. Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma. Int J Genomics 2021;2021:1326463. [PMID: 34988221 DOI: 10.1155/2021/1326463] [Reference Citation Analysis]
401 Li Z, Spoelstra NS, Sikora MJ, Sams SB, Elias A, Richer JK, Lee AV, Oesterreich S. Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer. NPJ Breast Cancer 2022;8:62. [PMID: 35538119 DOI: 10.1038/s41523-022-00426-w] [Reference Citation Analysis]
402 Shen W, Tong D, Chen J, Li H, Hu Z, Xu S, He S, Ge Z, Zhang J, Mao Q, Chen H, Xu G. Silencing oncogene cell division cycle associated 5 induces apoptosis and G1 phase arrest of non‐small cell lung cancer cells via p53‐p21 signaling pathway. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24396] [Reference Citation Analysis]
403 Nagariya N, Chaudhari K, Vasu VT. Circadian disruption in lung cancer. Chronobiol Int 2021;:1-12. [PMID: 34369216 DOI: 10.1080/07420528.2021.1963759] [Reference Citation Analysis]
404 Wu Y, Deng Y, Wei B, Xiang D, Hu J, Zhao P, Lin S, Zheng Y, Yao J, Zhai Z, Wang S, Lou W, Yang S, Zhang D, Lyu J, Dai Z. Global, regional, and national childhood cancer burden, 1990-2019: An analysis based on the Global Burden of Disease Study 2019. J Adv Res 2022:S2090-1232(22)00127-8. [PMID: 35700919 DOI: 10.1016/j.jare.2022.06.001] [Reference Citation Analysis]
405 Bytnar JA, Shriver CD, Zhu K. Incidence rates of digestive cancers among U.S. military servicemen: Comparison with the rates in the general U.S. population. PLoS One 2021;16:e0257087. [PMID: 34478468 DOI: 10.1371/journal.pone.0257087] [Reference Citation Analysis]
406 Aristizabal P, Winestone LE, Umaretiya P, Bona K. Disparities in Pediatric Oncology: The 21st Century Opportunity to Improve Outcomes for Children and Adolescents With Cancer. Am Soc Clin Oncol Educ Book 2021;41:e315-26. [PMID: 34061564 DOI: 10.1200/EDBK_320499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
407 Zhang W, Zhang R, Zeng Y, Li Y, Chen Y, Zhou J, Zhang Y, Wang A, Zhu J, Liu Z, Yan Z, Huang JA. ALCAP2 inhibits lung adenocarcinoma cell proliferation, migration and invasion via the ubiquitination of β-catenin by upregulating the E3 ligase NEDD4L. Cell Death Dis 2021;12:755. [PMID: 34330894 DOI: 10.1038/s41419-021-04043-6] [Reference Citation Analysis]
408 Rounds L, Nagle RB, Muranyi A, Jandova J, Gill S, Vela E, Wondrak GT. Glyoxalase 1 Expression as a Novel Diagnostic Marker of High-Grade Prostatic Intraepithelial Neoplasia in Prostate Cancer. Cancers (Basel) 2021;13:3608. [PMID: 34298821 DOI: 10.3390/cancers13143608] [Reference Citation Analysis]
409 Wu X, Jiang D, Liu H, Lu X, Lv D, Liang L. CD8+ T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma. Front Immunol 2021;12:745945. [PMID: 34970257 DOI: 10.3389/fimmu.2021.745945] [Reference Citation Analysis]
410 Kim SH, Singh SV. The FoxQ1 transcription factor is a novel regulator of electron transport chain complex I subunits in human breast cancer cells. Mol Carcinog 2021. [PMID: 34939230 DOI: 10.1002/mc.23381] [Reference Citation Analysis]
411 Tang X, Wang J, Tao H, Yuan L, Du G, Ding Y, Xu K, Bai X, Li Y, Sun Y, Huang X, Zheng X, Li Q, Gong B, Zheng Y, Xu J, Xu X, Wang Z, Bo X, Lu M, Li H, Chen H. Regulatory patterns analysis of transcription factor binding site clustered regions and identification of key genes in endometrial cancer. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.014] [Reference Citation Analysis]
412 Zhu Y, Yang L, Li Q, Chen B, Hao Q, Sun X, Tan J, Li W. Factors associated with concurrent malignancy risk among patients with incidental solitary pulmonary nodule: A systematic review taskforce for developing rapid recommendations. J Evid Based Med 2022. [PMID: 35794787 DOI: 10.1111/jebm.12481] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
413 Li JJ, Zhu M, Kashyap PC, Chia N, Tran NH, McWilliams RR, Bekaii-Saab TS, Ma WW. The role of microbiome in pancreatic cancer. Cancer Metastasis Rev 2021;40:777-89. [PMID: 34455517 DOI: 10.1007/s10555-021-09982-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
414 Schröder SK, Pinoé-schmidt M, Weiskirchen R. Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3. Cells 2022;11:260. [DOI: 10.3390/cells11020260] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
415 Wang CQ, Tang CH, Wang Y, Huang BF, Hu GN, Wang Q, Shao JK. Upregulated WTAP expression appears to both promote breast cancer growth and inhibit lymph node metastasis. Sci Rep 2022;12:1023. [PMID: 35046505 DOI: 10.1038/s41598-022-05035-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
416 Shah RM, Sheikh S, Shah J, Vivian E, Mejia A, Shahin I, Mantry PS. Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center. J Gastrointest Oncol 2021;12:1718-31. [PMID: 34532122 DOI: 10.21037/jgo-20-435] [Reference Citation Analysis]
417 Du K, Sun S, Jiang T, Liu T, Zuo X, Xia X, Liu X, Wang Y, Bu Y. E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry. Int J Biol Sci 2022;18:4151-70. [PMID: 35844795 DOI: 10.7150/ijbs.72386] [Reference Citation Analysis]
418 Zeng W, Pan J, Fang Z, Jia J, Zhang R, He M, Zhong H, He J, Yang X, Shi Y, Zhong B, Zeng J, Fu B, Huang M, Liu H. A Novel PD-L1-Containing MSLN Targeting Vaccine for Lung Cancer Immunotherapy. Front Immunol 2022;13:925217. [DOI: 10.3389/fimmu.2022.925217] [Reference Citation Analysis]
419 Mickel TA, Kutlu OC, Silberfein EJ, Hsu C, Chai CY, Fisher WE, Van Buren G, Camp ER. Factors associated with inability to return to intended oncologic treatment in pancreatic cancer. The American Journal of Surgery 2022. [DOI: 10.1016/j.amjsurg.2022.02.058] [Reference Citation Analysis]
420 Sinawang PD, Soto F, Ozen MO, Akin D, Demirci U. Progress and challenges in biomarker enrichment for cancer early detection. Prog Biomed Eng 2021;3:043001. [DOI: 10.1088/2516-1091/ac1ea3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
421 Hannafon BN. Involvement of the Tumor Microenvironment in the Pathogenesis of Breast Cancer. Am J Pathol 2021;191:1328-9. [PMID: 34097898 DOI: 10.1016/j.ajpath.2021.05.012] [Reference Citation Analysis]
422 Feng Y, Lei X, Zhang L, Wan H, Pan H, Wu J, Zou M, Zhu L, Mi Y. COPB2: a transport protein with multifaceted roles in cancer development and progression. Clin Transl Oncol 2021. [PMID: 34101128 DOI: 10.1007/s12094-021-02630-9] [Reference Citation Analysis]
423 Tan ML, Ling L, Fischbach C. Engineering strategies to capture the biological and biophysical tumor microenvironment in vitro. Adv Drug Deliv Rev 2021;176:113852. [PMID: 34197895 DOI: 10.1016/j.addr.2021.113852] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
424 Huang S, Zhao J, Song J, Li Y, Zuo R, Sa Y, Ma Z, OuYang H. Interferon alpha-inducible protein 27 (IFI27) is a prognostic marker for pancreatic cancer based on comprehensive bioinformatics analysis. Bioengineered 2021;12:8515-28. [PMID: 34592906 DOI: 10.1080/21655979.2021.1985858] [Reference Citation Analysis]
425 Yang D, Piao Y, Yuan F, Chen H, Zhang D, Li X. Gastric side effects and the stomach dosimetric analysis in left-sided breast cancer radiotherapy in free-breathing and deep inspiration breath-hold technique. Radiat Oncol 2022;17:2. [PMID: 34980180 DOI: 10.1186/s13014-021-01963-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
426 Chou R, Dana T, Haymart M, Leung AM, Tufano RP, Sosa JA, Ringel MD. Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review. Thyroid 2022;32:351-67. [PMID: 35081743 DOI: 10.1089/thy.2021.0539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
427 Girish BP, Dariya B, Mannarapu M, Nagaraju GP, Raju GSR. Targeting the tumor microenvironment of pancreatic ductal adenocarcinoma using nano-phytomedicines. Semin Cancer Biol 2021:S1044-579X(21)00184-X. [PMID: 34147639 DOI: 10.1016/j.semcancer.2021.06.014] [Reference Citation Analysis]
428 Xu Y, Peng Y, Shen M, Liu L, Lei J, Gao S, Wang Y, Lan A, Li H, Liu S, Raza F. Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients. Journal of Oncology 2022;2022:1-21. [DOI: 10.1155/2022/1525245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
429 Pan T, Han D, Xu Y, Peng W, Bai L, Zhou X, He H. LC-MS Based Metabolomics Study of the Effects of EGCG on A549 Cells. Front Pharmacol 2021;12:732716. [PMID: 34650434 DOI: 10.3389/fphar.2021.732716] [Reference Citation Analysis]
430 Kwiatkowska D, Mazur E, Reich A. YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance. Front Oncol 2022;12:856963. [DOI: 10.3389/fonc.2022.856963] [Reference Citation Analysis]
431 Huang J, Xu Z, Jiang Y, Law WC, Dong B, Zeng X, Ma M, Xu G, Zou J, Yang C. Metal organic framework-coated gold nanorod as an on-demand drug delivery platform for chemo-photothermal cancer therapy. J Nanobiotechnology 2021;19:219. [PMID: 34281545 DOI: 10.1186/s12951-021-00961-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
432 Khachfe HH, Habib JR, Chahrour MA, Harthi SA, Suhool A, Hallal AH, Jamali FJ. Pancreaticoduodenectomy (Whipple Procedure) research output: A 30-year bibliometric analysis. Surgery in Practice and Science 2022;8:100053. [DOI: 10.1016/j.sipas.2021.100053] [Reference Citation Analysis]
433 Du X, He Q, Zhang B, Li N, Zeng X, Li W. Diagnostic accuracy of diffusion-weighted imaging in differentiating glioma recurrence from posttreatment-related changes: a meta-analysis. Expert Rev Anticancer Ther 2021;:1-8. [PMID: 34727815 DOI: 10.1080/14737140.2022.2000396] [Reference Citation Analysis]
434 Cheng S, Qu B, Qiu X, Li N, Wang X, Hao J. Efficacy and safety of Kanglaite injection combined with chemotherapy for women breast cancer: A protocol for systematic review and meta-analysis of randomized clinical trials. Medicine (Baltimore) 2021;100:e26245. [PMID: 34087912 DOI: 10.1097/MD.0000000000026245] [Reference Citation Analysis]
435 Philip EJ, Zhang S, Tahir P, Kim D, Wright F, Bell A, Borno HT. Cost-Effectiveness of Immunotherapy Treatments for Renal Cell Carcinoma: A Systematic Review. KCA 2021;5:47-62. [DOI: 10.3233/kca-200107] [Reference Citation Analysis]
436 Piao S, Zheng L, Zheng H, Zhou M, Feng Q, Zhou S, Ke M, Yang H, Wang X, Wang F. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration. Journal of Immunology Research 2022;2022:1-28. [DOI: 10.1155/2022/2922832] [Reference Citation Analysis]
437 Kappel C, Jiang DM, Wong B, Zhang T, Selvarajah S, Warner E, Hansen AR, Fallah-rad N, Sacher AG, Stockley TL, Bedard PL, Sridhar SS. Comprehensive Genomic Profiling of Treatment Resistant Metastatic Castrate Sensitive Prostate Cancer Reveals High Frequency of Potential Therapeutic Targets. Clinical Genitourinary Cancer 2022. [DOI: 10.1016/j.clgc.2022.02.004] [Reference Citation Analysis]
438 Liu L, Chen C, Tu G, Peng Y, Shen M, Xu Y, Liu S. Pyroptosis-Related lncRNAs for Predicting the Prognosis and Identifying Immune Microenvironment Infiltration in Breast Cancer Lung Metastasis. Front Cell Dev Biol 2022;10:821727. [DOI: 10.3389/fcell.2022.821727] [Reference Citation Analysis]
439 Suto H, Okano K, Oshima M, Ando Y, Matsukawa H, Takahashi S, Shibata T, Kamada H, Masaki T, Suzuki Y. Prediction of local tumor control and recurrence-free survival in patients with pancreatic cancer undergoing curative resection after neoadjuvant chemoradiotherapy. J Surg Oncol 2022. [PMID: 35289928 DOI: 10.1002/jso.26854] [Reference Citation Analysis]
440 Xie J, Li Y, Qiu M, Liu X, Zhou S, Jiang J. Risk factors and nursing countermeasures of postoperative pulmonary infection in patients with breast cancer: A retrospective analysis. Medicine (Baltimore) 2021;100:e26952. [PMID: 34664826 DOI: 10.1097/MD.0000000000026952] [Reference Citation Analysis]
441 Zhang X, Lu D, Szporn AH, Zakowski MF, Si Q. A comparative study of the genotype profiles of high-risk human papillomavirus infection in male and female HIV-positive patients and their correlation with anal cytology and biopsy. J Am Soc Cytopathol 2021:S2213-2945(21)00219-2. [PMID: 34625384 DOI: 10.1016/j.jasc.2021.08.005] [Reference Citation Analysis]
442 Woollam M, Wang L, Grocki P, Liu S, Siegel AP, Kalra M, Goodpaster JV, Yokota H, Agarwal M. Tracking the Progression of Triple Negative Mammary Tumors over Time by Chemometric Analysis of Urinary Volatile Organic Compounds. Cancers (Basel) 2021;13:1462. [PMID: 33806757 DOI: 10.3390/cancers13061462] [Reference Citation Analysis]
443 Maisel BA, Yi M, Peck AR, Sun Y, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Nevalainen MT, Tanaka T, Simone N, Wang LL, Rui H, Chervoneva I. Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer. Cancers (Basel) 2022;14:308. [PMID: 35053472 DOI: 10.3390/cancers14020308] [Reference Citation Analysis]
444 Wang X, Wang H, Zhou S. Progress and Perspective on Carbon-Based Nanozymes for Peroxidase-like Applications. J Phys Chem Lett 2021;12:11751-60. [PMID: 34854687 DOI: 10.1021/acs.jpclett.1c03219] [Reference Citation Analysis]
445 Hsu S, Chu Y, Syue W, Lin HY, Chang W, Chen JY, Wu C, Yen C, Cheng K, Chiu C. The Role of Nonapoptotic Programmed Cell Death — Ferroptosis, Necroptosis, and Pyroptosis — in Pancreatic Ductal Adenocarcinoma Treatment. Front Oncol 2022;12:872883. [DOI: 10.3389/fonc.2022.872883] [Reference Citation Analysis]
446 Hathaway C, Paetsch P, Li Y, Wu J, Asgarian S, Parker A, Welsh A, Deverka P, Cohain A. Association of Breast Cancer Screening Behaviors With Stage at Breast Cancer Diagnosis and Potential for Additive Multi-Cancer Detection via Liquid Biopsy Screening: A Claims-Based Study. Front Oncol 2021;11:688455. [PMID: 34222015 DOI: 10.3389/fonc.2021.688455] [Reference Citation Analysis]
447 Song C, Kim KB, Lee JH, Kim S. Bioinformatic Analysis for Influential Core Gene Identification and Prognostic Significance in Advanced Serous Ovarian Carcinoma. Medicina (Kaunas) 2021;57:933. [PMID: 34577856 DOI: 10.3390/medicina57090933] [Reference Citation Analysis]
448 Sun Y, Xie J, Cai S, Wang Q, Feng Z, Li Y, Lu JJ, Chen W, Ye Z. Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth. Cell Death Dis 2021;12:913. [PMID: 34615858 DOI: 10.1038/s41419-021-04205-6] [Reference Citation Analysis]
449 Zuo C, Zou Y, Gao G, Sun L, Yu B, Guo Y, Wang X, Han M. Photothermal combined with intratumoral injection of annonaceous acetogenin nanoparticles for breast cancer therapy. Colloids Surf B Biointerfaces 2022;213:112426. [PMID: 35219964 DOI: 10.1016/j.colsurfb.2022.112426] [Reference Citation Analysis]
450 Makboul R, Abdelkawi IF, Badary DM, Hussein MRA, Rhim JS, Toraih EA, Zerfaoui M, Abd Elmageed ZY. Transmembrane and Tetratricopeptide Repeat Containing 4 Is a Novel Diagnostic Marker for Prostate Cancer with High Specificity and Sensitivity. Cells 2021;10:1029. [PMID: 33925440 DOI: 10.3390/cells10051029] [Reference Citation Analysis]
451 Choi SH, Yoo SS, Lee SY, Park JY. Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer. Arch Pharm Res 2022. [PMID: 35449345 DOI: 10.1007/s12272-022-01382-6] [Reference Citation Analysis]
452 Badowska-Kozakiewicz A, Fudalej M, Kwaśniewska D, Durlik M, Nasierowska-Guttmejer A, Mormul A, Włoszek E, Czerw A, Banaś T, Deptała A. Diabetes Mellitus and Pancreatic Ductal Adenocarcinoma-Prevalence, Clinicopathological Variables, and Clinical Outcomes. Cancers (Basel) 2022;14:2840. [PMID: 35740504 DOI: 10.3390/cancers14122840] [Reference Citation Analysis]
453 Zhu Y, Yu J, Zhang K, Feng Y, Guo K, Sun L, Ruan S. Network Pharmacology Analysis to Explore the Pharmacological Mechanism of Effective Chinese Medicines in Treating Metastatic Colorectal Cancer using Meta-Analysis Approach. Am J Chin Med 2021;49:1839-70. [PMID: 34781857 DOI: 10.1142/S0192415X21500877] [Reference Citation Analysis]
454 Inoue A, Robinson FS, Minelli R, Tomihara H, Rizi BS, Rose JL, Kodama T, Srinivasan S, Harris AL, Zuniga AM, Mullinax RA, Ma X, Seth S, Daniele JR, Peoples MD, Loponte S, Akdemir KC, Khor TO, Feng N, Roszik J, Sobieski MM, Brunell D, Stephan C, Giuliani V, Deem AK, Shingu T, Deribe YL, Menter DG, Heffernan TP, Viale A, Bristow CA, Kopetz S, Draetta GF, Genovese G, Carugo A. Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer. Gastroenterology 2021;161:196-210. [PMID: 33745946 DOI: 10.1053/j.gastro.2021.03.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
455 Bie F, Tian H, Sun N, Zang R, Zhang M, Song P, Liu L, Peng Y, Bai G, Zhou B, Gao S. Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC. Front Oncol 2022;12:769124. [PMID: 35223466 DOI: 10.3389/fonc.2022.769124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
456 Yang K, Chen J, Wu H, Tian H, Ye X, Xu J, Luo X, Dong F. S-Thyroid Computer-Aided Diagnosis Ultrasound System of Thyroid Nodules: Correlation Between Transverse and Longitudinal Planes. Front Physiol 2022;13:909277. [DOI: 10.3389/fphys.2022.909277] [Reference Citation Analysis]
457 Toraih EA, Hussein MH, Zerfaoui M, Attia AS, Marzouk Ellythy A, Mostafa A, Ruiz EML, Shama MA, Russell JO, Randolph GW, Kandil E. Site-Specific Metastasis and Survival in Papillary Thyroid Cancer: The Importance of Brain and Multi-Organ Disease. Cancers (Basel) 2021;13:1625. [PMID: 33915699 DOI: 10.3390/cancers13071625] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
458 Chen H, Hu Z, Sang M, Ni S, Lin Y, Wu C, Mu Y, Liu K, Wu S, Li N, Xu G. Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma. Front Genet 2021;12:767694. [PMID: 34956321 DOI: 10.3389/fgene.2021.767694] [Reference Citation Analysis]
459 Wu Y, Zhang X, Zhou H, Xu B, Tian J, Sun S, Zhang J. Synthesis, preclinical evaluation, and first-in-human study of Al18F-PSMA-Q for prostate cancer imaging. Eur J Nucl Med Mol Imaging 2022. [PMID: 35396969 DOI: 10.1007/s00259-022-05775-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
460 Yi X, Shen M, Liu X, Gu J. Emerging strategies based on nanomaterials for ionizing radiation-optimized drug treatment of cancer. Nanoscale 2021;13:13943-61. [PMID: 34477676 DOI: 10.1039/d1nr03034e] [Reference Citation Analysis]
461 Yang KH, Lin YS, Wang SC, Lee MY, Tang JY, Chang FR, Chuang YT, Sheu JH, Chang HW. Soft Coral-Derived Dihydrosinularin Exhibits Antiproliferative Effects Associated with Apoptosis and DNA Damage in Oral Cancer Cells. Pharmaceuticals (Basel) 2021;14:994. [PMID: 34681218 DOI: 10.3390/ph14100994] [Reference Citation Analysis]
462 Bansod S, Dodhiawala PB, Lim KH. Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities. Cancers (Basel) 2021;13:5481. [PMID: 34771644 DOI: 10.3390/cancers13215481] [Reference Citation Analysis]
463 Santos T, Tariq A, Gichoya JW, Trivedi H, Banerjee I. Automatic Classification of Cancer Pathology Reports: A Systematic Review. J Pathol Inform 2022;13:100003. [PMID: 35242443 DOI: 10.1016/j.jpi.2022.100003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
464 Takahashi N, Takekuma M. Current trends in chemotherapy for advanced ovarian cancer. Jpn J Clin Oncol 2022:hyac065. [PMID: 35521913 DOI: 10.1093/jjco/hyac065] [Reference Citation Analysis]
465 Sun L, Gai Y, Li Z, Li H, Li J, Muschler J, Kang R, Tang D, Zeng D. Heterodimeric RGD-NGR PET Tracer for the Early Detection of Pancreatic Cancer. Mol Imaging Biol 2022. [PMID: 35229260 DOI: 10.1007/s11307-022-01704-6] [Reference Citation Analysis]
466 Shi X, Huang X, Chen R, Li Y, Xu Y, Zhang W, Zhu Q, Zha X, Wang J. The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing NONO. Clin Exp Metastasis 2021;38:551-71. [PMID: 34714466 DOI: 10.1007/s10585-021-10128-5] [Reference Citation Analysis]
467 Lazzeri M, Chiti A. PSMA PET-CT: the winner takes it all. Eur J Nucl Med Mol Imaging 2021;48:3760-1. [PMID: 34432119 DOI: 10.1007/s00259-021-05534-6] [Reference Citation Analysis]
468 Mehraj U, Mir IA, Hussain MU, Alkhanani M, Wani NA, Mir MA. Adapalene and Doxorubicin Synergistically Promote Apoptosis of TNBC Cells by Hyperactivation of the ERK1/2 Pathway Through ROS Induction. Front Oncol 2022;12:938052. [PMID: 35875119 DOI: 10.3389/fonc.2022.938052] [Reference Citation Analysis]
469 Hilmi M, Neuzillet C, Lefèvre JH, Svrcek M, Vacher S, Benhaim L, Dartigues P, Samalin E, Lazartigues J, Emile JF, Rigault E, Rioux-Leclercq N, de La Fouchardière C, Tougeron D, Cacheux W, Mariani P, Courtois L, Delaye M, Dangles-Marie V, Lièvre A, Bieche I. Prognostic Value of Fusobacterium nucleatum after Abdominoperineal Resection for Anal Squamous Cell Carcinoma. Cancers (Basel) 2022;14:1606. [PMID: 35406380 DOI: 10.3390/cancers14071606] [Reference Citation Analysis]
470 Chen H, Chen S, Chen C, Li A, Wei Z. Leucine zipper downregulated in cancer 1 may serve as a favorable prognostic biomarker by influencing proliferation, colony formation, cell cycle, apoptosis, and migration ability in hepatocellular carcinoma. Front Genet 2022;13:900951. [DOI: 10.3389/fgene.2022.900951] [Reference Citation Analysis]
471 Wang G, Gao Y, Chen Y, Wang K, Zhang S, Li G. Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development. Front Oncol 2022;12:921711. [DOI: 10.3389/fonc.2022.921711] [Reference Citation Analysis]
472 Chi F, Chen L, Jin X, He G, Liu Z, Han S. CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway. Experimental Cell Research 2022. [DOI: 10.1016/j.yexcr.2022.113035] [Reference Citation Analysis]
473 Long Q, Huang C, Huang J, Meng Q, Cheng Y, Li Y, He L, Chen M, Zhang C, Wang X, Zhu W, Peng J, Shi D, Zheng F, Dong P, Deng W. Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.11.016] [Reference Citation Analysis]
474 Pang X, Zhang J, He X, Gu Y, Qian BZ, Xie R, Yu W, Zhang X, Li T, Shi X, Zhou Y, Cui Y. SPP1 Promotes Enzalutamide Resistance and Epithelial-Mesenchymal-Transition Activation in Castration-Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways. Oxid Med Cell Longev 2021;2021:5806602. [PMID: 34721759 DOI: 10.1155/2021/5806602] [Reference Citation Analysis]
475 Zhou S, Sun Y, Chen T, Wang J, He J, Lyu J, Shen Y, Chen X, Yang R. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature. Front Cell Dev Biol 2021;9:739594. [PMID: 34660598 DOI: 10.3389/fcell.2021.739594] [Reference Citation Analysis]
476 Sahar L, Smith RA. If We Build It, They Will Come…Maybe. Chest 2021;160:34-5. [PMID: 34246373 DOI: 10.1016/j.chest.2021.04.029] [Reference Citation Analysis]
477 Zheng X, Gou Y, Jiang Z, Yang A, Yang Z, Qin S. Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma. Front Oncol 2021;11:740557. [PMID: 34765550 DOI: 10.3389/fonc.2021.740557] [Reference Citation Analysis]
478 Qiu Y, Wang X, Fan Z, Zhan S, Jiang X, Huang J. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma. Immun Inflamm Dis 2021. [PMID: 34432955 DOI: 10.1002/iid3.513] [Reference Citation Analysis]
479 Saeednejad Zanjani L, Razmi M, Fattahi F, Kalantari E, Abolhasani M, Saki S, Madjd Z, Mohsenzadegan M. Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression. J Cancer Res Clin Oncol 2021. [PMID: 34837545 DOI: 10.1007/s00432-021-03859-1] [Reference Citation Analysis]
480 Wang J, Shi W, Miao Y, Gan J, Guan Q, Ran J. Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13. Bioengineered 2021;12:6286-304. [PMID: 34494914 DOI: 10.1080/21655979.2021.1971029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
481 Umakoshi N, Iguchi T, Hiraki T, Matsui Y, Tomita K, Uka M, Kajita S, Araki M, Mitsuhashi T, Gobara H, Kanazawa S. Correlation between renal ablation zone in contrast-enhanced CT and non-enhanced MRI during the early period following percutaneous cryoablation. Jpn J Radiol 2022. [PMID: 35556212 DOI: 10.1007/s11604-022-01285-y] [Reference Citation Analysis]
482 Moreno V, Roda D, Pikiel J, Trigo J, Bosch-barrera J, Drew Y, Kristeleit R, Hiret S, Bajor DL, Cruz P, Beck JT, Ghosh S, Dabrowski C, Antony G, Duan T, Veneris J, Zografos E, Subramanian J. Safety and Efficacy of Dostarlimab in Patients with Recurrent/Advanced Non-Small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial. Clinical Lung Cancer 2022. [DOI: 10.1016/j.cllc.2022.05.013] [Reference Citation Analysis]
483 Chalasani NP, Porter K, Bhattacharya A, Book AJ, Neis BM, Xiong KM, Ramasubramanian TS, Edwards V DK, Chen I, Johnson S, Roberts LR, Kisiel JB, Reddy KR, Singal AG, Olson MC, Bruinsma JJ. Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00866-1. [PMID: 34391922 DOI: 10.1016/j.cgh.2021.08.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
484 Yeo D, Giardina C, Saxena P, Rasko JEJ. The next wave of cellular immunotherapies in pancreatic cancer. Mol Ther Oncolytics 2022;24:561-76. [PMID: 35229033 DOI: 10.1016/j.omto.2022.01.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
485 Maino Vieytes CA, Rodriguez-Zas SL, Madak-Erdogan Z, Smith RL, Zarins KR, Wolf GT, Rozek LS, Mondul AM, Arthur AE. Adherence to a priori-Defined Diet Quality Indices Throughout the Early Disease Course Is Associated With Survival in Head and Neck Cancer Survivors: An Application Involving Marginal Structural Models. Front Nutr 2022;9:791141. [PMID: 35548563 DOI: 10.3389/fnut.2022.791141] [Reference Citation Analysis]
486 Ivanov V, Yeh S, Mayer J, Saini L, Unal A, Boyiadzis M, Hoffman DM, Kang K, Addo SN, Mendes WL, Fathi AT. Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia. Future Oncology. [DOI: 10.2217/fon-2022-0450] [Reference Citation Analysis]
487 Yan X, Qu X, Liu B, Zhao Y, Xu L, Yu S, Wang J, Wang L, Su J. Autophagy-Induced HDAC6 Activity During Hypoxia Regulates Mitochondrial Energy Metabolism Through the β-Catenin/COUP-TFII Axis in Hepatocellular Carcinoma Cells. Front Oncol 2021;11:742460. [PMID: 34868939 DOI: 10.3389/fonc.2021.742460] [Reference Citation Analysis]
488 Chen L, Zhang E, Guan J, Chen Z, Ye J, Liu W, He J, Yin B, Song Y, Zhang M. A Combined CRISP3 and SPINK1 Prognostic Grade in EPS-Urine and Establishment of Models to Predict Prognosis of Patients With Prostate Cancer. Front Med 2022;9:832415. [DOI: 10.3389/fmed.2022.832415] [Reference Citation Analysis]
489 Bonadio RC, Freitas GF, Batista DN, Moreira OAN, Dias CAR, Castria TB, Sabbaga J, Hoff PM. Epidemiology and Outcomes of Patients With Brain Metastases From Colorectal Cancer-Who Are These Patients? Clin Colorectal Cancer 2021;20:e195-200. [PMID: 33966961 DOI: 10.1016/j.clcc.2021.04.002] [Reference Citation Analysis]
490 Scandurra C, Mangiapia F, La Rocca R, Di Bello F, De Lucia N, Muzii B, Cantone M, Zampi R, Califano G, Maldonato NM, Longo N. A cross-sectional study on demoralization in prostate cancer patients: the role of masculine self-esteem, depression, and resilience. Support Care Cancer 2022. [PMID: 35585203 DOI: 10.1007/s00520-022-07145-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
491 Yue M, Liu T, Yan G, Luo X, Wang L. LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer. Cancer Cell Int 2021;21:504. [PMID: 34544413 DOI: 10.1186/s12935-021-02180-8] [Reference Citation Analysis]
492 Russo GI, Sholklapper TN, Cocci A, Broggi G, Caltabiano R, Smith AB, Lotan Y, Morgia G, Kamat AM, Witjes JA, Daneshmand S, Desai MM, Gill IS, Cacciamani GE. Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis. Cancers (Basel) 2021;13:4378. [PMID: 34503188 DOI: 10.3390/cancers13174378] [Reference Citation Analysis]
493 Montes M, Arnes L. lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer? Expert Opin Ther Targets 2021;25:521-8. [PMID: 34077329 DOI: 10.1080/14728222.2021.1938541] [Reference Citation Analysis]
494 Xie Y, Du X, Zhao Y, Gong C, Hu S, You S, Song S, Hu X, Yang Z, Wang B. Chemotherapy Shows a Better Efficacy Than Endocrine Therapy in Metastatic Breast Cancer Patients with a Heterogeneous Estrogen Receptor Expression Assessed by 18F-FES PET. Cancers 2022;14:3531. [DOI: 10.3390/cancers14143531] [Reference Citation Analysis]
495 Kim SH, Singh SV. Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfide. Mol Carcinog 2022. [PMID: 35512572 DOI: 10.1002/mc.23415] [Reference Citation Analysis]
496 Miao L, Feng G, Yuan H. CircRNAs: a family number of miRNA regulatory transcriptome in laryngeal carcinoma. J Clin Lab Anal 2021;35:e24038. [PMID: 34617636 DOI: 10.1002/jcla.24038] [Reference Citation Analysis]
497 Chen Q, Che C, Liu J, Gong Z, Si M, Yang S, Yang G. Construction of an exosome-functionalized graphene oxide based composite bionic smart drug delivery system and its anticancer activity. Nanotechnology 2022;33. [PMID: 35008083 DOI: 10.1088/1361-6528/ac49bf] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
498 Qu C, Zeng P, Wang H, Yuan C, Yuan H, Xiu D. Application of Magnetic Resonance Imaging in Neoadjuvant Treatment of Pancreatic Ductal Adenocarcinoma. Magnetic Resonance Imaging. [DOI: 10.1002/jmri.28096] [Reference Citation Analysis]
499 Agostini A, Orlacchio A, Carbone C, Guerriero I. Understanding Tricky Cellular and Molecular Interactions in Pancreatic Tumor Microenvironment: New Food for Thought. Front Immunol 2022;13:876291. [DOI: 10.3389/fimmu.2022.876291] [Reference Citation Analysis]
500 Zhu X, Chen D, Li S, Zhang W, Li Y, Wang X, Zhou J, Wen Z. Albumin-To-Alkaline Phosphatase Ratio as a Novel and Promising Prognostic Biomarker in Patients Undergoing Esophagectomy for Carcinoma: A Propensity Score Matching Study. Front Oncol 2021;11:764076. [PMID: 34746006 DOI: 10.3389/fonc.2021.764076] [Reference Citation Analysis]
501 Han P, Yue J, Kong K, Hu S, Cao P, Deng Y, Li F, Zhao B. Signature identification of relapse-related overall survival of early lung adenocarcinoma after radical surgery. PeerJ 2021;9:e11923. [PMID: 34430085 DOI: 10.7717/peerj.11923] [Reference Citation Analysis]
502 Huang J, Yang J, Ding J, Zhou J, Yang R, Li J, Luo Y, Lu Q. Development and validation of an ultrasound-based prediction model for differentiating between malignant and benign solid pancreatic lesions. Eur Radiol 2022. [PMID: 35751698 DOI: 10.1007/s00330-022-08930-0] [Reference Citation Analysis]
503 Li B, Shao H, Gao L, Li H, Sheng H, Zhu L. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Deliv 2022;29:2130-61. [PMID: 35815678 DOI: 10.1080/10717544.2022.2094498] [Reference Citation Analysis]
504 Rampariag R, Chernyavskiy I, Al-Ajam M, Tsay JJ. Controversies and challenges in lung cancer screening. Semin Oncol 2022:S0093-7754(22)00056-2. [PMID: 35907666 DOI: 10.1053/j.seminoncol.2022.07.002] [Reference Citation Analysis]
505 Madariaga A, Oza AM. Wee1 Inhibition in Recurrent Serous Uterine Cancer: Science Paving the Way in a Challenging Disease. J Clin Oncol 2021;39:1513-7. [PMID: 33797939 DOI: 10.1200/JCO.21.00288] [Reference Citation Analysis]
506 Wei Z, Sijia F, Rui T, Yang L, Jianjun H, Bin W, Jing X. Analysis of differentially expressed proteins between HER2 positive and triple negative breast cancer and their prognostic significance. Ann Diagn Pathol 2021;55:151834. [PMID: 34610510 DOI: 10.1016/j.anndiagpath.2021.151834] [Reference Citation Analysis]
507 Lawal B, Kuo YC, Wu ATH, Huang HS. BC-N102 suppress breast cancer tumorigenesis by interfering with cell cycle regulatory proteins and hormonal signaling, and induction of time-course arrest of cell cycle at G1/G0 phase. Int J Biol Sci 2021;17:3224-38. [PMID: 34421361 DOI: 10.7150/ijbs.62808] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
508 Perez JM, Twigg CAI, Guan W, Thomas SN. Proteomic Analysis Reveals Low-Dose PARP Inhibitor-Induced Differential Protein Expression in BRCA1-Mutated High-Grade Serous Ovarian Cancer Cells. J Am Soc Mass Spectrom . [DOI: 10.1021/jasms.1c00215] [Reference Citation Analysis]
509 Ćulum NM, Cooper TT, Lajoie GA, Dayarathna T, Pasternak SH, Liu J, Fu Y, Postovit LM, Lagugné-Labarthet F. Characterization of ovarian cancer-derived extracellular vesicles by surface-enhanced Raman spectroscopy. Analyst 2021;146:7194-206. [PMID: 34714898 DOI: 10.1039/d1an01586a] [Reference Citation Analysis]
510 Krok-Schoen JL, Pennell ML, Saquib N, Naughton M, Zhang X, Shadyab AH, Kroenke CH, Bea JW, Peterson LL, Crane T, Wactawski-Wende J, Paskett ED. Correlates of physical activity among older breast cancer survivors: Findings from the Women's Health Initiative LILAC study. J Geriatr Oncol 2021:S1879-4068(21)00258-7. [PMID: 34893462 DOI: 10.1016/j.jgo.2021.11.012] [Reference Citation Analysis]
511 Xiao Y, Peng L, Xu H, Huang M, Yang C, Liu G, Ouyang X, Li X, Wang Y, Sheng L, Zhai D, Lin L, Liu L, Liu G, Gong L. Mechanism of Liver Regeneration During ALPPS. Front Cell Dev Biol 2022;10:916286. [PMID: 35756996 DOI: 10.3389/fcell.2022.916286] [Reference Citation Analysis]
512 Singh CK, George J, Chhabra G, Nihal M, Chang H, Ahmad N. Genetic Manipulation of Sirtuin 3 Causes Alterations of Key Metabolic Regulators in Melanoma. Front Oncol 2021;11:676077. [PMID: 33937086 DOI: 10.3389/fonc.2021.676077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
513 Ohki D, Yamamichi N, Sakaguchi Y, Takahashi Y, Kageyama-Yahara N, Yamamichi M, Takeuchi C, Tsuji Y, Sakai Y, Sakurai K, Tomida S, Koike K, Fujishiro M. Transcriptome of sessile serrated adenoma/polyps is associated with MSI-high colorectal cancer and decreased expression of CDX2. Cancer Med 2022. [PMID: 35535692 DOI: 10.1002/cam4.4810] [Reference Citation Analysis]
514 Ullah S, Ullah F, Karras DA, Rahman W, Ahmad G, Ijaz M, Gao T. CRDB: A Centralized Cancer Research DataBase and an example use case mining correlation statistics of cancer and covid-19 (Preprint). JMIR Cancer. [DOI: 10.2196/35020] [Reference Citation Analysis]
515 Liu J, Zheng X, Lin S, Han H, Xu C. A systematic review and meta-analysis on the prepectoral single-stage breast reconstruction. Support Care Cancer 2022. [PMID: 35182228 DOI: 10.1007/s00520-022-06919-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
516 Soares MR, Melanda FN, Lima Neto GSD, Takagi VM, Anjos AASD, Cunha LADD, Silva GPD, Santos BCD, Souza PCFD, Corrêa MLM. Tendência de mortalidade e análise de anos potenciais de vida perdidos por leucemias e linfomas no Brasil e em Mato Grosso. Rev bras epidemiol 2022;25:e220008. [DOI: 10.1590/1980-549720220008.supl.1.1] [Reference Citation Analysis]
517 Liu S, Lao Y, Wang Y, Li R, Fang X, Wang Y, Gao X, Dong Z. Role of RNA N6-Methyladenosine Modification in Male Infertility and Genital System Tumors. Front Cell Dev Biol 2021;9:676364. [PMID: 34124065 DOI: 10.3389/fcell.2021.676364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
518 Bree KK, Hensley PJ, Pettaway CA. Germline Mutations in African American Men With Prostate Cancer: Incidence, Implications and Diagnostic Disparities. Urology 2021:S0090-4295(21)00796-2. [PMID: 34453957 DOI: 10.1016/j.urology.2021.08.017] [Reference Citation Analysis]
519 Zhang J, Zhou Q, Xie K, Cheng L, Peng S, Xie R, Liu L, Zhang Y, Dong W, Han J, Huang M, Chen Y, Lin T, Huang J, Chen X. Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer. J Exp Clin Cancer Res 2021;40:203. [PMID: 34154613 DOI: 10.1186/s13046-021-01989-5] [Reference Citation Analysis]
520 Zhang H, Lin W, Chen D, Wang K, Tu W, Lin H, Li K, Ye S, Guan T, Chen Y. Cardiovascular and Other Competing Causes of Death in Male Breast Cancer Patients: A Population-Based Epidemiologic Study. Clin Interv Aging 2021;16:1393-401. [PMID: 34321871 DOI: 10.2147/CIA.S314689] [Reference Citation Analysis]
521 Steck SE, Su LJ, Antwi SO, Morris BB, Crawford B, Adams SA, Hebert JR, Fontham ETH, Bensen JT, Mohler JL, Arab L. Recreational and occupational physical activity in relation to prostate cancer aggressiveness: the North Carolina-Louisiana Prostate Cancer Project (PCaP). Cancer Causes Control 2022;33:875-87. [PMID: 35320830 DOI: 10.1007/s10552-022-01572-z] [Reference Citation Analysis]
522 Dong N, Moreno-Manuel A, Calabuig-Fariñas S, Gallach S, Zhang F, Blasco A, Aparisi F, Meri-Abad M, Guijarro R, Sirera R, Camps C, Jantus-Lewintre E. Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients. Cancers (Basel) 2021;13:2950. [PMID: 34204662 DOI: 10.3390/cancers13122950] [Reference Citation Analysis]
523 Su M, Zhang Z, Zhou L, Han C, Huang C, Nice EC. Proteomics, Personalized Medicine and Cancer. Cancers (Basel) 2021;13:2512. [PMID: 34063807 DOI: 10.3390/cancers13112512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
524 Peterson E, Harris K, Farjah F, Akinsoto N, Marcotte LM. Improving smoking history documentation in the electronic health record for lung cancer risk assessment and screening in primary care: A case study. Healthc (Amst) 2021;9:100578. [PMID: 34450358 DOI: 10.1016/j.hjdsi.2021.100578] [Reference Citation Analysis]
525 Knisely A, Huang Y, Li Y, Prabhu VS, Wright JD. Adjuvant and First Line Chemotherapy Use for Endometrial Cancer. Gynecologic Oncology Reports 2022. [DOI: 10.1016/j.gore.2022.101002] [Reference Citation Analysis]
526 Santa-Inez DC, Fuziwara CS, Saito KC, Kimura ET. Targeting the Highly Expressed microRNA miR-146b with CRISPR/Cas9n Gene Editing System in Thyroid Cancer. Int J Mol Sci 2021;22:7992. [PMID: 34360757 DOI: 10.3390/ijms22157992] [Reference Citation Analysis]
527 Raj W, Jerczynski K, Rahimi M, Pavlova E, Šlouf M, Przekora A, Pietrasik J. Stimuli-responsive vitamin E-based micelles: Effective drug carriers with a controlled anticancer drug release. Polymer 2022;253:125001. [DOI: 10.1016/j.polymer.2022.125001] [Reference Citation Analysis]
528 Theodosakis N, Ugwu-Dike P, Pahalyants V, Reynolds K, Semenov Y. Title: Immune-checkpoint inhibitor therapy is underutilized in the US: A multi-institutional cohort analysis. Immunol Lett 2021:S0165-2478(21)00185-1. [PMID: 34974035 DOI: 10.1016/j.imlet.2021.12.005] [Reference Citation Analysis]
529 Mirzaei S, Gholami MH, Zabolian A, Saleki H, Farahani MV, Hamzehlou S, Far FB, Sharifzadeh SO, Samarghandian S, Khan H, Aref AR, Ashrafizadeh M, Zarrabi A, Sethi G. Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer. Pharmacol Res 2021;171:105759. [PMID: 34245864 DOI: 10.1016/j.phrs.2021.105759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
530 Wu Y, Zhang X, Wei X, Feng H, Hu B, Deng Z, Liu B, Luan Y, Ruan Y, Liu X, Liu Z, Liu J, Wang T. Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma. Front Cell Dev Biol 2021;9:684643. [PMID: 34239875 DOI: 10.3389/fcell.2021.684643] [Reference Citation Analysis]
531 Neil JM, Marotta C, Gonzalez I, Chang Y, Levy DE, Wint A, Harris K, Hawari S, Noonan E, Styklunas G, Crute S, Howard SE, Sheppard J, Lennes IT, Jacobson F, Flores EJ, Haas JS, Park ER, Rigotti NA. Integrating tobacco treatment into lung cancer screening practices: Study protocol for the Screen ASSIST randomized clinical trial. Contemp Clin Trials 2021;111:106586. [PMID: 34606988 DOI: 10.1016/j.cct.2021.106586] [Reference Citation Analysis]
532 Maurice NM, Tanner NT. Lung cancer screening at the VA: Past, present and future. Seminars in Oncology 2022. [DOI: 10.1053/j.seminoncol.2022.06.001] [Reference Citation Analysis]
533 Zhao L, Yin X, Qin J, Wang W, He X. Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis. Front Genet 2022;13:807466. [DOI: 10.3389/fgene.2022.807466] [Reference Citation Analysis]
534 Li Y, Wang S, Zhang X, Yang R, Wei X, Yan R, Jiang Y, Shen W. Expression Characteristics and Significant Prognostic Values of PGK1 in Breast Cancer. Front Mol Biosci 2021;8:695420. [PMID: 34291087 DOI: 10.3389/fmolb.2021.695420] [Reference Citation Analysis]
535 Wedding U. Palliative care of patients with haematological malignancies: strategies to overcome difficulties via integrated care. The Lancet Healthy Longevity 2021;2:e746-53. [DOI: 10.1016/s2666-7568(21)00213-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
536 Olesch C, Brunn D, Aktay-cetin Ö, Sirait-fischer E, Pullamsetti SS, Grimminger F, Seeger W, Brüne B, Weigert A, Savai R. Picturing of the Lung Tumor Cellular Composition by Multispectral Flow Cytometry. Front Immunol 2022;13:827719. [DOI: 10.3389/fimmu.2022.827719] [Reference Citation Analysis]
537 Girisa S, Saikia Q, Bordoloi D, Banik K, Monisha J, Daimary UD, Verma E, Ahn KS, Kunnumakkara AB. Xanthohumol from Hop: Hope for cancer prevention and treatment. IUBMB Life 2021;73:1016-44. [PMID: 34170599 DOI: 10.1002/iub.2522] [Reference Citation Analysis]
538 Shil R, Ghosh R, Banerjee AK, Mal C. LncRNA, miRNA and transcriptional co-regulatory network of breast and ovarian cancer reveals hub molecules. Meta Gene 2022. [DOI: 10.1016/j.mgene.2022.101024] [Reference Citation Analysis]
539 Tu L, Liao Z, Luo Z, Wu Y, Herrmann A, Huo S. Ultrasound‐controlled drug release and drug activation for cancer therapy. Exploration 2021;1:20210023. [DOI: 10.1002/exp.20210023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
540 Harrison R, Ahmed M, Billah M, Sheckley F, Lulla T, Caviasco C, Sanders A, Lovallo G, Stifelman M. Single-port versus multiport partial nephrectomy: a propensity-score-matched comparison of perioperative and short-term outcomes. J Robotic Surg. [DOI: 10.1007/s11701-022-01415-8] [Reference Citation Analysis]
541 Denhup C. "Parenting Beyond the Veil": The Continued Parenting Relationship After a Child's Death Due to Cancer. J Pediatr Oncol Nurs 2021;38:364-74. [PMID: 34494927 DOI: 10.1177/10434542211041928] [Reference Citation Analysis]
542 Xu F, Guan Y, Xue L, Zhang P, Li M, Gao M, Chong T. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study. Cancer Med 2021. [PMID: 34761566 DOI: 10.1002/cam4.4395] [Reference Citation Analysis]
543 Huang KS, Wang YT, Byadgi O, Huang TY, Tai MH, Shaw JF, Yang CH. Screening of Specific and Common Pathways in Breast Cancer Cell Lines MCF-7 and MDA-MB-231 Treated with Chlorophyllides Composites. Molecules 2022;27:3950. [PMID: 35745070 DOI: 10.3390/molecules27123950] [Reference Citation Analysis]
544 Liu L, Liu H, Luo S, Patz EF Jr, Glass C, Su L, Lin L, Christiani DC, Wei Q. Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival. Front Oncol 2021;11:717109. [PMID: 34692492 DOI: 10.3389/fonc.2021.717109] [Reference Citation Analysis]
545 Chlebowski RT, Aragaki AK, Pan K. Breast Cancer Prevention and Breast Cancer Mortality. JCO Oncol Pract 2022;:OP2200091. [PMID: 35312344 DOI: 10.1200/OP.22.00091] [Reference Citation Analysis]
546 Feng D, Shi X, Zhang F, Xiong Q, Wei Q, Yang L. Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy. Front Oncol 2022;12:858479. [PMID: 35463369 DOI: 10.3389/fonc.2022.858479] [Reference Citation Analysis]
547 Hu C, Tang J, Gao Y, Cao R. Effects of physical exercise on body fat and laboratory biomarkers in cancer patients: a meta-analysis of 35 randomized controlled trials. Support Care Cancer. [DOI: 10.1007/s00520-022-07013-6] [Reference Citation Analysis]
548 Zhao R, Dai Y, Li X, Zhu C. Construction and validation of a nomogram for non small cell lung cancer patients with liver metastases based on a population analysis. Sci Rep 2022;12:4011. [PMID: 35256719 DOI: 10.1038/s41598-022-07978-8] [Reference Citation Analysis]
549 He RQ, Li JD, Du XF, Dang YW, Yang LJ, Huang ZG, Liu LM, Liao LF, Yang H, Chen G. LPCAT1 overexpression promotes the progression of hepatocellular carcinoma. Cancer Cell Int 2021;21:442. [PMID: 34419067 DOI: 10.1186/s12935-021-02130-4] [Reference Citation Analysis]
550 Zangooei MH, Margolis R, Hoyt K. Multiscale computational modeling of cancer growth using features derived from microCT images. Sci Rep 2021;11:18524. [PMID: 34535748 DOI: 10.1038/s41598-021-97966-1] [Reference Citation Analysis]
551 Yang L, Wang Z. Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer. Biomedicines 2021;9:689. [PMID: 34207313 DOI: 10.3390/biomedicines9060689] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
552 Du XW, Li G, Liu J, Zhang CY, Liu Q, Wang H, Chen TS. Comprehensive analysis of the cancer driver genes in breast cancer demonstrates their roles in cancer prognosis and tumor microenvironment. World J Surg Oncol 2021;19:273. [PMID: 34507558 DOI: 10.1186/s12957-021-02387-z] [Reference Citation Analysis]
553 Zhang Z, Xu Y, Ma B, Ma Z, Han H. A novel electrochemical sensor based on process-formed laccase-like catalyst to degrade polyhydroquinone for tumor marker. Talanta 2021;235:122736. [PMID: 34517604 DOI: 10.1016/j.talanta.2021.122736] [Reference Citation Analysis]
554 Mattes MD, Ye JC, Peters GW, Rizvi F, Thomas TO, Chandra RA, Weiss E, Gutiontov SI, Motwani SB. Pilot Study Demonstrating the Value of Interdisciplinary Education on the Integration of Radiation Therapy in Lung Cancer Management. J Cancer Educ 2022. [PMID: 35357645 DOI: 10.1007/s13187-022-02158-8] [Reference Citation Analysis]
555 Li J, Peng L, Chen Q, Ye Z, Zhao T, Hou S, Gu J, Hang Q. Integrin β1 in Pancreatic Cancer: Expressions, Functions, and Clinical Implications. Cancers 2022;14:3377. [DOI: 10.3390/cancers14143377] [Reference Citation Analysis]
556 Ishibashi M, Norikane T, Yamamoto Y, Imajo M, Takami Y, Mitamura K, Tanaka T, Tsuruta T, Kanenishi K, Nishiyama Y. Correlation of bone marrow 2-deoxy-2-[18F]fluoro-D-glucose uptake with systemic inflammation in patients with newly diagnosed endometrial cancer. Nuclear Medicine Communications 2022;Publish Ahead of Print. [DOI: 10.1097/mnm.0000000000001583] [Reference Citation Analysis]
557 Hou W, Li Q, Liu X, Zeng Y, Cheng AS. Exploring the employment readiness and return to work status of breast cancer patients and related factors. Int J Nurs Sci 2021;8:426-31. [PMID: 34631993 DOI: 10.1016/j.ijnss.2021.09.001] [Reference Citation Analysis]
558 Walker EJ, Blanco AM, Carnevale J, Cinar P, Collisson EA, Tempero MA, Ko AH. The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing. Pancreas 2022;51:302-4. [PMID: 35695740 DOI: 10.1097/MPA.0000000000002021] [Reference Citation Analysis]
559 Arulkumar M, Yang K, Wang N, Penislusshiyan S, Palvannan T, Ramalingam K, Chen F, Luo S, Zhou Y, Wang Z. Synthesis of benzimidazole/triphenylamine-based compounds, evaluation of their bioactivities and an in silico study with receptor tyrosine kinases. New J Chem 2022;46:675-85. [DOI: 10.1039/d1nj05073g] [Reference Citation Analysis]
560 Jiang S, Fu Y, Zhang X, Yu T, Lu B, Du J. Research Progress of Carrier-Free Antitumor Nanoparticles Based on Phytochemicals. Front Bioeng Biotechnol 2021;9:799806. [PMID: 34957085 DOI: 10.3389/fbioe.2021.799806] [Reference Citation Analysis]
561 Candido JB, Maiques O, Boxberg M, Kast V, Peerani E, Tomás-Bort E, Weichert W, Sananes A, Papo N, Magdolen V, Sanz-Moreno V, Loessner D. Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 2021;13:3969. [PMID: 34439122 DOI: 10.3390/cancers13163969] [Reference Citation Analysis]
562 Dominguez-martinez I, Joaquin-ovalle F, Ferrer-acosta Y, Griebenow KH. Folate-Decorated Cross-Linked Cytochrome c Nanoparticles for Active Targeting of Non-Small Cell Lung Carcinoma (NSCLC). Pharmaceutics 2022;14:490. [DOI: 10.3390/pharmaceutics14030490] [Reference Citation Analysis]
563 Miriyala LKV, Avasthi D. Cutaneous Multiple Myeloma. Cureus 2021;13:e17779. [PMID: 34659990 DOI: 10.7759/cureus.17779] [Reference Citation Analysis]
564 Lee TY, Bates SE, Abou-Alfa GK. Equipoise, drug development, and biliary cancer. Cancer 2021. [PMID: 34817855 DOI: 10.1002/cncr.34020] [Reference Citation Analysis]
565 Malvi D, Vasuri F, Maloberti T, Sanza V, De Leo A, Fornelli A, Masetti M, Benini C, Lombardi R, Offi MF, Di Marco M, Ravaioli M, Fiorino S, Franceschi E, Brandes AA, Jovine E, D’errico A, Tallini G, de Biase D. Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel. Diagnostics 2022;12:1058. [DOI: 10.3390/diagnostics12051058] [Reference Citation Analysis]
566 George B. Precision Medicine and Pancreatic Cancer. Surg Oncol Clin N Am 2021;30:693-708. [PMID: 34511190 DOI: 10.1016/j.soc.2021.06.008] [Reference Citation Analysis]
567 Gu J, Huang W, Wang X, Zhang J, Tao T, Zheng Y, Liu S, Yang J, Chen ZS, Cai CY, Li J, Wang H, Fan Y. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. Mol Cancer 2022;21:112. [PMID: 35538494 DOI: 10.1186/s12943-022-01587-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
568 Bajbouj K, Al-Ali A, Ramakrishnan RK, Saber-Ayad M, Hamid Q. Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets. Int J Mol Sci 2021;22:11701. [PMID: 34769131 DOI: 10.3390/ijms222111701] [Reference Citation Analysis]
569 Wang C, Wang Y, Fu Z, Huang W, Yu Z, Wang J, Zheng K, Zhang S, Li S, Chen J. MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1. Front Oncol 2022;12:837581. [DOI: 10.3389/fonc.2022.837581] [Reference Citation Analysis]
570 Gaggianesi M, Mangiapane LR, Modica C, Pantina VD, Porcelli G, Di Franco S, Lo Iacono M, D'Accardo C, Verona F, Pillitteri I, Turdo A, Veschi V, Brancato OR, Muratore G, Pistone G, Bongiorno MR, Todaro M, De Maria R, Stassi G. Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells. Cancers (Basel) 2022;14:673. [PMID: 35158939 DOI: 10.3390/cancers14030673] [Reference Citation Analysis]
571 Hutchins T. Image Guided Head and Neck Biopsies: From Superficial to Deep. Tech Vasc Interv Radiol 2021;24:100769. [PMID: 34861969 DOI: 10.1016/j.tvir.2021.100769] [Reference Citation Analysis]
572 Doan DK, Schmidt KT, Chau CH, Figg WD. Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management. Cancers (Basel) 2021;13:2154. [PMID: 33947030 DOI: 10.3390/cancers13092154] [Reference Citation Analysis]
573 Newbury A, Ferguson C, Valero DA, Kutcher-Diaz R, McIntosh L, Karamanian A, Harman A. Interventional oncology update. Eur J Radiol Open 2022;9:100430. [PMID: 35761853 DOI: 10.1016/j.ejro.2022.100430] [Reference Citation Analysis]
574 Hou J, Li H, Ma S, He Z, Yang S, Hao L, Zhou H, Zhang Z, Han J, Wang L, Wang Q. EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives. Biomark Res 2022;10:21. [PMID: 35418149 DOI: 10.1186/s40364-022-00372-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
575 Lv J, Liu YY, Jia YT, He JL, Dai GY, Guo P, Zhao ZL, Zhang YN, Li ZX. A nomogram model for predicting prognosis of obstructive colorectal cancer. World J Surg Oncol 2021;19:337. [PMID: 34857001 DOI: 10.1186/s12957-021-02445-6] [Reference Citation Analysis]
576 Su Y, Gu X, Zheng Q, Zhu L, Lu J, Li L. LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility. Front Oncol 2022;12:847745. [DOI: 10.3389/fonc.2022.847745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
577 Rogers JE, Dasari A. Pharmacotherapy for unresectable metastatic colorectal cancer. Expert Opin Pharmacother 2021;:1-10. [PMID: 34534031 DOI: 10.1080/14656566.2021.1982895] [Reference Citation Analysis]
578 Ramírez H, Charris K, Fernandez-Moreira E, Nogueda-Torres B, Capparelli MV, Ángel J, Charris J. One-Pot Multicomponent Synthesis of Methoxybenzo[h]quinoline-3-carbonitrile Derivatives; Anti-Chagas, X-ray, and In Silico ADME/Tox Profiling Studies. Molecules 2021;26:6977. [PMID: 34834070 DOI: 10.3390/molecules26226977] [Reference Citation Analysis]
579 Wang L, Liu Z, Zhou Q, Gu S, Liu X, Huang J, Jiang H, Wang H, Cao L, Sun J, Shen Y, Meng H, Liu X. Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. Biomaterials 2021;278:121176. [PMID: 34656882 DOI: 10.1016/j.biomaterials.2021.121176] [Reference Citation Analysis]
580 Lee CT, Galloway TJ. Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis. Curr Treat Options Oncol 2022. [PMID: 35244887 DOI: 10.1007/s11864-022-00959-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
581 Petrella F. Diagnosis and Treatment of Primary and Secondary Lung Cancers. Cancers (Basel) 2021;13:448. [PMID: 33503954 DOI: 10.3390/cancers13030448] [Reference Citation Analysis]
582 Ren X, Ma L, Wang N, Zhou R, Wu J, Xie X, Zhang H, Liu D, Ma X, Dang C, Kang H, Zhou Z. Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma. Front Genet 2021;12:721252. [PMID: 34490047 DOI: 10.3389/fgene.2021.721252] [Reference Citation Analysis]
583 Hou M, Sun JH. Emerging applications of radiomics in rectal cancer: State of the art and future perspectives. World J Gastroenterol 2021; 27(25): 3802-3814 [PMID: 34321845 DOI: 10.3748/wjg.v27.i25.3802] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
584 Newhook TE, Vauthey J. Colorectal liver metastases: state-of-the-art management and surgical approaches. Langenbecks Arch Surg. [DOI: 10.1007/s00423-022-02496-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
585 Li D, Chen X, Wang D, Wu H, Wen H, Wang L, Jin Q, Wang D, Ji J, Tang BZ. Synchronously boosting type-I photodynamic and photothermal efficacies via molecular manipulation for pancreatic cancer theranostics in the NIR-II window. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
586 Abd-rabou AA, Edris AE. Frankincense essential oil nanoemulsion specifically induces lung cancer apoptosis and inhibits survival pathways. Cancer Nano 2022;13. [DOI: 10.1186/s12645-022-00128-9] [Reference Citation Analysis]
587 Gu L, Gong T, Ma Q, Zhong D. Retrospective study of EGFR-mutant lung adenocarcinoma with bone metastatic clinical features. Cancer Rep (Hoboken) 2022;:e1628. [PMID: 35614541 DOI: 10.1002/cnr2.1628] [Reference Citation Analysis]
588 Yu X, Wu M, Ding L, Yang J, Bai S. Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer. CMAR 2021;Volume 13:9297-304. [DOI: 10.2147/cmar.s343602] [Reference Citation Analysis]
589 Bou-Dargham MJ, Draughon S, Cantrell V, Khamis ZI, Sang QA. Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy. J Cancer 2021;12:6949-63. [PMID: 34729098 DOI: 10.7150/jca.64205] [Reference Citation Analysis]
590 Altschuler J, Stockert JA, Kyprianou N. Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance. Int J Mol Sci 2021;22:2100. [PMID: 33672595 DOI: 10.3390/ijms22042100] [Reference Citation Analysis]
591 Trivedi T, Pagnotti GM, Guise TA, Mohammad KS. The Role of TGF-β in Bone Metastases. Biomolecules 2021;11:1643. [PMID: 34827641 DOI: 10.3390/biom11111643] [Reference Citation Analysis]
592 Imai H, Onozato R, Ginnan M, Kobayashi D, Kaira K, Minato K. Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations. Medicina (Kaunas) 2021;57:508. [PMID: 34069436 DOI: 10.3390/medicina57050508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
593 Velasco RM, García AG, Sánchez PJ, Sellart IM, Sánchez-Arévalo Lobo VJ. Tumour microenvironment and heterotypic interactions in pancreatic cancer. J Physiol Biochem 2022. [PMID: 35102531 DOI: 10.1007/s13105-022-00875-8] [Reference Citation Analysis]
594 Song J, Zheng Y, Wang J, Ullah MZ, Li X, Zou Z, Ding G. Multi-feature deep information bottleneck network for breast cancer classification in contrast enhanced spectral mammography. Pattern Recognition 2022;131:108858. [DOI: 10.1016/j.patcog.2022.108858] [Reference Citation Analysis]
595 Shoucair S, Baker AR, Yu J. Germline Variants in DNA Damage Repair Genes: An Emerging Role in the Era of Precision Medicine in Pancreatic Adenocarcinoma. Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12514] [Reference Citation Analysis]
596 Galgano SJ, West JT, Rais-Bahrami S. Role of molecular imaging in the detection of localized prostate cancer. Ther Adv Urol 2022;14:17562872221105018. [PMID: 35755177 DOI: 10.1177/17562872221105018] [Reference Citation Analysis]
597 Hiatt RA, Kobetz EN, Paskett ED. Catchment Areas, Community Outreach and Engagement Revisited: The 2021 Guidelines for Cancer Center Support Grants from the National Cancer Institute. Cancer Prev Res (Phila) 2022;15:349-54. [PMID: 35652232 DOI: 10.1158/1940-6207.CAPR-22-0034] [Reference Citation Analysis]
598 Chen R, Hou B, Qiu S, Shao S, Yu Z, Zhou F, Guo B, Li Y, Zhang Y, Han T. Development and Validation of Nomogram for Predicting Survival of Primary Liver Cancers Using Machine Learning. Front Oncol 2022;12:926359. [DOI: 10.3389/fonc.2022.926359] [Reference Citation Analysis]
599 Niu G, Zhang X, Hong R, Yang X, Gu J, Song T, Hu Z, Chen L, Wang X, Xia J, Ke Z, Ren J, Hong L. GJA1 promotes hepatocellular carcinoma progression by mediating TGF-β-induced activation and the epithelial-mesenchymal transition of hepatic stellate cells. Open Med (Wars) 2021;16:1459-71. [PMID: 34693020 DOI: 10.1515/med-2021-0344] [Reference Citation Analysis]
600 Feng T, Zhao J, Wei D, Guo P, Yang X, Li Q, Fang Z, Wei Z, Li M, Jiang Y, Luo Y. Immunogenomic Analyses of the Prognostic Predictive Model for Patients With Renal Cancer. Front Immunol 2021;12:762120. [PMID: 34712244 DOI: 10.3389/fimmu.2021.762120] [Reference Citation Analysis]
601 Li X, Feng Y, Shang F, Yu Z, Wang T, Zhang J, Song Z, Wang P, Shi B, Wang J. Characterization of the Therapeutic Effects of Novel Chimeric Antigen Receptor T Cells Targeting CD38 on Multiple Myeloma. Front Oncol 2021;11:703087. [PMID: 34513682 DOI: 10.3389/fonc.2021.703087] [Reference Citation Analysis]
602 Hutchinson ID, Ata A, DiCaprio MR. Is Metformin Use Associated With Prolonged Overall Survival In Patients with Soft Tissue Sarcoma? A Surveillance, Epidemiology, and End Results-Medicare Study. Clin Orthop Relat Res 2021. [PMID: 34779790 DOI: 10.1097/CORR.0000000000002045] [Reference Citation Analysis]
603 Yao W, Wang J, Zhu L, Jia X, Xu L, Tian X, Hu S, Wu S, Wei L. Epigenetic Regulator KDM4D Restricts Tumorigenesis via Modulating SYVN1/HMGB1 Ubiquitination Axis in Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:761346. [PMID: 34820329 DOI: 10.3389/fonc.2021.761346] [Reference Citation Analysis]
604 Liu F, Lu X, Zhou X, Huang H. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis. Thorac Cancer 2021;12:2907-13. [PMID: 34545707 DOI: 10.1111/1759-7714.14151] [Reference Citation Analysis]
605 De La Torre S, Spruijt-Metz D, Farias AJ. Survivors' health competence mediates the association between wearable activity tracker use and self-rated health: HINTS analysis. J Cancer Surviv 2022. [PMID: 35001258 DOI: 10.1007/s11764-021-01112-9] [Reference Citation Analysis]
606 Flörsch B, Taugner J, Käsmann L, Kenndoff S, Guggenberger J, Tufman A, Reinmuth N, Duell T, Belka C, Eze C, Manapov F. Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis. J Cancer Res Clin Oncol 2022. [PMID: 35915184 DOI: 10.1007/s00432-022-04174-z] [Reference Citation Analysis]
607 Lin X, Qiu G, Li F, Deng H, Qin Y, Xie X, Jiang J, Song Y, Liu M, Zhou C. Case Report: A Rare Case of Metachronous Multiple Primary Lung Cancers in a Patient With Successful Management by Switching From Anti-PD-1 Therapy to Anti-PD-L1 Therapy. Front Immunol 2021;12:683202. [PMID: 34149722 DOI: 10.3389/fimmu.2021.683202] [Reference Citation Analysis]
608 Jordan RW, Shlapak DP, Benson JC, Diehn FE, Kim DK, Lehman VT, Liebo GB, Madhavan AA, Morris JM, Morris PP, Verdoorn JT, Carr CM. Percutaneous CT-Guided Core Needle Biopsies of Head and Neck Masses: Review of 184 Cases at a Single Academic Institution, Common and Special Techniques, Diagnostic Yield, and Safety. AJNR Am J Neuroradiol 2021. [PMID: 34887246 DOI: 10.3174/ajnr.A7348] [Reference Citation Analysis]
609 Satheeshkumar PS, Mohan MP. Association and risk factors of healthcare-associated infection and burden of illness among chemotherapy-induced ulcerative mucositis patients. Clin Oral Investig 2021. [PMID: 34355291 DOI: 10.1007/s00784-021-04106-0] [Reference Citation Analysis]
610 Zhou C, Jiang T, Xiao Y, Wang Q, Zeng Z, Cai P, Zhao Y, Zhao Z, Wu D, Lin H, Sun C, Zhang R, Xiao W, Gao Y. Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series. Front Immunol 2021;12:784336. [PMID: 34975873 DOI: 10.3389/fimmu.2021.784336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
611 Zhou WH, Wang Y, Yan C, Du WD, Al-Aroomi MA, Zheng L, Lin SF, Gao JX, Jiang S, Wang ZX, Sun CF, Liu FY. CC chemokine receptor 7 promotes macrophage recruitment and induces M2-polarization through CC chemokine ligand 19&21 in oral squamous cell carcinoma. Discov Oncol 2022;13:67. [PMID: 35904690 DOI: 10.1007/s12672-022-00533-x] [Reference Citation Analysis]
612 Cogliandro A, Salzillo R, Barone M, Tenna S, Cagli B, Persichetti P. Direct-to-Implant Breast Reconstruction After Unilateral and Bilateral Mastectomy: Cross-Sectional Study of Patient Satisfaction and Quality of Life with BREAST-Q. Aesthetic Plast Surg 2022. [PMID: 35927501 DOI: 10.1007/s00266-022-02986-5] [Reference Citation Analysis]
613 Zhang Y, Zhang B, Zhou W, Lu T. Management of Long-Term Sores and Ulcers of Breast Cancer Survivors With Chinese Herbal Medicines: A Case Report. Front Psychiatry 2022;13:874691. [DOI: 10.3389/fpsyt.2022.874691] [Reference Citation Analysis]
614 Zhao C, Zhang Z, Hu X, Zhang L, Liu Y, Wang Y, Guo Y, Zhang T, Li W, Li B. Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients. Front Endocrinol 2022;12:785192. [DOI: 10.3389/fendo.2021.785192] [Reference Citation Analysis]
615 Fang Y, Yang G, Yang J, Ren J, You L, Zhao Y. Human microbiota colonization and pancreatic ductal carcinoma. Crit Rev Microbiol 2022;:1-14. [PMID: 35924947 DOI: 10.1080/1040841X.2022.2080526] [Reference Citation Analysis]
616 Spicer JL. Retroperitoneal Liposarcoma: An Unusual Presentation of a Rare Cancer. J Adv Pract Oncol 2021;12:854-62. [PMID: 35295543 DOI: 10.6004/jadpro.2021.12.8.6] [Reference Citation Analysis]
617 Kalavska K, Sestakova Z, Mlcakova A, Gronesova P, Miskovska V, Rejlekova K, Svetlovska D, Sycova-mila Z, Obertova J, Palacka P, Mardiak J, Chovanec M, Chovanec M, Mego M. Comprehensive Assessment of Selected Immune Cell Subpopulations Changes in Chemotherapy-Naïve Germ Cell Tumor Patients. Front Oncol 2022;12:858797. [DOI: 10.3389/fonc.2022.858797] [Reference Citation Analysis]
618 Han X, Liu J, Liu Y, Mou L, Li C. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p. Cancer Manag Res 2021;13:4393-401. [PMID: 34103994 DOI: 10.2147/CMAR.S305547] [Reference Citation Analysis]
619 De Leo A, Santini D, Ceccarelli C, Santandrea G, Palicelli A, Acquaviva G, Chiarucci F, Rosini F, Ravegnini G, Pession A, Turchetti D, Zamagni C, Perrone AM, De Iaco P, Tallini G, de Biase D. What Is New on Ovarian Carcinoma: Integrated Morphologic and Molecular Analysis Following the New 2020 World Health Organization Classification of Female Genital Tumors. Diagnostics (Basel) 2021;11:697. [PMID: 33919741 DOI: 10.3390/diagnostics11040697] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 22.0] [Reference Citation Analysis]
620 Ranjan P, Abubakar Sadique M, Yadav S, Khan R. An Electrochemical Immunosensor Based on Gold-Graphene Oxide Nanocomposites with Ionic Liquid for Detecting the Breast Cancer CD44 Biomarker. ACS Appl Mater Interfaces 2022;14:20802-12. [PMID: 35482593 DOI: 10.1021/acsami.2c03905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
621 Liu Q, Shen H, Naguib A, Weiss RM, Martin DT. Knocking down claudin receptors leads to a decrease in prostate cancer cell migration, cell growth, cell viability and clonogenic cell survival. Mol Biomed 2021;2:31. [PMID: 35006480 DOI: 10.1186/s43556-021-00053-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
622 Wu SC, Li XY, Liao BJ, Xie K, Chen WM. Thyroid follicular renal cell carcinoma excluding thyroid metastases: A case report . World J Clin Cases 2022; 10(18): 6307-6313 [DOI: 10.12998/wjcc.v10.i18.6307] [Reference Citation Analysis]
623 Dong Y, Yin A, Xu C, Jiang H, Wang Q, Wu W, Guo S. OLA1 is a potential prognostic molecular biomarker for endometrial cancer and promotes tumor progression. Oncol Lett 2021;22:576. [PMID: 34122627 DOI: 10.3892/ol.2021.12837] [Reference Citation Analysis]
624 Eng C, Ciombor KK, Cho M, Dorth JA, Rajdev LN, Horowitz DP, Gollub MJ, Jácome AA, Lockney NA, Muldoon RL, Washington MK, O'Brian BA, Benny A, Lebeck Lee CM, Benson AB 3rd, Goodman KA, Morris VK. Anal Cancer: Emerging Standards in a Rare Rare Disease. J Clin Oncol 2022;:JCO2102566. [PMID: 35649196 DOI: 10.1200/JCO.21.02566] [Reference Citation Analysis]
625 Michaud D, Mirlekar B, Steward C, Bishop G, Pylayeva-Gupta Y. B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer. Front Immunol 2021;12:745873. [PMID: 35046933 DOI: 10.3389/fimmu.2021.745873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
626 Ramer R, Wendt F, Wittig F, Schäfer M, Boeckmann L, Emmert S, Hinz B. Impact of Cannabinoid Compounds on Skin Cancer. Cancers 2022;14:1769. [DOI: 10.3390/cancers14071769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
627 Dong L, Lin S, Zhong L, Nian D, Li Y, Wang R, Zhou W, Weng X, Xu X. Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis. Clin Breast Cancer 2021:S1526-8209(21)00146-4. [PMID: 34238670 DOI: 10.1016/j.clbc.2021.06.001] [Reference Citation Analysis]
628 Yang C, Chien T, Yen C, Wu W, Sheu J, Chang H. Antibladder Cancer Effects of Excavatolide C by Inducing Oxidative Stress, Apoptosis, and DNA Damage In Vitro. Pharmaceuticals 2022;15:917. [DOI: 10.3390/ph15080917] [Reference Citation Analysis]
629 Allelein S, Aerchlimann K, Rösch G, Khajehamiri R, Kölsch A, Freese C, Kuhlmeier D. Prostate-Specific Membrane Antigen (PSMA)-Positive Extracellular Vesicles in Urine-A Potential Liquid Biopsy Strategy for Prostate Cancer Diagnosis? Cancers (Basel) 2022;14:2987. [PMID: 35740652 DOI: 10.3390/cancers14122987] [Reference Citation Analysis]
630 Courand PY, Berger M, Bouali A, Harbaoui B, Lantelme P, Dalle S. Cardiac Effects of BRAF and MEK Inhibitors: Mechanisms and Clinical Management. Curr Oncol Rep 2022. [PMID: 35102484 DOI: 10.1007/s11912-022-01205-3] [Reference Citation Analysis]
631 Liu J, Shang G. The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets. Front Cell Dev Biol 2022;10:773038. [PMID: 35252166 DOI: 10.3389/fcell.2022.773038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
632 Ge L, Sun Y, Shi Y, Liu G, Teng F, Geng Z, Chen X, Xu H, Xu J, Jia X. Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer. J Ovarian Res 2022;15:58. [PMID: 35550610 DOI: 10.1186/s13048-022-00988-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
633 Fu Z, Li H, Xue P, Yu H, Yang S, Tao C, Li W, Wang Y, Zhang J, Wang Y. Implantable Bioresponsive Hydrogel Prevents Local Recurrence of Breast Cancer by Enhancing Radiosensitivity. Front Bioeng Biotechnol 2022;10:881544. [DOI: 10.3389/fbioe.2022.881544] [Reference Citation Analysis]
634 Li G, Guo BY, Wang HD, Lin GT, Lan TJ, Ying H, Xu J. CircRNA hsa_circ_0014130 function as a miR-132-3p sponge for playing oncogenic roles in bladder cancer via upregulating KCNJ12 expression. Cell Biol Toxicol 2021. [PMID: 34755307 DOI: 10.1007/s10565-021-09668-z] [Reference Citation Analysis]
635 Li L, Li P, Ma X, Zeng S, Peng Y, Zhang G. Therapeutic restoring p53 function with small molecule for oncogene-driven non-small cell lung cancer by targeting serine 392 phosphorylation. Biochem Pharmacol 2022;203:115188. [PMID: 35902040 DOI: 10.1016/j.bcp.2022.115188] [Reference Citation Analysis]
636 Zhang L, Zhang J, Liu T, Zhang J, Cui Y. Prognostic implication and immunological value of contactin 1 expression in pan‐cancer. Clinical and Translational Dis 2022;2. [DOI: 10.1002/ctd2.70] [Reference Citation Analysis]
637 de Andrade DAP, da Silva LS, Laus AC, de Lima MA, Berardinelli GN, da Silva VD, Matsushita GM, Bonatelli M, da Silva ALV, Evangelista AF, Carvalho JP, Reis RM, Dos Reis R. A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer. Front Oncol 2021;11:729219. [PMID: 34485158 DOI: 10.3389/fonc.2021.729219] [Reference Citation Analysis]
638 Gao L, Tang X, He Q, Sun G, Wang C, Qu H. Exosome-transmitted circCOG2 promotes colorectal cancer progression via miR-1305/TGF-β2/SMAD3 pathway. Cell Death Discov 2021;7:281. [PMID: 34635639 DOI: 10.1038/s41420-021-00680-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
639 Rahnamay Farnood P, Danesh Pazhooh R, Asemi Z, Yousefi B. DNA damage response and repair in pancreatic cancer development and therapy. DNA Repair (Amst) 2021;103:103116. [PMID: 33882393 DOI: 10.1016/j.dnarep.2021.103116] [Reference Citation Analysis]
640 Chen Y, Yi X, Sun N, Guo W, Li C. Epigenetics Regulates Antitumor Immunity in Melanoma. Front Immunol 2022;13:868786. [PMID: 35693795 DOI: 10.3389/fimmu.2022.868786] [Reference Citation Analysis]
641 Cui Y, Yu Y, Yu S, Li W, Wang Y, Li Q, Liu T. Phase I study of adjuvant chemotherapy with nab-paclitaxel and S-1 for stage III Lauren's diffuse-type gastric cancer after D2 resection (NORDICA study). Cancer Med 2022. [PMID: 35751496 DOI: 10.1002/cam4.4966] [Reference Citation Analysis]
642 Chi M, Xi Q, Su D, Li H, Wei N, Shi X, Wang S, Zuo Y, Yang L. Characterized the diversity of ABCB1 subtypes in immunogenomic landscape for predicting the drug response in breast cancer. Methods 2022:S1046-2023(22)00003-2. [PMID: 34999214 DOI: 10.1016/j.ymeth.2022.01.003] [Reference Citation Analysis]
643 Mckinnish TR, Greenwade MM, Wilkinson-ryan I, Schwarz JK, Powell MA, Mutch DG, Massad LS, Grigsby PW, Siegel BA, Thaker PH. Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomography. Gynecologic Oncology 2022. [DOI: 10.1016/j.ygyno.2022.04.018] [Reference Citation Analysis]
644 Wang G, Wang Y, Yang X, Zhang Y, Lu Y, Li Y. The expression and diagnostic value of serum levels of EphA2 and VEGF-A in patients with colorectal cancer. Cancer Biomark 2021;31:399-408. [PMID: 34092605 DOI: 10.3233/CBM-201745] [Reference Citation Analysis]
645 Group Young Researchers In Inflammatory Carcinogenesis, Wandmacher AM, Mehdorn AS, Sebens S. The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer. Cancers (Basel) 2021;13:4932. [PMID: 34638420 DOI: 10.3390/cancers13194932] [Reference Citation Analysis]
646 Li Y, Fang M, Xu Z, Li X. Tetrathiomolybdate as an old drug in a new use: As a chemotherapeutic sensitizer for non-small cell lung cancer. Journal of Inorganic Biochemistry 2022. [DOI: 10.1016/j.jinorgbio.2022.111865] [Reference Citation Analysis]
647 St-Denis-Bissonnette F, Khoury R, Mediratta K, El-Sahli S, Wang L, Lavoie JR. Applications of Extracellular Vesicles in Triple-Negative Breast Cancer. Cancers (Basel) 2022;14:451. [PMID: 35053616 DOI: 10.3390/cancers14020451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
648 Barry EL, Fedirko V, Jin Y, Liu K, Mott LA, Peacock JL, Passarelli MN, Baron JA, Jones DP. Plasma Metabolomics Analysis of Aspirin Treatment and Risk of Colorectal Adenomas. Cancer Prev Res (Phila) 2022:canprevres. [PMID: 35653338 DOI: 10.1158/1940-6207.CAPR-21-0555] [Reference Citation Analysis]
649 Gujrati H, Ha S, Mohamed A, Wang BD. MicroRNA-mRNA Regulatory Network Mediates Activation of mTOR and VEGF Signaling in African American Prostate Cancer. Int J Mol Sci 2022;23:2926. [PMID: 35328346 DOI: 10.3390/ijms23062926] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
650 Ma C, Wang X, Guo J, Liu P. Prognostic significance of preoperative serum triglycerides and high-density lipoproteins cholesterol in patients with non-small cell lung cancer: a retrospective study. Lipids Health Dis 2021;20:69. [PMID: 34598703 DOI: 10.1186/s12944-021-01492-y] [Reference Citation Analysis]
651 Pang Y, Bai G, Zhao J, Wei X, Li R, Li J, Hu S, Peng L, Liu P, Mao H. The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer. J Transl Med 2022;20:336. [PMID: 35902869 DOI: 10.1186/s12967-022-03545-x] [Reference Citation Analysis]
652 Hong S, Kim KW, Park HJ, Ko Y, Yoo C, Park SY, Khang S, Jeong H, Lee J. Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in Patients With Initially Metastatic Pancreatic Cancer. Front Oncol 2022;12:878472. [DOI: 10.3389/fonc.2022.878472] [Reference Citation Analysis]
653 An Y, Fan F, Jiang X, Sun K. Recent Advances in Liquid Biopsy of Brain Cancers. Front Genet 2021;12:720270. [PMID: 34603383 DOI: 10.3389/fgene.2021.720270] [Reference Citation Analysis]
654 Matulonis UA, Huang HQ, Filiaci VL, Randall M, DiSilvestro PA, Moxley KM, Fowler JM, Powell MA, Spirtos NM, Tewari KS, Richards WE, Nakayama JM, Mutch DG, Miller DS, Matei D, Wenzel LB. Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study. Gynecol Oncol 2021:S0090-8258(21)01625-5. [PMID: 34903380 DOI: 10.1016/j.ygyno.2021.11.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
655 Somasegar S, Hoppenot C, Kuchta K, Sereika A, Khandekar J, Rodriguez G, Moore E, Hurteau J, Vogel TJ. Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers. Gynecol Oncol 2021;163:220-8. [PMID: 34511240 DOI: 10.1016/j.ygyno.2021.08.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
656 Chiaino E, Micucci M, Budriesi R, Mattioli LB, Marzetti C, Corsini M, Frosini M. Hibiscus Flower and Olive Leaf Extracts Activate Apoptosis in SH-SY5Y Cells. Antioxidants (Basel) 2021;10:1962. [PMID: 34943065 DOI: 10.3390/antiox10121962] [Reference Citation Analysis]
657 Ghione S, Racoeur C, Mabrouk N, Shan J, Groetz E, Ballot E, Truntzer C, Chouchane L, Végran F, Paul C, Plenchette S, Bettaieb A. Protein Kinase Inhibitor-Mediated Immunoprophylactic and Immunotherapeutic Control of Colon Cancer. Front Immunol 2022;13:875764. [PMID: 35572581 DOI: 10.3389/fimmu.2022.875764] [Reference Citation Analysis]
658 Nozawa H, Ishizawa T, Yasunaga H, Ishii H, Sonoda H, Emoto S, Murono K, Sasaki K, Kawai K, Akamatsu N, Kaneko J, Arita J, Hasegawa K, Ishihara S. Open and/or laparoscopic one-stage resections of primary colorectal cancer and synchronous liver metastases: An observational study. Medicine (Baltimore) 2021;100:e25205. [PMID: 33726015 DOI: 10.1097/MD.0000000000025205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
659 Sartor O, Appukkuttan S, Weiss J, Tsao CK. Clinical outcomes, management, and treatment patterns in patients with metastatic castration-resistant prostate cancer treated with radium-223 in community compared to academic settings. Prostate 2021;81:657-66. [PMID: 33978244 DOI: 10.1002/pros.24143] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
660 Fang Q, Ni C, Cai Z, Li W, Xie J. Prognostic significance of hsa_circ_0048122 to predict liver metastasis in early‐stage colorectal cancer. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24577] [Reference Citation Analysis]
661 Ilyas AO, Alam MK, Musah JD, Yang M, Lam YW, Roy VAL, Lau C. Investigation on the Direct and Bystander Effects in HeLa Cells Exposed to Very Low α-Radiation Using Electrical Impedance Measurement. ACS Omega 2021;6:13995-4003. [PMID: 34124424 DOI: 10.1021/acsomega.0c05888] [Reference Citation Analysis]
662 Abufaied M, Jumbo U, Alqalalwah A, Hamad MK. Alpelisib-Induced Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer. Cureus 2021;13:e19441. [PMID: 34909343 DOI: 10.7759/cureus.19441] [Reference Citation Analysis]
663 Huo CL, Deng Y, Sun ZG. A comprehensive analysis of gasdermin family gene as therapeutic targets in pan-cancer. Sci Rep 2022;12:13329. [PMID: 35922531 DOI: 10.1038/s41598-022-17100-7] [Reference Citation Analysis]
664 Luo HL, Luo T, Liu JJ, Wu FX, Bai T, Ou C, Chen J, Li LQ, Zhong JH. Macrophage polarization-associated lnc-Ma301 interacts with caprin-1 to inhibit hepatocellular carcinoma metastasis through the Akt/Erk1 pathway. Cancer Cell Int 2021;21:422. [PMID: 34376192 DOI: 10.1186/s12935-021-02133-1] [Reference Citation Analysis]
665 Rivera-Soto R, Yu Y, Dittmer DP, Damania B. Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas. Front Oncol 2021;11:670275. [PMID: 34221985 DOI: 10.3389/fonc.2021.670275] [Reference Citation Analysis]
666 Godfrey TM, Villavicencio EA, Barra K, Sanderson PR, Shea K, Sun X, Garcia DO. Advancing Liver Cancer Prevention for American Indian Populations in Arizona: An Integrative Review. Int J Environ Res Public Health 2022;19:3268. [PMID: 35328956 DOI: 10.3390/ijerph19063268] [Reference Citation Analysis]
667 Zou X, He R, Zhang Z, Yan Y. Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma. Front Genet 2022;13:818403. [DOI: 10.3389/fgene.2022.818403] [Reference Citation Analysis]
668 Xu S, Liu Y, Ma H, Fang S, Wei S, Li X, Lu Z, Zheng Y, Liu T, Zhu X, Xu D, Pan Y. A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer. Front Genet 2022;13:834731. [DOI: 10.3389/fgene.2022.834731] [Reference Citation Analysis]
669 Shen Z, Liu S, Liu J, Liu J, Yao C. Weighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma. Front Genet 2021;12:756235. [PMID: 34868230 DOI: 10.3389/fgene.2021.756235] [Reference Citation Analysis]
670 Shaath H, Elango R, Alajez NM. Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer. Cancers (Basel) 2021;13:5350. [PMID: 34771513 DOI: 10.3390/cancers13215350] [Reference Citation Analysis]
671 Venugopal A, Carethers JM. Epidemiology and biology of early onset colorectal cancer. EXCLI J 2022;21:162-82. [PMID: 35221839 DOI: 10.17179/excli2021-4456] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
672 Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, Gao F. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol 2021; 27(27): 4298-4321 [PMID: 34366606 DOI: 10.3748/wjg.v27.i27.4298] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
673 Zhu J, Jiang Z, Xie B, Fu C, Xiao W, Li Y. Comparison of oncologic outcomes between pancreaticoduodenectomy and total pancreatectomy for pancreatic adenocarcinoma. Surg Endosc. [DOI: 10.1007/s00464-022-09441-1] [Reference Citation Analysis]
674 dos Reis AFP, Simão D, Odeny T, Rodrigues C, Fontes-sousa M, Luz RD, Chowdry RP, Welsh SJ, Paller C, Barata PC. A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer. KCA 2022. [DOI: 10.3233/kca-210012] [Reference Citation Analysis]
675 Ahmad IM, Dafferner AJ, O'Connell KA, Mehla K, Britigan BE, Hollingsworth MA, Abdalla MY. Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 2021;13:2264. [PMID: 34066839 DOI: 10.3390/cancers13092264] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
676 Wu Z, Lu Z, Li L, Ma M, Long F, Wu R, Huang L, Chou J, Yang K, Zhang Y, Li X, Hu G, Zhang Y, Lin C. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer. Front Immunol 2021;12:783362. [PMID: 35154072 DOI: 10.3389/fimmu.2021.783362] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
677 Zhang Y, Li JH, Yuan QG, Yang WB. Restraint of FAM60A has a cancer-inhibiting role in pancreatic carcinoma via the effects on the Akt/GSK-3β/β-catenin signaling pathway. Environ Toxicol 2022. [PMID: 35213078 DOI: 10.1002/tox.23496] [Reference Citation Analysis]
678 Guo X, Chen H, Zhou Y, Shen L, Wu S, Chen Y. Cyclin-dependent kinase inhibition and its intersection with immunotherapy in breast cancer: more than CDK4/6 inhibition. Expert Opin Investig Drugs 2022;:1-12. [PMID: 35786092 DOI: 10.1080/13543784.2022.2097067] [Reference Citation Analysis]
679 Soyama H, Nishio M, Otani J, Sakuma T, Takao S, Hara S, Masuda T, Mimori K, Toyokuni S, Lydon JP, Nakao K, Nishina H, Fukumoto T, Maehama T, Suzuki A. Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers. Proc Natl Acad Sci U S A 2022;119:e2123134119. [DOI: 10.1073/pnas.2123134119] [Reference Citation Analysis]
680 Liu Y, Shu X, Qiao X, Ai G, Liu L, Liao J, Qian S, He X. Radiomics-Based Machine Learning Models for Predicting P504s/P63 Immunohistochemical Expression: A Noninvasive Diagnostic Tool for Prostate Cancer. Front Oncol 2022;12:911426. [DOI: 10.3389/fonc.2022.911426] [Reference Citation Analysis]
681 Hinterleitner C, Strähle J, Malenke E, Hinterleitner M, Henning M, Seehawer M, Bilich T, Heitmann J, Lutz M, Mattern S, Scheuermann S, Horger M, Maurer S, Walz J, Fend F, Handgretinger R, Seitz C, Weigelin B, Singer S, Salih H, Borst O, Kopp HG, Zender L. Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer. Nat Commun 2021;12:7005. [PMID: 34853305 DOI: 10.1038/s41467-021-27303-7] [Reference Citation Analysis]
682 Ye J, Feng JW, Wu WX, Hu J, Hong LZ, Qin AC, Shi WH, Jiang Y. Papillary Thyroid Microcarcinoma: A Nomogram Based on Clinical and Ultrasound Features to Improve the Prediction of Lymph Node Metastases in the Central Compartment. Front Endocrinol (Lausanne) 2021;12:770824. [PMID: 35095755 DOI: 10.3389/fendo.2021.770824] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
683 Shalata W, Jacob BM, Agbarya A. Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future. Cancers (Basel) 2021;13:4119. [PMID: 34439273 DOI: 10.3390/cancers13164119] [Reference Citation Analysis]
684 Kawamoto M, Kohi S, Abe T, Dbouk M, Macgregor-Das A, Koi C, Song KB, Borges M, Sugimine R, Laheru D, Hruban RH, Roberts N, Klein AP, Goggins M. Endoplasmic stress-inducing variants in CPB1 and CPA1 and risk of pancreatic cancer: A case-control study and meta-analysis. Int J Cancer 2021. [PMID: 34817877 DOI: 10.1002/ijc.33883] [Reference Citation Analysis]
685 Roller JF, Veeramachaneni NK, Zhang J. Exploring the Evolving Scope of Neoadjuvant Immunotherapy in NSCLC. Cancers (Basel) 2022;14:741. [PMID: 35159008 DOI: 10.3390/cancers14030741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
686 Yoshihara M, Mogi K, Kitami K, Uno K, Iyoshi S, Tano S, Fujimoto H, Miyamoto E, Yoshikawa N, Emoto R, Matsui S, Kajiyama H. Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter study. Int J Clin Oncol 2022. [PMID: 35906336 DOI: 10.1007/s10147-022-02214-9] [Reference Citation Analysis]
687 Carter RR, Chum AP, Sanchez R, Guha A, Dey AK, Reinbolt R, Kim L, Otchere P, Oppong-Nkrumah O, Abraham WT, Lustberg M, Addison D. Hypertensive events after the initiation of contemporary cancer therapies for breast cancer control. Cancer Med 2022. [PMID: 35633055 DOI: 10.1002/cam4.4862] [Reference Citation Analysis]
688 Hooshangnejad H, Han-Oh S, Shin EJ, Narang A, Rao AD, Lee J, McNutt T, Hu C, Wong J, Ding K. Demonstrating the benefits of corrective intraoperative feedback in improving the quality of duodenal hydrogel spacer placement. Med Phys 2022. [PMID: 35394064 DOI: 10.1002/mp.15665] [Reference Citation Analysis]
689 Hu H, Yin S, Ma R, Chen R, Li S, Chen Y, Fei H, Yang L. CREBBP knockdown suppressed proliferation and promoted chemo-sensitivity via PERK-mediated unfolded protein response in ovarian cancer. J Cancer 2021;12:4595-603. [PMID: 34149923 DOI: 10.7150/jca.56135] [Reference Citation Analysis]
690 Cheng Z, Lu C, Wang H, Wang N, Cui S, Yu C, Wang C, Zuo Q, Wang S, Lv Y, Yao M, Jiang L, Qin W. Long noncoding RNA LHFPL3-AS2 suppresses metastasis of non-small cell lung cancer by interacting with SFPQ to regulate TXNIP expression. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.01.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
691 Gallazzi M, Ucciero MAM, Faraci DG, Mahmoud AM, Al Essa W, Gaidano G, Mouhssine S, Crisà E. New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes. IJMS 2022;23:7542. [DOI: 10.3390/ijms23147542] [Reference Citation Analysis]
692 Borden ES, Adams AC, Buetow KH, Wilson MA, Bauman JE, Curiel-Lewandrowski C, Chow HS, LaFleur BJ, Hastings KT. Shared Gene Expression and Immune Pathway Changes Associated with Progression from Nevi to Melanoma. Cancers (Basel) 2021;14:3. [PMID: 35008167 DOI: 10.3390/cancers14010003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
693 Murray R, Zimmerman T, Agarwal A, Palevsky PM, Quaggin S, Rosas SE, Kramer H. Kidney-Related Research in the United States: A Position Statement From the National Kidney Foundation and the American Society of Nephrology. Am J Kidney Dis 2021;78:161-7. [PMID: 33984405 DOI: 10.1053/j.ajkd.2021.04.006] [Reference Citation Analysis]
694 Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ. Response to "Addiction is a social disease: just as tenable as calling it a brain disease". Neuropsychopharmacology 2021;46:1713-4. [PMID: 34108632 DOI: 10.1038/s41386-021-01037-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
695 Yang J, Das BC, Aljitawi O, Kumar A, Das S, Van Veldhuizen P. Magmas Inhibition in Prostate Cancer: A Novel Target for Treatment-Resistant Disease. Cancers (Basel) 2022;14:2732. [PMID: 35681713 DOI: 10.3390/cancers14112732] [Reference Citation Analysis]
696 Long X, Wu B, Zhang W, Lv G, Yu D, Peng J, Wei Y, Lei Y. Effects of Vessel Interruption Sequence During Lobectomy for Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Front Surg 2021;8:694005. [PMID: 34381809 DOI: 10.3389/fsurg.2021.694005] [Reference Citation Analysis]
697 Hou R, Li X, Xiong J, Shen T, Yu W, Schwartz LH, Zhao B, Zhao J, Fu X. Predicting Tyrosine Kinase Inhibitor Treatment Response in Stage IV Lung Adenocarcinoma Patients With EGFR Mutation Using Model-Based Deep Transfer Learning. Front Oncol 2021;11:679764. [PMID: 34354943 DOI: 10.3389/fonc.2021.679764] [Reference Citation Analysis]
698 Zhang CL, Fan K, Gao MQ, Pang B. Prognostic Value of Glasgow Prognostic Score in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Pathol Oncol Res 2022;28:1610109. [PMID: 35241974 DOI: 10.3389/pore.2022.1610109] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
699 Kumar P, Brazel D, DeRogatis J, Valerin JBG, Whiteson K, Chow WA, Tinoco R, Moyers JT. The cure from within? a review of the microbiome and diet in melanoma. Cancer Metastasis Rev 2022. [PMID: 35474500 DOI: 10.1007/s10555-022-10029-3] [Reference Citation Analysis]
700 Perez VM, Kearney JF, Yeh JJ. The PDAC Extracellular Matrix: A Review of the ECM Protein Composition, Tumor Cell Interaction, and Therapeutic Strategies. Front Oncol 2021;11:751311. [PMID: 34692532 DOI: 10.3389/fonc.2021.751311] [Reference Citation Analysis]
701 Mirón-barroso S, Correia JS, Frampton AE, Lythgoe MP, Clark J, Tookman L, Ottaviani S, Castellano L, Porter AE, Georgiou TK, Krell J. Polymeric Carriers for Delivery of RNA Cancer Therapeutics. ncRNA 2022;8:58. [DOI: 10.3390/ncrna8040058] [Reference Citation Analysis]
702 Gerald T, Margulis V. Variability in prognostic models for localized renal cell carcinoma. Nat Rev Urol. [DOI: 10.1038/s41585-022-00590-5] [Reference Citation Analysis]
703 Coffman AR, Tao R, Cohan JN, Huang LC, Pickron TB, Torgeson AM, Lloyd S. Factors associated with the refusal of surgery and the associated impact on survival in patients with rectal cancer using the National Cancer Database. J Gastrointest Oncol 2021;12:1482-97. [PMID: 34532104 DOI: 10.21037/jgo-20-437] [Reference Citation Analysis]
704 Xia PS, Li LY, Li YK, Chen F, Liu ZQ, Wu JJ, Wu P. Three new compounds from Artemisia anomala and their antitumor activities. Phytochemistry Letters 2022;50:50-6. [DOI: 10.1016/j.phytol.2022.05.006] [Reference Citation Analysis]
705 Yu Z, Song M, Chouchane L, Ma X. Functional Genomic Analysis of Breast Cancer Metastasis: Implications for Diagnosis and Therapy. Cancers (Basel) 2021;13:3276. [PMID: 34208889 DOI: 10.3390/cancers13133276] [Reference Citation Analysis]
706 Zhang ZX, Han Q, Liu SY. Clinical significance of PDE2A in prognosis and immune infiltration in gastrointestinal cancer based on bioinformatics analysis. Shijie Huaren Xiaohua Zazhi 2021; 29(18): 1055-1063 [DOI: 10.11569/wcjd.v29.i18.1055] [Reference Citation Analysis]
707 Cahn F, Revon-Riviere G, Min V, Rome A, Filaine P, Pelletier A, Abed S, Gentet JC, Verschuur A, André N. Blood-Derived Liquid Biopsies Using Foundation One® Liquid CDx for Children and Adolescents with High-Risk Malignancies: A Monocentric Experience. Cancers (Basel) 2022;14:2774. [PMID: 35681754 DOI: 10.3390/cancers14112774] [Reference Citation Analysis]
708 Feng LS, Cheng JB, Su WQ, Li HZ, Xiao T, Chen DA, Zhang ZL. Cinnamic acid hybrids as anticancer agents: A mini-review. Arch Pharm (Weinheim) 2022;:e2200052. [PMID: 35419808 DOI: 10.1002/ardp.202200052] [Reference Citation Analysis]
709 Zhang C, Xin L, Li J, Cao J, Sun Y, Wang X, Luo J, Zeng Y, Li Q, Zhang Y, Zhang T, Huang P. Metal-Organic Framework (MOF)-Based Ultrasound-Responsive Dual-Sonosensitizer Nanoplatform for Hypoxic Cancer Therapy. Adv Healthc Mater 2022;11:e2101946. [PMID: 34706160 DOI: 10.1002/adhm.202101946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
710 Liu M, Du Q, Mao G, Dai N, Zhang F. MYB proto-oncogene like 2 promotes hepatocellular carcinoma growth and glycolysis via binding to the Optic atrophy 3 promoter and activating its expression. Bioengineered 2022;13:5344-56. [PMID: 35176941 DOI: 10.1080/21655979.2021.2017630] [Reference Citation Analysis]
711 Dang S, Mo Y, Zeng J, Xu Y, Xie Z, Zhang H, Zhang B, Nie G. Three birds with one stone: oxygen self-supply engineering palladium nanocluster/titanium carbide hybrid for single-NIR laser-triggered synergistic photodynamic-photothermal therapy. Nanophotonics 2022;0. [DOI: 10.1515/nanoph-2022-0268] [Reference Citation Analysis]
712 Zhang Y, Jin M, Zhu X, Jin W. Reclassification of Hepatocellular Cancer With Neural-Related Genes. Front Oncol 2022;12:877657. [DOI: 10.3389/fonc.2022.877657] [Reference Citation Analysis]
713 Yang J, Cheng S, Zhang N, Jin Y, Wang Y. Liquid biopsy for ovarian cancer using circulating tumor cells: Recent advances on the path to precision medicine. Biochim Biophys Acta Rev Cancer 2021;1877:188660. [PMID: 34800546 DOI: 10.1016/j.bbcan.2021.188660] [Reference Citation Analysis]
714 Mohamed AA, Allam AE, Aref AM, Mahmoud MO, Eldesoky NA, Fawazy N, Sakr Y, Sobeih ME, Albogami S, Fayad E, Althobaiti F, Jafri I, Alsharif G, El-sayed M, Abdelgeliel AS, Abdel Aziz RS. Evaluation of Expressed MicroRNAs as Prospective Biomarkers for Detection of Breast Cancer. Diagnostics 2022;12:789. [DOI: 10.3390/diagnostics12040789] [Reference Citation Analysis]
715 Fucikova J, Coosemans A, Orsulic S, Cibula D, Vergote I, Galluzzi L, Spisek R. Immunological configuration of ovarian carcinoma: features and impact on disease outcome. J Immunother Cancer 2021;9:e002873. [PMID: 34645669 DOI: 10.1136/jitc-2021-002873] [Reference Citation Analysis]
716 Blair BB, Funkhouser AT, Goodwin JL, Strigenz AM, Chaballout BH, Martin JC, Arthur CM, Funk CR, Edenfield WJ, Blenda AV. Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer. Cancers (Basel) 2021;13:4819. [PMID: 34638303 DOI: 10.3390/cancers13194819] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
717 Feng Z, Zhang Y, He M, Han Y, Cai C, Liu S, Liu P, Chen Y, Shen H, Zeng S. AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02517-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
718 Fleshner K, Carlsson SV. Re: Changes in Prostate-specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening. Eur Urol 2022:S0302-2838(21)02276-4. [PMID: 35027257 DOI: 10.1016/j.eururo.2021.12.028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
719 Xing QQ, Li JM, Dong X, Zeng DY, Chen ZJ, Lin XY, Pan JS. Socioeconomics and attributable etiology of primary liver cancer, 1990-2019. World J Gastroenterol 2022; 28(21): 2361-2382 [DOI: 10.3748/wjg.v28.i21.2361] [Reference Citation Analysis]
720 Acosta AM, Gordetsky JB, Collins K, Osunkoya AO, Sangoi AR, Miyamoto H, Kao C, Trpkov K, Van Leenders GJ, Wobker SE, Maclean F, Lal P, Daniel RE, Brimo F, Wasco M, Hirsch MS, Baniak N, Diaz-perez JA, Cornejo KM, Choy B, Mehra R, Williamson SR, Epstein JI, Matoso A. Clinicopathologic Spectrum of Secondary Solid Tumors of the Prostate of Nonurothelial Origin: Multi-institutional Evaluation of 85 Cases. American Journal of Surgical Pathology 2022;Publish Ahead of Print. [DOI: 10.1097/pas.0000000000001907] [Reference Citation Analysis]
721 Bilger G, Girard N, Doubre H, Levra MG, Giroux-Leprieur E, Giraud F, Decroisette C, Carton M, Massiani MA. Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective study. Cancer Immunol Immunother 2021. [PMID: 34821950 DOI: 10.1007/s00262-021-03114-z] [Reference Citation Analysis]
722 Marzęda P, Wróblewska-Łuczka P, Drozd M, Florek-Łuszczki M, Załuska-Ogryzek K, Łuszczki JJ. Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines-An Isobolographic Analysis. Int J Mol Sci 2022;23:6752. [PMID: 35743195 DOI: 10.3390/ijms23126752] [Reference Citation Analysis]
723 Elhelbawy NG, Zaid IF, Khalifa AA, Gohar SF, Fouda EA. miRNA-148a and miRNA-30c expressions as potential biomarkers in breast cancer patients. Biochem Biophys Rep 2021;27:101060. [PMID: 34195390 DOI: 10.1016/j.bbrep.2021.101060] [Reference Citation Analysis]
724 Jiao JY, Cheng CS, Cao ZQ, Chen LY, Chen Z. Evidence-Based Dampness-Heat ZHENG (Syndrome) in Cancer: Current Progress toward Establishing Relevant Animal Model with Pancreatic Tumor. Chin J Integr Med 2022. [PMID: 35723813 DOI: 10.1007/s11655-022-3675-8] [Reference Citation Analysis]
725 Kithsiri Wijeratne EM, Xu YM, Liu MX, Inacio MC, Brooks AD, Tewary P, Sayers TJ, Gunatilaka AAL. Ring A/B-Modified 17β-Hydroxywithanolide Analogues as Antiproliferative Agents for Prostate Cancer and Potentiators of Immunotherapy for Renal Carcinoma and Melanoma. J Nat Prod 2021;84:3029-38. [PMID: 34851111 DOI: 10.1021/acs.jnatprod.1c00724] [Reference Citation Analysis]
726 Zhang M, Zhao L, Zhang Y, Jing H, Wei L, Li Z, Zhang H, Zhang Y, Zhu S, Zhang S, Zhang X. Colorectal Cancer Screening With High Risk-Factor Questionnaire and Fecal Immunochemical Tests Among 5, 947, 986 Asymptomatic Population: A Population-Based Study. Front Oncol 2022;12:893183. [PMID: 35712520 DOI: 10.3389/fonc.2022.893183] [Reference Citation Analysis]
727 Wang T, Zhang Y, He Y, Liu Y, Qi P. Screening and Bioinformatics Analysis of Competitive Endogenous RNA Regulatory Network --Related to Circular RNA in Breast Cancer. Biomed Res Int 2021;2021:5575286. [PMID: 34545330 DOI: 10.1155/2021/5575286] [Reference Citation Analysis]
728 Stakhovskyi O, Kobyliak N, Voylenko O, Stakhovskyi E, Ponomarchuk R, Sulaieva O. Immune Microenvironment of Muscular-Invasive Urothelial Carcinoma: The Link to Tumor Immune Cycle and Prognosis. Cells 2022;11:1802. [DOI: 10.3390/cells11111802] [Reference Citation Analysis]
729 Liu Y, Zhao C, Sun J, Wang G, Ju S, Qian C, Wang X. Overexpression of small nucleolar RNA SNORD1C is associated with unfavorable outcome in colorectal cancer. Bioengineered 2021;12:8943-52. [PMID: 34702132 DOI: 10.1080/21655979.2021.1990194] [Reference Citation Analysis]
730 Liu M, Li H, Wang X, Xia R, Li X, Ma Y, Wang M, Zhang H. TIGAR drives colorectal cancer ferroptosis resistance through ROS/AMPK/SCD1 pathway. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
731 Yousef YA, Mohammad M, Al-Nawaiseh I, Mahafza H, Halalsheh H, Mehyar M, AlJabari R, Al-Rawashdeh K, Jaradat I, Sultan I, Al-Hussaini M. Retinoblastoma and uveal melanoma in Jordan: incidence, demographics, and survival (2011-2020). Ophthalmic Genet 2022;:1-8. [PMID: 35848346 DOI: 10.1080/13816810.2022.2090008] [Reference Citation Analysis]
732 Wang K, Zhong W, Long Z, Guo Y, Zhong C, Yang T, Wang S, Lai H, Lu J, Zheng P, Mao X. 5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer. Front Mol Biosci 2021;8:775304. [PMID: 34926580 DOI: 10.3389/fmolb.2021.775304] [Reference Citation Analysis]
733 Tang M, Shen X, Chai J, Cheng J, Wang D. Dose-Effect Relationship Between Gastric Cancer and Common Digestive Tract Symptoms and Diagnoses in Anhui, China. Cancer Manag Res 2021;13:4955-66. [PMID: 34188548 DOI: 10.2147/CMAR.S313771] [Reference Citation Analysis]
734 Oukil S, Kasmi R, Mokrani K, García-Zapirain B. Automatic segmentation and melanoma detection based on color and texture features in dermoscopic images. Skin Res Technol 2021. [PMID: 34779062 DOI: 10.1111/srt.13111] [Reference Citation Analysis]
735 Ruszczyńska A, Skrajnowska D, Jagielska A, Bobrowska-korczak B, Wagner B. Laser Ablation ICP-MS Analysis of Chemically Different Regions of Rat Prostate Gland with Implanted Cancer Cells. Applied Sciences 2022;12:1474. [DOI: 10.3390/app12031474] [Reference Citation Analysis]
736 Barnes JM, Johnson KJ, Grove JL, Srivastava AJ, Osazuwa-Peters N, Perkins SM. Risk of suicide among individuals with a history of childhood cancer. Cancer 2021. [PMID: 34693522 DOI: 10.1002/cncr.33957] [Reference Citation Analysis]
737 Lu Y, Chan YT, Tan HY, Zhang C, Guo W, Xu Y, Sharma R, Chen ZS, Zheng YC, Wang N, Feng Y. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma. J Exp Clin Cancer Res 2022;41:3. [PMID: 34980204 DOI: 10.1186/s13046-021-02208-x] [Reference Citation Analysis]
738 Matsuo K, Klar M, Harter P, Miller H, Nusbaum DJ, Matsuzaki S, Roman LD, Wright JD. Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United States. Gynecol Oncol 2021;161:710-9. [PMID: 33726962 DOI: 10.1016/j.ygyno.2021.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
739 Sunami Y, Häußler J, Zourelidis A, Kleeff J. Cancer-Associated Fibroblasts and Tumor Cells in Pancreatic Cancer Microenvironment and Metastasis: Paracrine Regulators, Reciprocation and Exosomes. Cancers (Basel) 2022;14:744. [PMID: 35159011 DOI: 10.3390/cancers14030744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
740 Xiao Y, Yin X, Sun P, Sun Y, Qu L, Li Z. Dual microenvironmental parameter-responsive lysosome-targeting carbon dots for the high contrast discrimination of a broad spectrum of cancer cells. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.03.109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
741 Zou Y, Zeng Y, Li S, Zhu Q. Machine learning model with physical constraints for diffuse optical tomography. Biomed Opt Express 2021;12:5720-35. [PMID: 34692211 DOI: 10.1364/BOE.432786] [Reference Citation Analysis]
742 Zuo W, Kwok HF. Development of Marine-Derived Compounds for Cancer Therapy. Mar Drugs 2021;19:342. [PMID: 34203870 DOI: 10.3390/md19060342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
743 Balachander K, Paramasivam A. Selective autophagy as a potential therapeutic target for oral cancer. Oral Oncology 2022;130:105934. [DOI: 10.1016/j.oraloncology.2022.105934] [Reference Citation Analysis]
744 Liu R, Yu X, Zeng X, Wang Z, Zhou D, Liu Z, Liu F, Zhuang C, Zhuang Y, Zhang J, Niu P, Yan B, Zhi R, Li J, Huang J, Qin H. Preliminary evaluation of a new initiative to centralize colorectal cancer care during the COVID-19 epidemic in Shanghai, China: a retrospective study. Ann Transl Med 2022;10:94. [PMID: 35282090 DOI: 10.21037/atm-21-7030] [Reference Citation Analysis]
745 Quintana M, Saavedra E, Del Rosario H, González I, Hernández I, Estévez F, Quintana J. Ethanol Enhances Hyperthermia-Induced Cell Death in Human Leukemia Cells. Int J Mol Sci 2021;22:4948. [PMID: 34066632 DOI: 10.3390/ijms22094948] [Reference Citation Analysis]
746 Meti N, Kelly D, Allen MJ, Lanys A, Fazelzad R, Ramjeesingh R, Zogopoulos G, Notta F, Knox JJ, Amir E, Gallinger S, O'Kane G, Grant RC. Genomic sequencing to inform therapy in advanced pancreatic cancer: A systematic review and meta-analysis of prospective studies. Cancer Treat Rev 2021;101:102310. [PMID: 34757307 DOI: 10.1016/j.ctrv.2021.102310] [Reference Citation Analysis]
747 Wei X, Chen L, Yang A, Lv Z, Xiong M, Shan C. ADRB2 is a potential protective gene in breast cancer by regulating tumor immune microenvironment. Transl Cancer Res 2021;10:5280-94. [PMID: 35116377 DOI: 10.21037/tcr-21-1257] [Reference Citation Analysis]
748 Vallet-Regí M, Schüth F, Lozano D, Colilla M, Manzano M. Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? Chem Soc Rev 2022. [PMID: 35642539 DOI: 10.1039/d1cs00659b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
749 Hou H, Qu B, Su C, Hou G, Gao F. Design, Synthesis and Anti-Lung Cancer Evaluation of 1, 2, 3-Triazole Tethered Dihydroartemisinin-Isatin Hybrids. Front Pharmacol 2021;12:801580. [PMID: 34975498 DOI: 10.3389/fphar.2021.801580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
750 Liu X, Li N, Zhang C, Wu X, Zhang S, Dong G, Liu G. Identification of metastasis-associated exoDEPs in colorectal cancer using label-free proteomics. Transl Oncol 2022;19:101389. [PMID: 35303583 DOI: 10.1016/j.tranon.2022.101389] [Reference Citation Analysis]
751 Abe A, Imoto I, Tange S, Nishimura M, Iwasa T. Prevalence of Pathogenic Germline BRCA1/2 Variants and Their Association with Clinical Characteristics in Patients with Epithelial Ovarian Cancer in a Rural Area of Japan. Genes (Basel) 2022;13:1085. [PMID: 35741847 DOI: 10.3390/genes13061085] [Reference Citation Analysis]
752 Garrido MP, Vallejos C, Girardi S, Gabler F, Selman A, López F, Vega M, Romero C. NGF/TRKA Promotes ADAM17-Dependent Cleavage of P75 in Ovarian Cells: Elucidating a Pro-Tumoral Mechanism. Int J Mol Sci 2022;23:2124. [PMID: 35216240 DOI: 10.3390/ijms23042124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
753 Ning X, Hittman J, Lubek J, Malek R. Thyroid carcinoma discovered incidentally during surgical resection of head and neck squamous cell carcinoma: A case series. Oral Surg Oral Med Oral Pathol Oral Radiol 2021:S2212-4403(21)00481-8. [PMID: 34511345 DOI: 10.1016/j.oooo.2021.06.012] [Reference Citation Analysis]
754 Itonaga M, Ashida R, Murata S, Yamashita Y, Hatamaru K, Tamura T, Kawaji Y, Kayama Y, Emori T, Kawai M, Yamaue H, Matsuzaki I, Nagai H, Kinoshita Y, Wan K, Shimokawa T, Kitano M. Kras Gene Analysis Using Liquid-Based Cytology Specimens Predicts Therapeutic Responses and Prognosis in Patients with Pancreatic Cancer. Cancers 2022;14:551. [DOI: 10.3390/cancers14030551] [Reference Citation Analysis]
755 Li H, Yu Z, Wang H, Wang N, Sun X, Yang S, Hua X, Liu Z. Role of ANO1 in tumors and tumor immunity. J Cancer Res Clin Oncol 2022. [PMID: 35471604 DOI: 10.1007/s00432-022-04004-2] [Reference Citation Analysis]
756 Eggermont AM, Ascierto PA, Khushalani NI, Schadendorf D, Boland G, Weber J, Lewis KD, Johnson D, Rivalland G, Khattak A, Majem M, Gogas H, Long GV, Currie SL, Chien D, Tagliaferri MA, Carlino MS, Diab A. PIVOT-12: a Phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence. Future Oncology. [DOI: 10.2217/fon-2021-1286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
757 Huang L, Ye T, Wang J, Gu X, Ma R, Sheng L, Ma B. Identification of Survival-Associated Hub Genes in Pancreatic Adenocarcinoma Based on WGCNA. Front Genet 2021;12:814798. [PMID: 35047023 DOI: 10.3389/fgene.2021.814798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
758 Bax C, Prudenza S, Gaspari G, Capelli L, Grizzi F, Taverna G. Drift compensation on electronic nose data for non-invasive diagnosis of prostate cancer by urine analysis. iScience 2022;25:103622. [PMID: 35024578 DOI: 10.1016/j.isci.2021.103622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
759 Liu D, Qiu M. Immune and Metabolic Dysregulated Coding and Non-coding RNAs Reveal Survival Association in Uterine Corpus Endometrial Carcinoma. Front Genet 2021;12:673192. [PMID: 34249094 DOI: 10.3389/fgene.2021.673192] [Reference Citation Analysis]
760 Pandey RR, Chusuei CC. Electrochemical Detection of Dopamine Using a Prussian Blue Carbon Nanotube Composite Decorated with Agglomerated ZnO Particles. Analytical Letters. [DOI: 10.1080/00032719.2021.2010090] [Reference Citation Analysis]
761 Rathi S, Griffith JI, Zhang W, Zhang W, Oh JH, Talele S, Sarkaria JN, Elmquist WF. The influence of the blood-brain barrier in the treatment of brain tumours. J Intern Med 2022. [PMID: 35040235 DOI: 10.1111/joim.13440] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
762 Li J, Ming Z, Yang L, Wang T, Liu G, Ma Q. Long noncoding RNA XIST: Mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.04.007] [Reference Citation Analysis]
763 Jiang Y, Sun M, Ouyang N, Tang Y, Miao P. Synergistic Chemo-thermal Therapy of Cancer by DNA-Templated Silver Nanoclusters and Polydopamine Nanoparticles. ACS Appl Mater Interfaces 2021;13:21653-60. [PMID: 33905235 DOI: 10.1021/acsami.1c04608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
764 Tommasi C, Pellegrino B, Boggiani D, Sikokis A, Michiara M, Uliana V, Bortesi B, Bonatti F, Mozzoni P, Pinelli S, Squadrilli A, Viani MV, Cassi D, Maglietta G, Meleti M, Musolino A. Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers. Front Oncol 2021;11:700853. [PMID: 34552867 DOI: 10.3389/fonc.2021.700853] [Reference Citation Analysis]
765 Burstein HJ. Unmet challenges in systemic therapy for early stage breast cancer. Breast 2021:S0960-9776(21)01015-8. [PMID: 34924252 DOI: 10.1016/j.breast.2021.12.009] [Reference Citation Analysis]
766 Uson Junior PLS, Majeed U, Yin J, Botrus G, Sonbol MB, Ahn DH, Starr JS, Jones JC, Babiker H, Inabinett SR, Wylie N, Boyle AWR, Bekaii-Saab TS, Gores GJ, Smoot R, Barrett M, Nagalo B, Meurice N, Elliott N, Petit J, Zhou Y, Arora M, Dumbauld C, Barro O, Baker A, Bogenberger J, Buetow K, Mansfield A, Mody K, Borad MJ. Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy. JCO Precis Oncol 2022;6:e2100274. [PMID: 35666960 DOI: 10.1200/PO.21.00274] [Reference Citation Analysis]
767 Lim H, In Shim J, Park SJ, Noh J, Kim TM, Lee M, Choi CH, Chung HH, Kim TJ, Lee JW, Kim JW, Kim BG, Park NH, Song YS, Kim SY, Park SY, Kim HS, Lee YY. Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery. Gynecol Oncol 2022:S0090-8258(22)00196-2. [PMID: 35367074 DOI: 10.1016/j.ygyno.2022.03.014] [Reference Citation Analysis]
768 Benbrook DM, Hocker JRS, Moxley KM, Hanas JS. Sera Protein Signatures of Endometrial Cancer Lymph Node Metastases. Int J Mol Sci 2022;23:3277. [PMID: 35328698 DOI: 10.3390/ijms23063277] [Reference Citation Analysis]
769 Hampel H, Yurgelun MB. Point/Counterpoint: Is It Time for Universal Germline Genetic Testing for all GI Cancers? J Clin Oncol 2022;:JCO2102764. [PMID: 35649230 DOI: 10.1200/JCO.21.02764] [Reference Citation Analysis]
770 Lamba N, Groves A, Torre M, Yeo KK, Iorgulescu JB. The epidemiology of primary and metastatic brain tumors in infancy through childhood. J Neurooncol 2022. [PMID: 35037155 DOI: 10.1007/s11060-021-03927-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
771 Yuan D, Ma R, Sun T, Zhu K, Dang C, Ye H, Li K. Knockdown of RSPH14 inhibits proliferation, migration, and invasion and promotes apoptosis of hepatocellular carcinoma via RelA. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02515-z] [Reference Citation Analysis]
772 Owens-Walton J, Williams C, Rompré-Brodeur A, Pinto PA, Ball MW. Minority Enrollment in Phase II and III Clinical Trials in Urologic Oncology. J Clin Oncol 2022;:JCO2101885. [PMID: 35196107 DOI: 10.1200/JCO.21.01885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
773 Quinn ZL, Barta JA, Johnson JM. Molecular lung cancer: How targeted therapies and personalized medicine are re-defining cancer care. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2022.04.019] [Reference Citation Analysis]
774 Liao Z, Fang Z, Gou S, Luo Y, Liu Y, He Z, Li X, Peng Y, Fu Z, Li D, Chen H, Luo Z. The role of diet in renal cell carcinoma incidence: an umbrella review of meta-analyses of observational studies. BMC Med 2022;20:39. [PMID: 35109847 DOI: 10.1186/s12916-021-02229-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
775 Zhou W, He X, Wang J, He S, Xie C, Fan Q, Pu K. Semiconducting Polymer Nanoparticles for Photoactivatable Cancer Immunotherapy and Imaging of Immunoactivation. Biomacromolecules 2022. [PMID: 35286085 DOI: 10.1021/acs.biomac.2c00065] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
776 Ramirez MU, Clear KYJ, Cornelius Z, Bawaneh A, Feliz-Mosquea YR, Wilson AS, Ruggiero AD, Cruz-Diaz N, Shi L, Kerr BA, Soto-Pantoja DR, Cook KL. Diet impacts triple-negative breast cancer growth, metastatic potential, chemotherapy responsiveness, and doxorubicin-mediated cardiac dysfunction. Physiol Rep 2022;10:e15192. [PMID: 35439354 DOI: 10.14814/phy2.15192] [Reference Citation Analysis]
777 Zarei M, Hue JJ, Hajihassani O, Graor HJ, Katayama ES, Loftus AW, Bajor D, Rothermel LD, Vaziri-Gohar A, Winter JM. Clinical development of IDH1 inhibitors for cancer therapy. Cancer Treat Rev 2021;103:102334. [PMID: 34974243 DOI: 10.1016/j.ctrv.2021.102334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
778 Moskovich D, Finkelshtein Y, Alfandari A, Rosemarin A, Lifschytz T, Weisz A, Mondal S, Ungati H, Katzav A, Kidron D, Mugesh G, Ellis M, Lerer B, Ashur-Fabian O. Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. Oncogene 2021;40:6248-57. [PMID: 34556811 DOI: 10.1038/s41388-021-02020-z] [Reference Citation Analysis]
779 Gao Y, Zhang N, Zeng Z, Wu Q, Jiang X, Li S, Sun W, Zhang J, Li Y, Li J, He F, Huang Z, Zhang J, Gong Y, Xie C. LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non-small cell lung cancer. Clin Transl Med 2022;12:e792. [PMID: 35415876 DOI: 10.1002/ctm2.792] [Reference Citation Analysis]
780 Chen J, Song P, Peng Z, Liu Z, Yang L, Wang L, Zhou J, Dong Q. The Controlling Nutritional Status (CONUT) Score and Prognosis in Malignant Tumors: A Systematic Review and Meta-Analysis. Nutr Cancer 2022;:1-18. [PMID: 35382655 DOI: 10.1080/01635581.2022.2059091] [Reference Citation Analysis]
781 Xu J, Sun Z, Ju H, Xie E, Mu Y, Xu J, Pan S. Construction of Novel Prognostic Nomogram for Mucinous and Signet Ring Cell Colorectal Cancer Patients with a Survival Longer Than 5 Years. IJGM 2022;Volume 15:2549-73. [DOI: 10.2147/ijgm.s353523] [Reference Citation Analysis]
782 Jia H, Sun W, Li X, Xu W. Melatonin promotes apoptosis of thyroid cancer cells via regulating the signaling of microRNA-21 (miR-21) and microRNA-30e (miR-30e). Bioengineered 2022;13:9588-601. [PMID: 35412442 DOI: 10.1080/21655979.2022.2054206] [Reference Citation Analysis]
783 Yadav P, Yadav R, Jain S, Vaidya A. Caspase-3: A primary target for natural and synthetic compounds for cancer therapy. Chem Biol Drug Des 2021;98:144-65. [PMID: 33963665 DOI: 10.1111/cbdd.13860] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
784 Srivastava SK, Khan MA, Anand S, Zubair H, Deshmukh SK, Patel GK, Singh S, Andrews J, Wang B, Carter JE, Singh AP. MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer. Br J Cancer 2021. [PMID: 34837075 DOI: 10.1038/s41416-021-01641-1] [Reference Citation Analysis]
785 Peng S, Xiao F, Chen M, Gao H. Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy. Adv Sci (Weinh) 2022;9:e2103836. [PMID: 34796689 DOI: 10.1002/advs.202103836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
786 Reppel L, Tsahouridis O, Akulian J, Davis IJ, Lee H, Fucà G, Weiss J, Dotti G, Pecot CV, Savoldo B. Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer. J Immunother Cancer 2022;10:e003897. [PMID: 35022195 DOI: 10.1136/jitc-2021-003897] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
787 Wang J, Xu P, Hao Y, Yu T, Liu L, Song Y, Li Y. Interaction between DNMT3B and MYH11 via hypermethylation regulates gastric cancer progression. BMC Cancer 2021;21:914. [PMID: 34380460 DOI: 10.1186/s12885-021-08653-3] [Reference Citation Analysis]
788 Kim EY, Cha YJ, Lee SH, Jeong S, Choi YJ, Moon DH, Lee S, Chang YS. Early lung carcinogenesis and tumor microenvironment observed by single-cell transcriptome analysis. Transl Oncol 2021;15:101277. [PMID: 34800916 DOI: 10.1016/j.tranon.2021.101277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
789 Lundy J, McKay O, Croagh D, Ganju V. Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and Literature Review. JCO Precis Oncol 2022;6:e2100437. [PMID: 35085003 DOI: 10.1200/PO.21.00437] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
790 Hsieh PF, Jiang WP, Basavaraj P, Huang SY, Ruangsai P, Wu JB, Huang GJ, Huang WC. Cell suspension culture extract of Eriobotrya japonica attenuates growth and induces apoptosis in prostate cancer cells via targeting SREBP-1/FASN-driven metabolism and AR. Phytomedicine 2021;93:153806. [PMID: 34740154 DOI: 10.1016/j.phymed.2021.153806] [Reference Citation Analysis]
791 Guo Z, Ji X, Wang S, Zhang Y, Liu K, Wang C, Deng Y, Zhang T, Cheng X, Zhao R. Clinical Status and Future Prospects of Transanal Total Mesorectal Excision. Front Oncol 2021;11:752737. [PMID: 35047386 DOI: 10.3389/fonc.2021.752737] [Reference Citation Analysis]
792 Moshe Halamish H, Zlotver I, Sosnik A. Polymeric nanoparticles surface-complexed with boric acid actively target solid tumors overexpressing sialic acid. J Colloid Interface Sci 2022;626:916-29. [PMID: 35835042 DOI: 10.1016/j.jcis.2022.07.027] [Reference Citation Analysis]
793 Xiong W, Zhao Y, Du H, Wang Y, Xu M, Guo X. Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer. Thromb J 2021;19:95. [PMID: 34863189 DOI: 10.1186/s12959-021-00339-x] [Reference Citation Analysis]
794 Wang T, Ashrafi A, Modareszadeh P, Deese AR, Chacon Castro MDC, Alemi PS, Zhang L. An Analysis of the Multifaceted Roles of Heme in the Pathogenesis of Cancer and Related Diseases. Cancers (Basel) 2021;13:4142. [PMID: 34439295 DOI: 10.3390/cancers13164142] [Reference Citation Analysis]
795 Thaiss WM, Moser S, Hepp T, Kruck S, Rausch S, Scharpf M, Nikolaou K, Stenzl A, Bedke J, Kaufmann S. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy. World J Urol 2022. [PMID: 35922717 DOI: 10.1007/s00345-022-04120-1] [Reference Citation Analysis]
796 Çelik ZE, Akar S, Fındık S, Aytekin E, Çelik Ç. Nicotinamide N-methyltransferase expression in squamous cell carcinoma of the vulva. J Obstet Gynaecol 2022;:1-6. [PMID: 35499473 DOI: 10.1080/01443615.2022.2049722] [Reference Citation Analysis]
797 Arbel Rubinstein T, Reuveni I, Hesin A, Klein-goldberg A, Olauson H, Larsson TE, Abraham CR, Zeldich E, Bosch A, Chillón M, Hollander KS, Shabtay-orbach A, Vainer GW, Wolf I, Rubinek T. A Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based Therapy. Cancers 2021;13:6297. [DOI: 10.3390/cancers13246297] [Reference Citation Analysis]
798 Ding L, Yu Q, Yang S, Yang WJ, Liu T, Xian JR, Tian TT, Li T, Chen W, Wang BL, Pan BS, Zhou J, Fan J, Yang XR, Guo W. Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma. Front Immunol 2022;13:831101. [PMID: 35371079 DOI: 10.3389/fimmu.2022.831101] [Reference Citation Analysis]
799 Leeming RC, Karagas MR, Zens MS, Schned AR, Seigne JD, Passarelli MN. Bladder cancer risk variants and overall and disease-specific survival in two independent cohorts. BJU Int 2021. [PMID: 34775665 DOI: 10.1111/bju.15640] [Reference Citation Analysis]
800 Liu P, Fu R, Chen K, Zhang L, Wang S, Liang W, Zou H, Tao L, Jia W. ETV5-mediated upregulation of lncRNA CTBP1-DT as a ceRNA facilitates HGSOC progression by regulating miR-188-5p/MAP3K3 axis. Cell Death Dis 2021;12:1146. [PMID: 34887384 DOI: 10.1038/s41419-021-04256-9] [Reference Citation Analysis]
801 Qiu H, Shao Z, Wen X, Jiang J, Ma Q, Wang Y, Huang L, Ding X, Zhang L. TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy. Front Immunol 2021;12:716710. [PMID: 34539652 DOI: 10.3389/fimmu.2021.716710] [Reference Citation Analysis]
802 Mazanec SR, Park S, Connolly MC, Rosenzweig MQ. Factors associated with symptom distress in women with breast cancer prior to initiation of chemotherapy. Appl Nurs Res 2021;62:151515. [PMID: 34815009 DOI: 10.1016/j.apnr.2021.151515] [Reference Citation Analysis]
803 Shi Z, Li X, Zhang L, Luo Y, Shrestha B, Hu X. Potential Novel Modules and Hub Genes as Prognostic Candidates of Thyroid Cancer by Weighted Gene Co-Expression Network Analysis. Int J Gen Med 2021;14:9433-44. [PMID: 34908870 DOI: 10.2147/IJGM.S329128] [Reference Citation Analysis]
804 Yang P, Qu Y, Wang M, Chu B, Chen W, Zheng Y, Niu T, Qian Z. Pathogenesis and treatment of multiple myeloma. MedComm (2020) 2022;3:e146. [PMID: 35665368 DOI: 10.1002/mco2.146] [Reference Citation Analysis]
805 Emam KK, Abdel Fattah ME, El Rayes SM, Hebishy MA, Dessouki AA. Assessment of Wheat Germ Oil Role in the Prevention of Induced Breast Cancer in Rats. ACS Omega 2022;7:13942-52. [PMID: 35559156 DOI: 10.1021/acsomega.2c00434] [Reference Citation Analysis]
806 Wang J, Xia HH, Zhang Y, Zhang L. Trends in treatments for prostate cancer in the United States, 2010-2015. Am J Cancer Res 2021;11:2351-68. [PMID: 34094691] [Reference Citation Analysis]
807 Wang WZ, Shulman A, Amann JM, Carbone DP, Tsichlis PN. Small cell lung cancer: Subtypes and therapeutic implications. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
808 Jia Q, Zhang R, Wang Y, Yan H, Li Z, Feng Y, Ji Y, Yang Z, Yang Y, Pu K, Wang Z. A metabolic acidity-activatable calcium phosphate probe with fluorescence signal amplification capabilities for non-invasive imaging of tumor malignancy. Science Bulletin 2022;67:288-98. [DOI: 10.1016/j.scib.2021.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
809 Chen M, Rubin GM, Jiang G, Raad Z, Ding Y. Biosynthesis and Heterologous Production of Mycosporine-Like Amino Acid Palythines. J Org Chem 2021;86:11160-8. [PMID: 34006097 DOI: 10.1021/acs.joc.1c00368] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
810 Li YL, Zhu XM, Chen NF, Chen ST, Yang Y, Liang H, Chen ZF. Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest. Eur J Med Chem 2022;236:114312. [PMID: 35421660 DOI: 10.1016/j.ejmech.2022.114312] [Reference Citation Analysis]
811 Cheng Y, Shi D, Xu Z, Gao Z, Si Z, Zhao Y, Ye R, Fu Z, Fu W, Yang T, Xiu Y, Lin Q, Cheng D. 124I-Labeled Monoclonal Antibody and Fragment for the Noninvasive Evaluation of Tumor PD-L1 Expression In Vivo. Mol Pharm 2022. [PMID: 35244407 DOI: 10.1021/acs.molpharmaceut.2c00084] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
812 Krishnan R, Patel PS, Hakem R. BRCA1 and Metastasis: Outcome of Defective DNA Repair. Cancers (Basel) 2021;14:108. [PMID: 35008272 DOI: 10.3390/cancers14010108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
813 Yang K, Tian C, Zhang C, Xiang M. The Controversial Role of IL-33 in Lung Cancer. Front Immunol 2022;13:897356. [DOI: 10.3389/fimmu.2022.897356] [Reference Citation Analysis]
814 Klaassen Z, Scarpato KR, Ristau BT, Stratton KL, Porten SP, Smaldone MC, Chapin BF, Psutka SP. Research highlights of the 2020 society of urologic oncology young urologic oncologists' program. Urol Oncol 2021;39:452-4. [PMID: 33858748 DOI: 10.1016/j.urolonc.2021.03.020] [Reference Citation Analysis]
815 Worlikar T, Zhang M, Ganguly A, Hall TL, Shi J, Zhao L, Lee FT, Mendiratta-Lala M, Cho CS, Xu Z. Impact of Histotripsy on Development of Intrahepatic Metastases in a Rodent Liver Tumor Model. Cancers (Basel) 2022;14:1612. [PMID: 35406383 DOI: 10.3390/cancers14071612] [Reference Citation Analysis]
816 Wu Y, You Z, Xu M, Hashmi MF. Genetic Polymorphism of E2F1 Influences Susceptibility to Ovarian Cancer in a Chinese Population. Contrast Media & Molecular Imaging 2022;2022:1-5. [DOI: 10.1155/2022/7808726] [Reference Citation Analysis]
817 Muñoz Velasco R, Jiménez Sánchez P, García García A, Blanco Martinez-Illescas R, Pastor Senovilla Á, Lozano Yagüe M, Trento A, García-Martin RM, Navarro D, Sainz B Jr, Rodríguez Peralto JL, Sánchez-Arévalo Lobo VJ. Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR). Cancers (Basel) 2022;14:1518. [PMID: 35326669 DOI: 10.3390/cancers14061518] [Reference Citation Analysis]
818 Cheng S, Pei R, Li J, Li B, Tang L, Yin T, Liu S. Atezolizumab compared to chemotherapy for first-line treatment in non-small cell lung cancer with high PD-L1 expression: a cost-effectiveness analysis from US and Chinese perspectives. Ann Transl Med 2021;9:1481. [PMID: 34734033 DOI: 10.21037/atm-21-4294] [Reference Citation Analysis]
819 Kasi A, Dotan E, Poage GM, Catteau A, Vernerey D, George M, Barzi A. Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician Survey. Cancers (Basel) 2021;13:5467. [PMID: 34771628 DOI: 10.3390/cancers13215467] [Reference Citation Analysis]
820 Zhao Y, Wang Y, Chen W, Bai S, Peng W, Zheng M, Yang Y, Cheng B, Luan Z. Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling. Cancer Cell Int 2021;21:670. [PMID: 34906136 DOI: 10.1186/s12935-021-02390-0] [Reference Citation Analysis]
821 Guo T, Zhang Z, Zhu L, Chen W, Ding Y, Li W, Huang Y, Huang J, Pan X. TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1. Cancer Biol Ther 2022;:1-10. [PMID: 34974792 DOI: 10.1080/15384047.2021.2004835] [Reference Citation Analysis]
822 Yu A, Dai X, Wang Z, Chen H, Guo B, Huang L. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors (Basel) 2022;12:109. [PMID: 35200369 DOI: 10.3390/bios12020109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
823 Pichler M, Steyrer J. Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1. ESMO Open 2021;6:100198. [PMID: 34175674 DOI: 10.1016/j.esmoop.2021.100198] [Reference Citation Analysis]
824 Nasser NJ. Applicator for cervical brachytherapy for MRI or CT guided therapy. Tech Innov Patient Support Radiat Oncol 2021;20:23-7. [PMID: 34765750 DOI: 10.1016/j.tipsro.2021.10.002] [Reference Citation Analysis]
825 Pestana RC, Beal JR, Parkes A, Hamerschlak N, Subbiah V. Impact of tissue-agnostic approvals for patients with sarcoma. Trends Cancer 2021:S2405-8033(21)00233-8. [PMID: 34887213 DOI: 10.1016/j.trecan.2021.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
826 Chen WK, Oon CE, Kaur G, Sainson RC, Li J. Downregulation of Manic fringe impedes angiogenesis and cell migration of renal carcinoma. Microvascular Research 2022. [DOI: 10.1016/j.mvr.2022.104341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
827 Hassan MR, Islam MF, Uddin MZ, Ghoshal G, Hassan MM, Huda S, Fortino G. Prostate cancer classification from ultrasound and MRI images using deep learning based Explainable Artificial Intelligence. Future Generation Computer Systems 2022;127:462-72. [DOI: 10.1016/j.future.2021.09.030] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
828 Schneider G, Wirth M, Keller U, Saur D. Rationale for MYC imaging and targeting in pancreatic cancer. EJNMMI Res 2021;11:104. [PMID: 34637026 DOI: 10.1186/s13550-021-00843-1] [Reference Citation Analysis]
829 Holland R, Ben-ishay O, Ben-aharon I. Concomitant Kinase-Dead BRAF and Oncogenic KRAS Lead to an Aggressive Biologic Behavior and Tumor Lysis Syndrome: A Case Report. Front Oncol 2022;12:885814. [DOI: 10.3389/fonc.2022.885814] [Reference Citation Analysis]
830 Teruyama F, Kuno A, Murata Y, Nakagawa T, Shiba-Ishii A, Yuguchi S, Noguchi M. Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report. Pathol Int 2022. [PMID: 35801418 DOI: 10.1111/pin.13257] [Reference Citation Analysis]
831 Sunami Y, Böker V, Kleeff J. Targeting and Reprograming Cancer-Associated Fibroblasts and the Tumor Microenvironment in Pancreatic Cancer. Cancers (Basel) 2021;13:697. [PMID: 33572223 DOI: 10.3390/cancers13040697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
832 Meng C, Fan L, Wang X, Wang Y, Li Y, Pang S, Lv S, Zhang J, Ding Y. Preparation and Evaluation of Animal Models of Cardiotoxicity in Antineoplastic Therapy. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/3820591] [Reference Citation Analysis]
833 Long JM, Powers JM, Katona BW. Evaluation of Classic, Attenuated, and Oligopolyposis of the Colon. Gastrointest Endosc Clin N Am 2022;32:95-112. [PMID: 34798989 DOI: 10.1016/j.giec.2021.08.003] [Reference Citation Analysis]
834 McFadden M, Singh SK, Oprea-Ilies G, Singh R. Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers. Cancers (Basel) 2021;13:5480. [PMID: 34771642 DOI: 10.3390/cancers13215480] [Reference Citation Analysis]
835 Zhu L, Yang Q, Hu R, Li Y, Peng Y, Liu H, Ye M, Zhang B, Zhang P, Liu-Smith F, Li H, Liu J. Novel therapeutic strategy for melanoma based on albendazole and the CDK4/6 inhibitor palbociclib. Sci Rep 2022;12:5706. [PMID: 35383224 DOI: 10.1038/s41598-022-09592-0] [Reference Citation Analysis]
836 Ahmad SR, Ghosh P. A systematic investigation on flavonoids, catechin, β-sitosterol and lignin glycosides from Saraca asoca (ashoka) having anti-cancer & antioxidant properties with no side effect. Journal of the Indian Chemical Society 2022;99:100293. [DOI: 10.1016/j.jics.2021.100293] [Reference Citation Analysis]
837 Yang Z, Liu Z, Zhu J, Xu J, Pu Y, Bao Y. Green synthesis and characterization of gold nanoparticles from Pholiota adiposa and their anticancer effects on hepatic carcinoma. Drug Deliv 2022;29:997-1006. [PMID: 35363110 DOI: 10.1080/10717544.2022.2056664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
838 Shen YJ, Qian LQ, Ding ZP, Luo QQ, Zhao H, Xia WY, Fu YY, Feng W, Zhang Q, Yu W, Cai XW, Fu XL. Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection. Front Oncol 2021;11:711206. [PMID: 34540678 DOI: 10.3389/fonc.2021.711206] [Reference Citation Analysis]
839 Kong W, Liu Z, Sun M, Liu H, Kong C, Ma J, Wang R, Qian F. Synergistic autophagy blockade and VDR signaling activation enhance stellate cell reprogramming in pancreatic ductal adenocarcinoma. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215718] [Reference Citation Analysis]
840 Kang J, La Manna F, Bonollo F, Sampson N, Alberts I, Mingels C, Afshar-oromieh A, Thalmann GN, Karkampouna S. Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.01.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
841 Choi SS, Kim SE, Oh SY, Ahn Y. Clinical Implications of Circulating Circular RNAs in Lung Cancer. Biomedicines 2022;10:871. [DOI: 10.3390/biomedicines10040871] [Reference Citation Analysis]
842 Carter ME, Koch A, Lauer UM, Hartkopf AD. Clinical Trials of Oncolytic Viruses in Breast Cancer. Front Oncol 2021;11:803050. [PMID: 35004328 DOI: 10.3389/fonc.2021.803050] [Reference Citation Analysis]
843 Liliac IM, Ungureanu BS, Mărgăritescu C, Sacerdoțianu VM, Săftoiu A, Mogoantă L, Moraru E, Pirici D. E-Cadherin Modulation and Inter-Cellular Trafficking in Tubular Gastric Adenocarcinoma: A High-Resolution Microscopy Pilot Study. Biomedicines 2022;10:349. [DOI: 10.3390/biomedicines10020349] [Reference Citation Analysis]
844 Guo Y, Chen Y, Zhang L, Ma L, Jiang K, Yao G, Zhu L, Li X. TERT Promoter Mutations and Telomerase in Melanoma. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/6300329] [Reference Citation Analysis]
845 Yang X, Li M, Peng Q, Huang J, Liu L, Li P, Shu C, Hu X, Fang J, Ye F, Zhu W. Label-free detection of living cervical cells based on microfluidic device with terahertz spectroscopy. J Biophotonics 2021;:e202100241. [PMID: 34704671 DOI: 10.1002/jbio.202100241] [Reference Citation Analysis]
846 Xin S, Deng Y, Mao J, Wang T, Liu J, Wang S, Song X, Song W, Liu X. Characterization of 7-Methylguanosine Identified Biochemical Recurrence and Tumor Immune Microenvironment in Prostate Cancer. Front Oncol 2022;12:900203. [PMID: 35677157 DOI: 10.3389/fonc.2022.900203] [Reference Citation Analysis]
847 Szeto CH, Shalata W, Yakobson A, Agbarya A. Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and Future. J Clin Med 2021;10:5614. [PMID: 34884316 DOI: 10.3390/jcm10235614] [Reference Citation Analysis]
848 Mo A, Velten C, Jiang JM, Tang J, Ohri N, Kalnicki S, Mirhaji P, Nemoto K, Aasman B, Garg M, Guha C, Brodin NP, Kabarriti R. Improving Adjuvant Liver-Directed Treatment Recommendations for Unresectable Hepatocellular Carcinoma: An Artificial Intelligence-Based Decision-Making Tool. JCO Clin Cancer Inform 2022;6:e2200024. [PMID: 35671414 DOI: 10.1200/CCI.22.00024] [Reference Citation Analysis]
849 Zhu D, Wang J, Marjanovic M, Chaney EJ, Cradock KA, Higham AM, Liu ZG, Gao Z, Boppart SA. Differentiation of breast tissue types for surgical margin assessment using machine learning and polarization-sensitive optical coherence tomography. Biomed Opt Express 2021;12:3021-36. [PMID: 34168912 DOI: 10.1364/BOE.423026] [Reference Citation Analysis]
850 Lotz M, Ghebremichael M, Chervinsky K, Zorc T, Brenner C, Bousvaros G, Pories SE. Effective Surveillance of High-Risk Women. Clin Breast Cancer 2021:S1526-8209(21)00200-7. [PMID: 34429241 DOI: 10.1016/j.clbc.2021.07.014] [Reference Citation Analysis]
851 Nobuhara H, Matsugu Y, Tanaka J, Akita T, Ito K. The preventive effects of perioperative oral care on surgical site infections after pancreatic cancer surgery: a retrospective study. Support Care Cancer 2022;30:3337-44. [PMID: 34988706 DOI: 10.1007/s00520-021-06791-9] [Reference Citation Analysis]
852 Zhu R, Tu Y, Chang J, Xu H, Li JC, Liu W, Do AD, Zhang Y, Wang J, Li B. The Orphan Nuclear Receptor Gene NR0B2 Is a Favorite Prognosis Factor Modulated by Multiple Cellular Signal Pathways in Human Liver Cancers. Front Oncol 2021;11:691199. [PMID: 34055653 DOI: 10.3389/fonc.2021.691199] [Reference Citation Analysis]
853 Orlandella FM, Auletta L, Greco A, Zannetti A, Salvatore G. Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review. Cancers (Basel) 2021;13:6020. [PMID: 34885130 DOI: 10.3390/cancers13236020] [Reference Citation Analysis]
854 Park JH, Lee HK. Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy. Cancers (Basel) 2022;14:1176. [PMID: 35267480 DOI: 10.3390/cancers14051176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
855 Perez SJLP, Fu CW, Li WS. Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives. Molecules 2021;26:5673. [PMID: 34577144 DOI: 10.3390/molecules26185673] [Reference Citation Analysis]
856 Cho E, Dietrich MS, Friedman DL, Gilmer MJ, Gerhardt CA, Given BA, Hendricks-Ferguson VL, Hinds PS, Akard TF. Effects of a Web-Based Pediatric Oncology Legacy Intervention on the Coping of Children With Cancer. Am J Hosp Palliat Care 2022;:10499091221100809. [PMID: 35535490 DOI: 10.1177/10499091221100809] [Reference Citation Analysis]
857 Hu P, Zhang X, Li Y, Xu L, Qiu H. Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration. Front Genet 2022;13:882794. [PMID: 35873458 DOI: 10.3389/fgene.2022.882794] [Reference Citation Analysis]
858 Reyes-González JM, Vivas-Mejía PE. c-MYC and Epithelial Ovarian Cancer. Front Oncol 2021;11:601512. [PMID: 33718147 DOI: 10.3389/fonc.2021.601512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
859 Petrovic LZ, Oumano M, Hanlon J, Arnoldussen M, Koruga I, Yasmin-karim S, Ngwa W, Celli J. Image-Based Quantification of Gold Nanoparticle Uptake and Localization in 3D Tumor Models to Inform Radiosensitization Schedule. Pharmaceutics 2022;14:667. [DOI: 10.3390/pharmaceutics14030667] [Reference Citation Analysis]
860 Han N, Li LG, Peng XC, Ma QL, Yang ZY, Wang XY, Li J, Li QR, Yu TT, Xu HZ, Xu X, Chen X, Wang MF, Li TF. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy by inhibiting GPX4 and enhancing ROS. Eur J Pharmacol 2022;:174797. [PMID: 35122867 DOI: 10.1016/j.ejphar.2022.174797] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
861 Ristau J, Hörner-rieber J, Buchele C, Klüter S, Jäkel C, Baumann L, Andratschke N, Garcia Schüler H, Guckenberger M, Li M, Niyazi M, Belka C, Herfarth K, Debus J, Koerber SA. Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial. Radiat Oncol 2022;17. [DOI: 10.1186/s13014-022-02047-w] [Reference Citation Analysis]
862 Li Q, Nie F, Yang D, Dong T, Liu T, Wang Y. Role of Contrast-Enhanced Ultrasound in Pulmonary Lesions: 5-Year Experience at a Single Center. Ultrasound Med Biol 2022;48:257-64. [PMID: 34819236 DOI: 10.1016/j.ultrasmedbio.2021.10.015] [Reference Citation Analysis]
863 Zou Z, Liu R, Liang Y, Zhou R, Dai Q, Han Z, Jiang M, Zhuo Y, Zhang Y, Feng Y, Zhu X, Cai S, Lin J, Tang Z, Zhong W, Liang Y. Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer. Front Genet 2021;12:703210. [PMID: 34484299 DOI: 10.3389/fgene.2021.703210] [Reference Citation Analysis]
864 Tang YL, Li GS, Li DM, Tang D, Huang JZ, Feng H, He RQ, Huang ZG, Dang YW, Kong JL, Gan TQ, Zhou HF, Zeng JJ, Chen G. The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer. BMC Pulm Med 2022;22:300. [PMID: 35927660 DOI: 10.1186/s12890-022-02095-8] [Reference Citation Analysis]
865 Sanches SM, Braun AC, Calsavara VF, Barbosa PNVP, Chinen LTD. Comparison of hormonal receptor expression and HER2 status between circulating tumor cells and breast cancer metastases. Clinics (Sao Paulo) 2021;76:e2971. [PMID: 34644733 DOI: 10.6061/clinics/2021/e2971] [Reference Citation Analysis]
866 Da Rosa RB, Borsoi G, Conter LU, Feistel C, Gottems AL, Reginatto FH, Grivicich I, De Barros Falcão Ferraz A. Bioguided isolation of a selective compound from Calea phyllolepis leaves against breast cancer cells. Basic Clin Pharmacol Toxicol 2021. [PMID: 34605186 DOI: 10.1111/bcpt.13664] [Reference Citation Analysis]
867 Chang SH, Patel N, Du M, Liang PS. Trends in Early-onset vs Late-onset Colorectal Cancer Incidence by Race/Ethnicity in the United States Cancer Statistics Database. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00817-X. [PMID: 34325062 DOI: 10.1016/j.cgh.2021.07.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
868 Xiao ZM, Lv DJ, Yu YZ, Wang C, Xie T, Wang T, Song XL, Zhao SC. SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer. Front Cell Dev Biol 2021;9:678967. [PMID: 34249931 DOI: 10.3389/fcell.2021.678967] [Reference Citation Analysis]
869 Warren BR, Grandis JR, Johnson DE, Villa A. Head and Neck Cancer among American Indian and Alaska Native Populations in California, 2009-2018. Cancers (Basel) 2021;13:5195. [PMID: 34680342 DOI: 10.3390/cancers13205195] [Reference Citation Analysis]
870 Ju X, Tang Y, Qu R, Hao S. The Emerging Role of Circ-SHPRH in Cancer. Onco Targets Ther 2021;14:4177-88. [PMID: 34285509 DOI: 10.2147/OTT.S317403] [Reference Citation Analysis]
871 Pekmezi DW, Crane TE, Oster RA, Rogers LQ, Hoenemeyer T, Farrell D, Cole WW, Wolin K, Badr H, Demark-Wahnefried W. Rationale and Methods for a Randomized Controlled Trial of a Dyadic, Web-Based, Weight Loss Intervention among Cancer Survivors and Partners: The DUET Study. Nutrients 2021;13:3472. [PMID: 34684474 DOI: 10.3390/nu13103472] [Reference Citation Analysis]
872 Luo G, Feng R, Li W, Chen Y, Sun Y, Ma J, Duo Y, Wen T. Dcf1 induces glioblastoma cells apoptosis by blocking autophagy. Cancer Med 2021. [PMID: 34799992 DOI: 10.1002/cam4.4440] [Reference Citation Analysis]
873 Gan K, Gao Y, Liu K, Xu B, Qin W. The Clinical Significance and Prognostic Value of HER2 Expression in Bladder Cancer: A Meta-Analysis and a Bioinformatic Analysis. Front Oncol 2021;11:653491. [PMID: 34540657 DOI: 10.3389/fonc.2021.653491] [Reference Citation Analysis]
874 Hu Y, Zheng M, Zhang D, Gou R, Liu O, Wang S, Lin B. Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data. Cancer Cell Int 2021;21:516. [PMID: 34565373 DOI: 10.1186/s12935-021-02215-0] [Reference Citation Analysis]
875 Ni X, Chen C, Cui G, Ding W, Liu J. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer. Front Immunol 2022;13:932876. [DOI: 10.3389/fimmu.2022.932876] [Reference Citation Analysis]
876 Nunes MDR, Jacob E, Lopes-júnior LC, Leite ACAB, Lima RAGD, Nascimento LC. Qualidade de vida da população infantojuvenil oncológica com e sem fadiga. Acta Paulista de Enfermagem 2022;35:eAPE0288345. [DOI: 10.37689/acta-ape/2022ao0288345] [Reference Citation Analysis]
877 Ulucan-karnak F, Akgöl S. A New Nanomaterial Based Biosensor for MUC1 Biomarker Detection in Early Diagnosis, Tumor Progression and Treatment of Cancer. Nanomanufacturing 2021;1:14-38. [DOI: 10.3390/nanomanufacturing1010003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
878 Keating NL, Cleveland JLF, Wright AA, Brooks GA, Meneades L, Riedel L, Zubizarreta JR, Landrum MB. Evaluation of Reliability and Correlations of Quality Measures in Cancer Care. JAMA Netw Open 2021;4:e212474. [PMID: 33749769 DOI: 10.1001/jamanetworkopen.2021.2474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
879 Yu M, Qian XX, Li G, Cheng Z, Lin Z. Prognostic biomarker IL17A correlated with immune infiltrates in head and neck cancer. World J Surg Oncol 2022;20:243. [PMID: 35902909 DOI: 10.1186/s12957-022-02703-1] [Reference Citation Analysis]
880 Afrin H, Salazar CJ, Kazi M, Ahamad SR, Alharbi M, Nurunnabi M. Methods of screening, monitoring and management of cardiac toxicity induced by chemotherapeutics. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.01.011] [Reference Citation Analysis]
881 Deng H, Hang Q, Shen D, Zhang Y, Chen M. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation. Cancer Cell Int 2021;21:259. [PMID: 33980221 DOI: 10.1186/s12935-021-01933-9] [Reference Citation Analysis]
882 Zhang Z, Ghosh A, Connolly PJ, King P, Wilde T, Wang J, Dong Y, Li X, Liao D, Chen H, Tian G, Suarez J, Bonnette WG, Pande V, Diloreto KA, Shi Y, Patel S, Pietrak B, Szewczuk L, Sensenhauser C, Dallas S, Edwards JP, Bachman KE, Evans DC. Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer. J Med Chem 2021;64:11570-96. [PMID: 34279934 DOI: 10.1021/acs.jmedchem.1c00890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
883 Kaur J, Singh RR, Khan E, Kumar A, Joshi A. Piperine-Loaded PLGA Nanoparticles as Cancer Drug Carriers. ACS Appl Nano Mater 2021;4:14197-207. [DOI: 10.1021/acsanm.1c03664] [Reference Citation Analysis]
884 Wu J, Xie RY, Cao CZ, Shang BQ, Shi HZ, Shou JZ. Disease Management of Clinical Complete Responders to Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer: A Review of Literature. Front Oncol 2022;12:816444. [PMID: 35494010 DOI: 10.3389/fonc.2022.816444] [Reference Citation Analysis]
885 Chahin M, Branham Z, Fox A, Leurinda C, Keruakous AR. Clinical Considerations for Immunoparesis in Multiple Myeloma. Cancers 2022;14:2278. [DOI: 10.3390/cancers14092278] [Reference Citation Analysis]
886 Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Boormans JL, Eckstein M, Mertens LS, Boevé ER, Neuzillet Y, Burger M, Pouessel D, Trombetta C, Wullich B, van der Kwast TH, Hartmann A, Allory Y, Lotan Y, Shariat SF, Zuiverloon TCM, Mir MC, van Rhijn BWG. Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival. World J Urol 2021. [PMID: 34196758 DOI: 10.1007/s00345-021-03776-5] [Reference Citation Analysis]
887 Mohammad Mirzaei N, Tatarova Z, Hao W, Changizi N, Asadpoure A, Zervantonakis IK, Hu Y, Chang YH, Shahriyari L. A PDE Model of Breast Tumor Progression in MMTV-PyMT Mice. JPM 2022;12:807. [DOI: 10.3390/jpm12050807] [Reference Citation Analysis]
888 Catalani E, Giovarelli M, Zecchini S, Perrotta C, Cervia D. Oxidative Stress and Autophagy as Key Targets in Melanoma Cell Fate. Cancers (Basel) 2021;13:5791. [PMID: 34830947 DOI: 10.3390/cancers13225791] [Reference Citation Analysis]
889 Tawfeeq N, Jin Y, Lamango NS. Synthetic Optimization and MAPK Pathway Activation Anticancer Mechanism of Polyisoprenylated Cysteinyl Amide Inhibitors. Cancers (Basel) 2021;13:5757. [PMID: 34830912 DOI: 10.3390/cancers13225757] [Reference Citation Analysis]
890 Bustos MA, Hoon DSB. Prognostic Utility of CpG Island Hypermethylated Phenotype in Early-Stage Invasive Primary Melanomas. J Invest Dermatol 2022;142:1770-2. [PMID: 35031134 DOI: 10.1016/j.jid.2021.12.013] [Reference Citation Analysis]
891 Noe O, Filipiak L, Royfman R, Campbell A, Lin L, Hamouda D, Stanbery L, Nemunaitis J. Adenomatous polyposis coli in cancer and therapeutic implications. Oncol Rev 2021;15:534. [PMID: 34267890 DOI: 10.4081/oncol.2021.534] [Reference Citation Analysis]
892 Alrawashdh N, Mcbride A, Erstad B, Sweasy J, Persky DO, Abraham I. Cost-Effectiveness and Economic Burden Analyses on all First-Line Treatments of Chronic Lymphocytic Leukemia. Value in Health 2022. [DOI: 10.1016/j.jval.2022.04.001] [Reference Citation Analysis]
893 Winters-Stone KM, Lyons KS, Beer TM, Skiba MB, Hung A. A pilot feasibility study of Exercising Together© during radiation therapy for prostate cancer: a dyadic approach for patients and spouses. Pilot Feasibility Stud 2021;7:216. [PMID: 34879873 DOI: 10.1186/s40814-021-00952-7] [Reference Citation Analysis]
894 Zheng X, Gao Y, Yu C, Fan G, Li P, Zhang M, Yu J, Xu M. Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy. Sci Rep 2021;11:19432. [PMID: 34593914 DOI: 10.1038/s41598-021-98966-x] [Reference Citation Analysis]
895 Stieg DC, Wang Y, Liu LZ, Jiang BH. ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance. Int J Mol Sci 2022;23:6702. [PMID: 35743145 DOI: 10.3390/ijms23126702] [Reference Citation Analysis]
896 Samson N, Khanolkar RA, Quirk S, Quon H, Roumeliotis M, Balogh A, Sia M, Thind K, Husain S, Martell K. Clinical Outcomes from Dose-Reduced Radiotherapy to the Prostate in Elderly Patients with Localized Prostate Cancer. Curr Oncol 2021;28:3729-37. [PMID: 34677236 DOI: 10.3390/curroncol28050318] [Reference Citation Analysis]
897 Chang Y, Wang Y, Li B, Lu X, Wang R, Li H, Yan B, Gu A, Wang W, Huang A, Wu S, Li R. Whole-Exome Sequencing on Circulating Tumor Cells Explores Platinum-Drug Resistance Mutations in Advanced Non-small Cell Lung Cancer. Front Genet 2021;12:722078. [PMID: 34616428 DOI: 10.3389/fgene.2021.722078] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
898 Fitzgerald B, Connolly KA, Cui C, Fagerberg E, Mariuzza DL, Hornick NI, Foster GG, William I, Cheung JF, Joshi NS. A mouse model for the study of anti-tumor T cell responses in Kras-driven lung adenocarcinoma. Cell Rep Methods 2021;1:100080. [PMID: 34632444 DOI: 10.1016/j.crmeth.2021.100080] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
899 Huang D, Wang G, Ke Z, Zhou Y, Yang H, Ma T, Guan C. Megakaryocytes in pulmonary diseases. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120602] [Reference Citation Analysis]
900 Huang J, Zhou M, Zhang H, Fang Y, Chen G, Wen J, Liu L. Characterization of the mechanism of Scutellaria baicalensis on reversing radio-resistance in colorectal cancer. Transl Oncol 2022;24:101488. [PMID: 35872478 DOI: 10.1016/j.tranon.2022.101488] [Reference Citation Analysis]
901 Liu Y, Huang J, Zhang Z, Huang Y, Du J, Wang S, Wu Z. Ultrasonic Characteristics Improve Prediction of Central Lymph Node Metastasis in cN0 Unifocal Papillary Thyroid Cancer. Front Endocrinol 2022;13:870813. [DOI: 10.3389/fendo.2022.870813] [Reference Citation Analysis]
902 Randhawa G, Jb D, Kaur K. Exophytic Mass Around the Tip of the Nose: Unusual Presentation of Metastatic Renal Cell Carcinoma. Cureus. [DOI: 10.7759/cureus.23113] [Reference Citation Analysis]
903 Song X, Chen B, Liang Y, Li Y, Zhang H, Han D, Wang Y, Ye F, Wang L, Zhao W, Yang Q. CircEIF3H-IGF2BP2-HuR scaffold complex promotes TNBC progression via stabilizing HSPD1/RBM8A/G3BP1 mRNA. Cell Death Discov 2022;8:261. [PMID: 35568705 DOI: 10.1038/s41420-022-01055-9] [Reference Citation Analysis]
904 Wang C, Sandhu J, Tsao A, Fakih M. Presence of Concurrent TP53 Mutations Is Necessary to Predict Poor Outcomes within the SMAD4 Mutated Subgroup of Metastatic Colorectal Cancer. Cancers (Basel) 2022;14:3644. [PMID: 35892903 DOI: 10.3390/cancers14153644] [Reference Citation Analysis]
905 Ming H, Li B, Tian H, Zhou L, Jiang J, Zhang T, Qiao L, Wu P, Nice EC, Zhang W, He W, Huang C, Zhang H. A minimalist and robust chemo-photothermal nanoplatform capable of augmenting autophagy-modulated immune response against breast cancer. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
906 Ma C, Ma RJ, Hu K, Zheng QM, Wang YP, Zhang N, Sun ZG. The molecular mechanism of METTL3 promoting the malignant progression of lung cancer. Cancer Cell Int 2022;22:133. [PMID: 35331234 DOI: 10.1186/s12935-022-02539-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
907 Ruan Y, Chen L, Xie D, Luo T, Xu Y, Ye T, Chen X, Feng X, Wu X. Mechanisms of Cell Adhesion Molecules in Endocrine-Related Cancers: A Concise Outlook. Front Endocrinol 2022;13:865436. [DOI: 10.3389/fendo.2022.865436] [Reference Citation Analysis]
908 Guo L, Luo X, Yang P, Zhang Y, Huang J, Wang H, Guo Y, Huang W, Chen Z, Wang S, Wang J, Lei J, Xiang S, Liu Y. Ilicicolin A Exerts Antitumor Effect in Castration-Resistant Prostate Cancer Via Suppressing EZH2 Signaling Pathway. Front Pharmacol 2021;12:723729. [PMID: 34776951 DOI: 10.3389/fphar.2021.723729] [Reference Citation Analysis]
909 Tang Y, Chen Y, Zhang Z, Tang B, Zhou Z, Chen H. Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective. Pharmaceutics 2021;13:2116. [PMID: 34959397 DOI: 10.3390/pharmaceutics13122116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
910 Lengyel CG, Hussain S, Seeber A, Jamil Nidhamalddin S, Trapani D, Habeeb BS, Elfaham E, Mazher SA, Seid F, Khan SZ, El Bairi K, Odhiambo A, Altuna SC, Petrillo A. FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target? Life (Basel) 2022;12:81. [PMID: 35054474 DOI: 10.3390/life12010081] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
911 Saini S, Pathak RA, Hemal AK. Robotic nephroureterectomy in the management of upper tract urothelial cancer: inching toward standard of care? Int Urol Nephrol 2022. [PMID: 35610528 DOI: 10.1007/s11255-022-03225-1] [Reference Citation Analysis]
912 Liu Y, He X, Zou J, Ouyang X, Huang C, Yang X, Wang Y. Detection of Carbohydrate Antigen 50 Based on a Novel Miniaturized Chemiluminescence Analyzer Enables Large-Scale Cancer Early Screening in Grassroots Community. Front Bioeng Biotechnol 2022;10:920972. [DOI: 10.3389/fbioe.2022.920972] [Reference Citation Analysis]
913 Ma X, Ren X, Ma F, Cai S, Ning C, Liu J, Chen X, Zhang G, Qiang J. Volumetric apparent diffusion coefficient (ADC) histogram metrics as imaging biomarkers for pretreatment predicting response to fertility-sparing treatment in patients with endometrial cancer. Gynecol Oncol 2022:S0090-8258(22)00249-9. [PMID: 35469683 DOI: 10.1016/j.ygyno.2022.04.008] [Reference Citation Analysis]
914 Wei R, Zhang H, Cao J, Qin D, Li S, Deng W. Sample-Specific Perturbation of Gene Interactions Identifies Pancreatic Cancer Subtypes. Int J Mol Sci 2022;23:4792. [PMID: 35563183 DOI: 10.3390/ijms23094792] [Reference Citation Analysis]
915 Tahir N, Ram A, Jain N, Vemireddy LP, Zahra F. Leptomeningeal Carcinomatosis in Epithelial Ovarian Cancer: A Diagnostic Challenge. Cureus 2021;13:e14440. [PMID: 33996304 DOI: 10.7759/cureus.14440] [Reference Citation Analysis]
916 Spitzner M, Emons G, Schütz KB, Wolff HA, Rieken S, Ghadimi BM, Schneider G, Grade M. Inhibition of Wnt/β-Catenin Signaling Sensitizes Esophageal Cancer Cells to Chemoradiotherapy. Int J Mol Sci 2021;22:10301. [PMID: 34638639 DOI: 10.3390/ijms221910301] [Reference Citation Analysis]
917 Wang CX, Wang TT, Zhang KD, Li MY, Shen QC, Lu SY, Zhang J. Pan-KRAS inhibitors suppress proliferation through feedback regulation in pancreatic ductal adenocarcinoma. Acta Pharmacol Sin 2022. [PMID: 35352018 DOI: 10.1038/s41401-022-00897-4] [Reference Citation Analysis]
918 Shi Y, Wang X, Meng Y, Ma J, Zhang Q, Shao G, Wang L, Cheng X, Hong X, Wang Y, Yan Z, Cao Y, Kang J, Fu C. A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer. Adv Sci (Weinh) 2021;8:e2101936. [PMID: 34605226 DOI: 10.1002/advs.202101936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
919 Yan J, Yu X, Chen X, Liu F, Chen F, Ding N, Yu L, Meng F, Shen J, Wei J, Liu B. Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma. Front Oncol 2021;11:679336. [PMID: 34150644 DOI: 10.3389/fonc.2021.679336] [Reference Citation Analysis]
920 You MH, Lee WK, Jin M, Song DE, Cheng SY, Kim TY, Kim WB, Jeon MJ, Kim WG. Death-Associated Protein Kinase 1 Inhibits Progression of Thyroid Cancer by Regulating Stem Cell Markers. Cells 2021;10:2994. [PMID: 34831219 DOI: 10.3390/cells10112994] [Reference Citation Analysis]
921 Fang C, Liang Y, Huang Y, Jiang D, Li J, Ma H, Guo L, Jiang W, Feng Y. P3H4 Promotes Malignant Progression of Lung Adenocarcinoma via Interaction with EGFR. Cancers 2022;14:3243. [DOI: 10.3390/cancers14133243] [Reference Citation Analysis]
922 Zhang T, Kephart J, Bronson E, Anand M, Daly C, Spasojevic I, Bakthavatsalam S, Franz K, Berg H, Karachaliou GS, James OG, Howard L, Halabi S, Harrison MR, Armstrong AJ, George DJ. Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer. Prostate 2022. [PMID: 35286730 DOI: 10.1002/pros.24329] [Reference Citation Analysis]
923 Auger N, Marcoux S, Bégin P, Lewin A, Lee GE, Healy-Profitós J, Luu TM. Matched cohort study of hospitalization in children who have siblings with cancer. Cancer 2022. [PMID: 35100438 DOI: 10.1002/cncr.34115] [Reference Citation Analysis]
924 Xu Q, Guo T. Somatic mutation-associated risk index based on lncRNA expression for predicting prognosis in acute myeloid leukemia. Hematology 2022;27:659-71. [PMID: 35666642 DOI: 10.1080/16078454.2022.2056677] [Reference Citation Analysis]
925 Zhang Y, Liu Q, Zhang X, Huang H, Tang S, Chai Y, Xu Z, Li M, Chen X, Liu J, Yang C. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. J Nanobiotechnology 2022;20:279. [PMID: 35701788 DOI: 10.1186/s12951-022-01472-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
926 Wu J, He X, Xiong Z, Shi L, Chen D, Feng Y, Wen Q. Bruceine H Mediates EGFR-TKI Drug Persistence in NSCLC by Notch3-Dependent β-Catenin Activating FOXO3a Signaling. Front Oncol 2022;12:855603. [PMID: 35463301 DOI: 10.3389/fonc.2022.855603] [Reference Citation Analysis]
927 Yuan J, Jiang X, Lan H, Zhang X, Ding T, Yang F, Zeng D, Yong J, Niu B, Xiao S. Multi-Omics Analysis of the Therapeutic Value of MAL2 Based on Data Mining in Human Cancers. Front Cell Dev Biol 2022;9:736649. [DOI: 10.3389/fcell.2021.736649] [Reference Citation Analysis]
928 Li X, Li K, Li M, Lin X, Mei Y, Huang X, Yang H. Chemoresistance Transmission via Exosome-Transferred MMP14 in Pancreatic Cancer. Front Oncol 2022;12:844648. [PMID: 35223528 DOI: 10.3389/fonc.2022.844648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
929 Sasaki T, Nishiwada S, Nakagawa K, Nagai M, Terai T, Hokuto D, Yasuda S, Matsuo Y, Doi S, Sho M. Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer. Int J Clin Oncol 2022. [PMID: 35142963 DOI: 10.1007/s10147-022-02131-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
930 Costa GJ, de Azevedo CRAS, Júnior JIC, Bergmann A, Thuler LCS. Higher severity and risk of in-hospital mortality for COVID-19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data. Cancer 2021. [PMID: 34343344 DOI: 10.1002/cncr.33832] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
931 Liu D, Xu Y, Fang Y, Hu K. Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer. Front Genet 2022;13:885553. [DOI: 10.3389/fgene.2022.885553] [Reference Citation Analysis]
932 González-Borja I, Alors-Pérez E, Amat I, Alonso L, Viyuela-García C, Goñi S, Reyes JC, Ceballos-Chávez M, Hernández-García I, Sánchez-Frías ME, Santamaría E, Razquin S, Arjona-Sánchez Á, Arrazubi V, Pérez-Sanz J, Vera R, Fernández-Irigoyen J, Castaño JP, Viúdez A. Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. Front Med (Lausanne) 2021;8:720128. [PMID: 34869418 DOI: 10.3389/fmed.2021.720128] [Reference Citation Analysis]
933 Rao H, Zhou S, Mei A, Yao A, Xie S. Advanced age is not the decisive factor in chemotherapy of small cell lung cancer: a population-based study. Aging (Albany NY) 2022;14:4827-38. [PMID: 35680571 DOI: 10.18632/aging.204114] [Reference Citation Analysis]
934 Xiao C, Miller AH, Peng G, Levine ME, Conneely KN, Zhao H, Eldridge RC, Wommack EC, Jeon S, Higgins KA, Shin DM, Saba NF, Smith AK, Burtness B, Park HS, Irwin ML, Ferrucci LM, Ulrich B, Qian DC, Beitler JJ, Bruner DW. Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck Cancer. Int J Radiat Oncol Biol Phys 2021;111:157-67. [PMID: 33882281 DOI: 10.1016/j.ijrobp.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
935 Lim SA, Hao SB, Boyd BA, Mitsakos A, Irish W, Burke AM, Parikh AA, Snyder RA. Opportunity Costs of Surgical Resection and Perioperative Chemotherapy for Locoregional Pancreatic Adenocarcinoma. JCO Oncol Pract 2021;:OP2100311. [PMID: 34709961 DOI: 10.1200/OP.21.00311] [Reference Citation Analysis]
936 You Q, Wang J, Yu Y, Li F, Meng L, Chen M, Yang Q, Xu Z, Sun J, Zhuo W, Chen Z. The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer. Apoptosis 2022. [PMID: 35915188 DOI: 10.1007/s10495-022-01751-y] [Reference Citation Analysis]
937 Kasius JC, Pijnenborg JMA, Lindemann K, Forsse D, van Zwol J, Kristensen GB, Krakstad C, Werner HMJ, Amant F. Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification. Cancers (Basel) 2021;13:5848. [PMID: 34831000 DOI: 10.3390/cancers13225848] [Reference Citation Analysis]
938 Yepes AF, Arias JD, Cardona-g W, Herrera-r A, Moreno G. New class of hybrids based on chalcone and melatonin: a promising therapeutic option for the treatment of colorectal cancer. Med Chem Res 2021;30:2240-55. [DOI: 10.1007/s00044-021-02805-7] [Reference Citation Analysis]
939 Meng H, Chen Y, Yu M, Wang X. Effectiveness of intervention for aromatase inhibitor-associated musculoskeletal symptoms: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e28982. [PMID: 35451389 DOI: 10.1097/MD.0000000000028982] [Reference Citation Analysis]
940 Liu L, Wang C, Li S, Bai H, Wang J. Tumor immune microenvironment in epidermal growth factor receptor-mutated non-small cell lung cancer before and after epidermal growth factor receptor tyrosine kinase inhibitor treatment: a narrative review. Transl Lung Cancer Res 2021;10:3823-39. [PMID: 34733631 DOI: 10.21037/tlcr-21-572] [Reference Citation Analysis]
941 Kanda T, Wakiya T, Ishido K, Kimura N, Fujita H, Yoshizawa T, Goto S, Tatara Y, Kijima H, Hakamada K. Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas. J Gastroenterol 2022. [PMID: 35780404 DOI: 10.1007/s00535-022-01898-0] [Reference Citation Analysis]
942 Xu X, Li X, Zhou J, Wang J. Mechanical Stimulus-Related Risk Signature Plays a Key Role in the Prognostic Nomogram For Endometrial Cancer. Front Oncol 2021;11:753910. [PMID: 34692538 DOI: 10.3389/fonc.2021.753910] [Reference Citation Analysis]
943 De Kesel J, Fijalkowski I, Taylor J, Ntziachristos P. Splicing dysregulation in human hematologic malignancies: beyond splicing mutations. Trends Immunol 2022;43:674-86. [PMID: 35850914 DOI: 10.1016/j.it.2022.06.006] [Reference Citation Analysis]
944 Hawranko R, Sohn JJ, Neiderer K, Bump E, Harris T, Fields EC, Weiss E, Song WY. Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer. J Clin Med 2022;11:2584. [PMID: 35566712 DOI: 10.3390/jcm11092584] [Reference Citation Analysis]
945 Qiong L, Yin J. Orosomucoid 1 promotes epirubicin resistance in breast cancer by upregulating the expression of matrix metalloproteinases 2 and 9. Bioengineered 2021;12:8822-32. [PMID: 34654351 DOI: 10.1080/21655979.2021.1987067] [Reference Citation Analysis]
946 Zhang X, Cheng L, Lu Y, Tang J, Lv Q, Chen X, Chen Y, Liu J. A MXene-Based Bionic Cascaded-Enzyme Nanoreactor for Tumor Phototherapy/Enzyme Dynamic Therapy and Hypoxia-Activated Chemotherapy. Nanomicro Lett 2021;14:22. [PMID: 34882297 DOI: 10.1007/s40820-021-00761-w] [Reference Citation Analysis]
947 Papenberg BW, Ingles J, Gao S, Feng J, Allen JL, Markwell SM, Interval ET, Montague PA, Wen S, Weed SA. Copy number alterations identify a smoking-associated expression signature predictive of poor outcome in head and neck squamous cell carcinoma. Cancer Genet 2021;256-257:136-48. [PMID: 34130230 DOI: 10.1016/j.cancergen.2021.05.011] [Reference Citation Analysis]
948 Yang Y, Kannisto E, Patnaik SK, Reid ME, Li L, Wu Y. Ultrafast Detection of Exosomal RNAs via Cationic Lipoplex Nanoparticles in a Micromixer Biochip for Cancer Diagnosis. ACS Appl Nano Mater 2021;4:2806-19. [PMID: 34849458 DOI: 10.1021/acsanm.0c03426] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
949 Quinn CH, Beierle AM, Hutchins SC, Marayati R, Bownes LV, Stewart JE, Markert HR, Erwin MH, Aye JM, Yoon KJ, Friedman GK, Willey CD, Markert JM, Beierle EA. Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy. Cancers (Basel) 2022;14:762. [PMID: 35159029 DOI: 10.3390/cancers14030762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
950 Zhong G, Luo X, Li J, Liao Y, Gui G, Sheng J. MTRR rs1532268 polymorphism and gastric cancer risk: evidence from a meta-analysis. J Int Med Res 2022;50:3000605221097486. [PMID: 35579185 DOI: 10.1177/03000605221097486] [Reference Citation Analysis]
951 Xu J, Palestino Dominguez M, Alewine C. Loss of ID3 in pancreatic cancer cells increases DNA damage without impairing MDC1 recruitment to the nuclear foci. Cancer Commun (Lond) 2021. [PMID: 34877804 DOI: 10.1002/cac2.12243] [Reference Citation Analysis]
952 Xiao L, Zhang C, Li X, Jia C, Chen L, Yuan Y, Gao Q, Lu Z, Feng Y, Zhao R, Zhao X, Cheng S, Shu Z, Xu J, Duan W, Nie G, Hou Y. LEF1 Enhances the Progression of Colonic Adenocarcinoma via Remodeling the Cell Motility Associated Structures. Int J Mol Sci 2021;22:10870. [PMID: 34639214 DOI: 10.3390/ijms221910870] [Reference Citation Analysis]
953 Calatayud DG, Neophytou S, Nicodemou E, Giuffrida SG, Ge H, Pascu SI. Corrigendum: Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers. Front Chem 2022;10:919505. [DOI: 10.3389/fchem.2022.919505] [Reference Citation Analysis]
954 Carmack CL, Parker NH, Demark-Wahnefried W, Shely L, Baum G, Yuan Y, Giordano SH, Rodriguez-Bigas M, Pettaway C, Basen-Engquist K. Healthy Moves to Improve Lifestyle Behaviors of Cancer Survivors and Their Spouses: Feasibility and Preliminary Results of Intervention Efficacy. Nutrients 2021;13:4460. [PMID: 34960013 DOI: 10.3390/nu13124460] [Reference Citation Analysis]
955 Davis L, Isali I, Prunty M, Calaway A, Mishra K, Miller A, Pope R, Magee D, Bigalli AC, Thirumavalavan N, Ponsky L, Bukavina L. Female Sexual Function Following Radical Cystectomy in Bladder Cancer. Sex Med Rev 2022:S2050-0521(21)00090-1. [PMID: 34992003 DOI: 10.1016/j.sxmr.2021.10.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
956 Horst EN, Novak CM, Burkhard K, Snyder CS, Verma R, Crochran DE, Geza IA, Fermanich W, Mehta P, Schlautman DC, Tran LA, Brezenger ME, Mehta G. Injectable three-dimensional tumor microenvironments to study mechanobiology in ovarian cancer. Acta Biomater 2022;146:222-34. [PMID: 35487424 DOI: 10.1016/j.actbio.2022.04.039] [Reference Citation Analysis]
957 Mare M, Colarossi L